Blood Control Devices

The fluid control device uses negative pressure to isolate an initial volume of body fluid, addressing contamination issues and enhancing the accuracy of diagnostic tests by ensuring pure samples for analysis.

JP7579321B2Active Publication Date: 2024-11-07MAGNOLIA MEDICAL TECHNOLOGIES INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2022212405
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-05-31
Filing Date
2022-12-28
Publication Date
2024-11-07
Estimated Expiration
2038-09-12

AI Technical Summary

Technical Problem

Existing devices for obtaining body fluid samples are prone to contamination from microorganisms present on the skin and other external sources, leading to inaccurate diagnostic test results, including false positives and negatives, which can result in misdiagnosis, unnecessary treatments, and increased healthcare costs.

Method used

A fluid control device with a housing, flow controller, and fluid collection system that uses negative pressure to isolate an initial volume of body fluid, separating it from subsequent samples, thereby reducing contamination and ensuring the purity of the sample for diagnostic testing.

Benefits of technology

The device effectively isolates contaminants in the initial fluid volume, ensuring that subsequent samples are substantially free of external contaminants, thereby improving the accuracy and reliability of diagnostic tests and reducing the risk of false results.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007579321000001
    Figure 0007579321000001
  • Figure 0007579321000002
    Figure 0007579321000002
  • Figure 0007579321000003
    Figure 0007579321000003
Patent Text Reader

Abstract

A bodily fluid sample is obtained that is reduced in contaminants, such as microorganisms present on the skin and / or other contaminants external to the source of the bodily fluid. The fluid control device includes an inlet configured to be in fluid communication with a bodily fluid source, either directly or indirectly, and an outlet configured to be in fluid communication with a fluid collection device. The fluid control device has a first state in which a negative pressure differential generated from an external source, such as a fluid collection device, is applied to the fluid control device to draw an initial volume of bodily fluid from the bodily fluid source through the inlet and into an isolation portion of the fluid control device. The fluid control device has a second state in which (1) the isolation portion isolates the initial volume, and (2) the negative pressure differential draws a subsequent volume of substantially contaminant-free bodily fluid from the bodily fluid source through the fluid control device and into the fluid collection device.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to and the benefit of U.S. Provisional Patent Application No. 62 / 557,530, filed September 12, 2017, entitled "Fluid Control Devices and Methods of Using the Same," the disclosure of which is incorporated by reference in its entirety.

[0002] This application also claims priority to and the benefit of U.S. Provisional Patent Application No. 62 / 634,569, filed February 23, 2018, entitled "Fluid Control Devices and Methods of Using the Same," the disclosure of which is incorporated herein by reference in its entirety.

[0003] This application also claims priority to and the benefit of U.S. Provisional Patent Application No. 62 / 678,632, filed May 31, 2018, entitled "Fluid Control Devices and Methods of Using the Same," the disclosure of which is incorporated herein by reference in its entirety. [Background technology]

[0004] The present invention relates generally to parenteral acquisition of bodily fluid samples, and more particularly to fluid diversion, sequestration, and / or separation devices and methods for obtaining bodily fluid samples with reduced contaminants, such as microorganisms present on the skin and / or other contaminants external to the source of the bodily fluid.

[0005] Medical practitioners routinely perform various types of microbiological tests and a wide range of other diagnostic tests on patients using parenterally obtained bodily fluids. As advanced diagnostic technologies evolve and improve, the speed, accuracy (both sensitivity and specificity), and value of the information that can be provided to clinicians continue to increase. Maintaining the integrity of the bodily fluid sample during and / or after collection also ensures that analytical diagnostic results represent the patient's internal situation. Examples of diagnostic techniques that rely on high quality, uncontaminated, and / or pure bodily fluid samples include, but are not limited to, microbial detection, molecular diagnostics, gene sequencing (e.g., deoxyribonucleic acid (DNA), ribonucleic acid (RNA), next generation sequencing (NGS), etc.), biomarker identification, etc. Inaccurate test results can be derived when the bodily fluid sample to be analyzed is inadvertently contaminated with biological material and / or other external contaminants, which may include cells that are external to the source from which the sample is intended to be obtained. In short, when the purity of a sample intended to be taken or collected from a particular bodily fluid source is compromised during the specimen acquisition process, the resulting analytical test results may be inaccurate, abnormal, poor, false positive, false negative, and / or otherwise not representative of the patient's actual situation, thereby resulting in incomplete, inaccurate, messy, uncertain, unreliable, and / or otherwise undesirable clinical decision-making.

[0006] In some examples, a patient sample (e.g., a bodily fluid) is tested for the presence of one or more potentially undesirable microorganisms, such as bacteria, fungi, or yeasts (e.g., Candida). In some examples, the microbiological testing can include culturing the patient sample in one or more sterile and / or non-sterile vessels that can contain culture media, general additives, and / or other types of solutions that are conducive to the growth of microorganisms. In other examples, the sample in the vessel may be analyzed directly (i.e., not cultured) and may not contain culture media or additives associated with culturing the specimen. In still other examples, various technologies can be employed to aid in the detection of the presence of microorganisms and other types of biological material, specific types of cells, biomarkers, proteins, antigens, enzymes, blood components, and / or the like during diagnostic testing. Examples include, but are not limited to, molecular polymerase chain reaction (PCR), magnetic resonance and other magnetic analysis platforms, automated microscopy, spatial clonal separation, flow cytometry, whole blood ("non-cultured") specimen analysis (e.g., NGS) and related techniques, morphokinetic cell analysis, and / or other common or advanced sophisticated techniques utilized in clinical laboratory settings to characterize patient samples and / or detect, identify, type, classify, and / or characterize specific organisms, antibiotic susceptibility, and / or the like.

[0007] In some instances, detecting the presence of a microorganism involves allowing the microorganism and / or organism to grow for a period of time (e.g., a variable period of time from less than an hour to several hours to several days, which may be longer or shorter depending on the diagnostic technique employed). Growth of the microorganism and / or organism can then be detected by automated continuous monitoring and / or other methods specific to the analytical platform and technique used for detection, identification, and / or the like.

[0008] In a culture test, for example, when a microorganism is present in a patient sample, the microorganism reproduces over time in the culture medium, and in some instances, automated monitoring techniques can detect the carbon dioxide produced by the growth of the organism. The presence of the microorganism in the culture medium (indicated by observation of carbon dioxide and / or via other detection methods) is indicative of the presence of the same microorganism in the patient sample, and thereby in the patient's bodily fluid from which the sample was obtained. Thus, when the presence of a microorganism is identified in the culture medium (or, more generally, in the sample used for the test), the patient may be diagnosed and prescribed one or more antibiotics or other treatments specifically designed to treat or otherwise remove the undesirable microorganism from the patient.

[0009] However, patient samples may become contaminated during acquisition and / or may be susceptible to false positive or false negative results. For example, body surface microorganisms (e.g., skin-resident microorganisms) that are dislodged during the specimen acquisition process (which may include needle insertion into the patient, specimen acquisition via a lumen-containing device such as a peripheral intravenous catheter (PIV), peripherally inserted central catheter (PICC), and / or other indwelling catheter(s), collection with a syringe, or any other suitable means employed to collect a patient specimen) may then be transferred directly or indirectly via tissue flakes, hair follicles, sweat glands, and other skin appendage structures to a culture medium, test vial, or other suitable specimen collection or transfer vessel with the patient sample and / or included in the specimen to be analyzed in a non-culture-based test. Another possible source of contamination is from the person (doctor, phlebotomist, nurse, technician, etc.) taking the patient sample. In particular, the equipment, articles, and / or devices used during the patient sample acquisition process often include multiple fluid interfaces (such as, but not limited to, patient-to-needle, needle-to-transfer adapter, transfer adapter-to-sample vessel, catheter hub-to-syringe, syringe-to-transfer adapter, needle / tube-to-sample vessel, and / or any other fluid interface or any combination thereof) that may each introduce a potential contamination point. In some instances, such contaminants may grow in culture media and / or be identified by other non-culture based diagnostic techniques, ultimately resulting in false positive and / or false negative microbiological test results that may inaccurately reflect the presence or absence of such microorganisms within the patient (i.e., within the body).

[0010] Such inaccurate results due to contamination and / or other causes of adulteration that compromise sample purity are of concern when diagnosing or treating a wide range of suspected illnesses, diseases, infections, patient conditions, or other diseases of concern. For example, a false negative microbiology test result may result in a misdiagnosis of a patient's illness and / or delayed treatment, and in some cases, may result in the patient's death. Conversely, a false positive microbiology test result may result in a patient being unnecessarily subjected to one or more antimicrobial therapies, which may cause serious side effects to the patient, including, for example, death, and may result in unnecessary burdens and costs to the healthcare system due to extended patient hospital stays and / or other complications associated with incorrect treatment. Additionally, the use of diagnostic imaging equipment resulting from these false positive results is of concern from both a cost and patient safety standpoint, due to the many known adverse effects on long-term patient health from unnecessary exposure to radiation associated with various imaging procedures (e.g., CT scans).

[0011] In some examples, devices and / or systems can be used to reduce the likelihood of contamination, tampering, and / or the like of bodily fluid samples for testing. For example, some known devices can be configured to collect, divert, separate, and / or separate or isolate an initial volume of bodily fluid that may be more likely to contain contaminants, such as microorganisms present on the skin. However, some such devices may be perceived as cumbersome, confusing, difficult to use, inappropriate or unusable, etc., when considering the intended patient population, etc. In addition, some such devices may present issues that may require training, user supervision, intervention by multiple users, and / or may otherwise be limited in effectiveness based on differences including environmental, educational, clinician skills, patient situation, and / or the like. In some examples, such issues may complicate the collection of reliable, high-quality samples that are uncontaminated, sterile, uncontaminated, etc., thereby affecting the validity of the conclusions of the test results.

[0012] On the other hand, some known passive diversion devices and / or systems (e.g., systems that do not specifically utilize or rely on direct user intervention, interaction, manipulation, and / or the like) may be unable to adequately divert, isolate, and / or separate a clinically desirable and useful pre-test volume of bodily fluid due to clinical realities such as, for example, the time required to fill an isolation reservoir with a significant volume of fluid. In some instances, the operation of some known passive devices relies on a positive pressure applied by a bodily fluid source (e.g., the patient's blood pressure). However, the positive pressure applied by the bodily fluid source may be insufficient to generate sufficient flow forces and / or flow rates to make such devices practical for use in various clinical settings, including emergency rooms and other centralized settings. For example, symptomatic patient populations requiring the above-mentioned diagnostic tests typically have physical conditions that make vascular access and / or collection of bodily fluid samples difficult to achieve due to hypotensive states (i.e., low blood pressure), hypovolemic states (i.e., low blood volume), and / or other physical issues (e.g., severe dehydration, obesity, difficult and / or inaccessible vasculature, etc.). Such conditions or physical conditions may make it difficult to provide sufficient blood flow and / or pressure to reliably achieve passive filling of an isolation chamber, channel, reservoir, container (or other diverted volume) in a volume sufficient to meet clinically validated evidence-based validity, and to divert, isolate, and / or separate contaminants that may otherwise lead to abnormal, inaccurate, false positive, false negative, and / or otherwise contaminated diagnostic test results. Issues associated with this approach (e.g., not utilizing a specific external energy source and / or negative pressure, but relying on a positive pressure differential applied by the fluid source to facilitate collection of an adequate and clinically useful initial volume of fluid) may render this approach impractical for the frail patient population from which these samples are collected, as failure rates may be unacceptably high.

[0013] Thus, there is a need for fluid diversion devices and methods for obtaining bodily fluid samples with reduced contaminants, such as microorganisms present on the skin and / or other contaminants external to the source of the bodily fluid, that result in consistent collection of bodily fluids (e.g., from general and / or problem patient populations). Some such devices and methods can include, for example, bodily fluid collection with the assistance of various external energy sources and / or negative pressure. Furthermore, there is a need for such devices that are easy to use, demonstrate consistent efficacy, and address issues associated with collecting samples from patients with challenging health conditions and / or physical characteristics that impact their ability to collect bodily fluid samples. Summary of the Invention

[0014] Described herein are devices and methods for obtaining a bodily fluid sample with reduced contaminants, such as microorganisms present on the skin and / or other contaminants external to the bodily fluid source. In some embodiments, the system includes a housing, a flow controller, and a fluid collection device. The housing has an inlet and an outlet, forming an isolation portion. The inlet is configured to be in fluid communication with a source of bodily fluid. The isolation portion is configured to receive an initial volume of bodily fluid from the source of bodily fluid. The flow controller is at least partially disposed in the isolation portion of the housing and configured to transition from a first state to a second state. The fluid collection device is fluidly coupled to the outlet and configured to generate a negative pressure differential within at least a portion of the housing. The negative pressure differential is operable to draw an initial volume of bodily fluid into the isolation portion when the flow controller is in the first state, and is operable to draw a test volume of bodily fluid through the outlet and into the fluid collection device when the flow controller is in the second state. [Brief description of the drawings]

[0015] [Figure 1] 1 is a schematic diagram of a fluid control device, according to one embodiment. [Diagram 2] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 3] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 4] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 5] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 6] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 7] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 8] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 9] FIG. 2 is a front view of a fluid control device in a first mode of operation, according to one embodiment. [Figure 10] FIG. 2 is a front view of a fluid control device in a second mode of operation, according to one embodiment. [Figure 11] FIG. 2 is a front view of a fluid control device in a first mode of operation, according to one embodiment. [Figure 12] FIG. 2 is a front view of a fluid control device in a second mode of operation, according to one embodiment. [Figure 13] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 14] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 15A] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 15B] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 16] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 17A] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 17B] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 18] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 19]1A-1D are various views of a fluid control device, according to one embodiment. [Figure 20] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 21] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 22] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 23] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 24] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 25] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 26] 1A-1D are perspective views of a fluid control device according to different embodiments. [Figure 27] 1A-1D are perspective views of a fluid control device according to different embodiments. [Figure 28] 1A-1D are perspective views of a fluid control device according to different embodiments. [Figure 29] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 30] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 31] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 32] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 33] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 34] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 35] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 36] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 37] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 38]1A-1D are various views of a fluid control device, according to one embodiment. [Figure 39] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 40] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 41] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 42] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 43] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 44] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 45] 1A-1D are various views of a fluid control device, according to one embodiment. [Diagram 46] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 47] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 48] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 49] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 50] 1A-1D are various views of a fluid control device, according to one embodiment. [Figure 51] FIG. 2 is a cross-sectional view of a fluid control device, according to one embodiment. [Figure 52] FIG. 2 is a cross-sectional view of a fluid control device, according to one embodiment. [Figure 53] 1 is a flow chart illustrating a method of using a fluid control device, according to one embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0016] Described herein are devices and methods for collecting, diverting, isolating, separating, etc., an initial volume of bodily fluid to reduce contamination in a subsequently acquired bodily fluid sample. Any of the fluid control devices described herein can be configured to receive, acquire, and / or transport a flow, bolus, volume, etc. of bodily fluid. A first reservoir, channel, flow path, or portion of the device can receive an initial volume of a flow of bodily fluid, which can then be substantially or completely sequestered (e.g., contained or held, avoided, separated, sequestered, vapor-occluded, separate, and / or the like) within or by the first reservoir or first portion of the device. In some examples, contaminants such as microorganisms present on the skin can be contained and / or entrained in the initial volume of bodily fluid, which is likewise sequestered by or by the first reservoir or first portion of the device. Once the initial volume is sequestered, any subsequent amount of bodily fluid flow can be diverted, directed, directed, flow controlled (manually, automatically, and / or semi-automatically) to a second reservoir, a second portion of the device, and / or any additional flow path(s). Thus, by isolating the initial volume, any additional and / or subsequent amount(s) of bodily fluid flow is / are substantially free of contaminants that may otherwise produce inaccurate, abnormal, poor, false positive, false negative, etc. results as occurs in some diagnoses and / or tests. In some instances, the initial volume of bodily fluid can be used, e.g., for other tests that are less affected by the presence of contaminants, can be disposed of as a waste volume, can be reinjected into the patient, and / or can be used for any other suitable clinical application.

[0017] In some embodiments, a feature of the fluid control devices and / or methods described herein is the use of an external negative pressure source (e.g., provided by a fluid collection device or any other suitable means) to (1) overcome physical patient issues that may limit and / or prevent sufficient pressure differential (e.g., difference in blood pressure relative to ambient air pressure) to fully engage the isolation chamber and / or transfer fluid flow to the fluid collection device, (2) adequately fill the isolation chamber with a clinically validated and / or desired amount of bodily fluid, (3) provide an efficient, timely, and / or user-acceptable consistency in the bodily fluid collection process, and / or (4) provide a means to manipulate and / or automatically transfer fluid flow (e.g., movement of physical components of the system, or altering, switching, engaging, and / or otherwise employing or achieving a desired fluid flow force) to enable isolation and / or separation of an initial sample and collection of subsequent samples.

[0018] In some embodiments, the fluid control device includes an inlet and an outlet. The inlet is configured to be fluidly disposed with a bodily fluid source or an intermediate bodily fluid transfer device, and the outlet is configured to be fluidly disposed with a fluid collection device, such as, for example, a sample reservoir, a syringe, a lumen containing device, and / or any other suitable bodily fluid collection and / or transfer device. The fluid control device has a first state in which a negative pressure differential generated from an external source (e.g., a fluid collection device, such as a sample reservoir, a syringe, a tank, and / or any suitable intermediate fluid reservoir) is applied to the fluid control device to draw an initial volume of bodily fluid from the bodily fluid source through the inlet and into an isolation and / or diversion portion of the fluid control device (which may be formed by or in the fluid control device or coupled to it). The fluid control device has a second state in which (1) the isolation chamber isolates the initial volume, and (2) the negative pressure differential draws a subsequent volume of substantially contaminant-free bodily fluid from the bodily fluid source, through the fluid control device, and into the fluid collection device.

[0019] In some embodiments, the system includes a housing, a flow controller, and a fluid collection device. The housing has an inlet and an outlet forming an isolated portion. The inlet is configured to be in fluid communication with a source of bodily fluid. The isolated portion is configured to receive an initial volume of bodily fluid from the source of bodily fluid. The flow controller is at least partially disposed in the isolated portion of the housing and configured to transition from a first state to a second state. The fluid collection device is fluidly coupled to the outlet and configured to generate a negative pressure differential within at least a portion of the housing. The negative pressure differential is operable to draw an initial volume of bodily fluid into the isolated portion when the flow controller is in the first state and is operable to draw a test volume of bodily fluid through the outlet and into the fluid collection device when the flow controller is in the second state.

[0020] In some embodiments, the apparatus includes a housing and an actuator coupled to the housing. The housing has an inlet configured to be fluidly disposed with a bodily fluid source and an outlet configured to be fluidly disposed with a fluid collection device. The housing forms an isolation portion configured to receive an initial volume of bodily fluid from the bodily fluid source. The actuator has a first configuration in which a first fluid flow path fluidly disposed with the inlet and the isolation portion and a second configuration in which a second fluid flow path fluidly disposed with the inlet and the outlet. The fluid collection device is fluidly disposed with the outlet and configured to (1) generate a negative pressure differential in the first fluid flow path operable to draw an initial volume of bodily fluid into the isolation portion when the actuator is in the first configuration, and (2) generate a negative pressure differential in the second fluid flow path operable to draw a volume of a bodily fluid sample into the fluid collection device when the actuator is in the second configuration.

[0021] In some embodiments, a method of obtaining a bodily fluid sample with reduced contamination using a fluid control device includes allowing fluid communication between a bodily fluid source and an inlet of the fluid control device. A fluid collection device is coupled to an outlet of the fluid control device and configured to generate a negative pressure differential within at least a portion of the fluid control device. An initial volume of bodily fluid is received from the inlet and into an isolation portion of the fluid control device in response to the negative pressure differential. In response to contacting a portion of the initial volume of bodily fluid, a flow controller disposed within the isolation portion is transitioned from a first state that allows gas to flow through the flow controller and prevents flow of bodily fluid through the flow controller to a second state in which the flow controller prevents flow of gas and bodily fluid through the flow controller. After the flow controller transitions to the second state and a subsequent volume of bodily fluid is transferred from the inlet to the outlet in fluid communication with the fluid collection device, the initial volume of bodily fluid is isolated within the isolation portion.

[0022] As used in this specification and claims, the singular forms "a," "an," and "the" include plural referents unless the content clearly dictates otherwise. Thus, for example, the term "element" is intended to mean a single element or a combination of elements, and "material" is intended to mean one or more materials, or combinations thereof.

[0023] As used herein, the terms "about," "approximately," and / or "substantially," when used in connection with a stated value and / or other geometric relationship, are intended to convey that the structure so defined is nominally the stated value and / or the described geometric relationship. In some instances, the terms "about," "approximately," and / or "substantially" may generally mean and / or generally assume plus or minus 10% of the stated value or relationship. For example, about 0.01 includes 0.009 and 0.011, about 0.5 includes 0.45 and 0.55, about 10 includes 9-11, and about 1000 includes 900-1100. While the stated value may be desirable, some variation may occur, for example, as a result of manufacturing tolerances or other practical considerations (e.g., pressure or force applied through a portion of a device, conduit, lumen, etc.). Thus, the terms "about," "approximately," and / or "substantially" may be used herein to account for such tolerances and / or considerations.

[0024] As used herein, "body fluid" can include any fluid obtained directly or indirectly from a patient's body. For example, "body fluid" can include, but is not limited to, blood, cerebrospinal fluid, urine, bile, lymphatic fluid, saliva, synovial fluid, serous fluid, pleural fluid, amniotic fluid, mucus, sputum, vitreous humor, air, and the like, or any combination thereof.

[0025] As used herein, the terms "proximal" and "distal" refer to directions closer to and away from a user who contacts the device with a patient, respectively. Thus, for example, the end of the device that first touches the patient's body is the distal end, while the opposite end of the device (e.g., the end of the device that is manipulated by the user) is the proximal end of the device.

[0026] As described in further detail herein, any of the devices and methods may be used to obtain a bodily fluid sample with reduced contamination, for example, by diverting a "pre-sample" volume of bodily fluid prior to collecting a "sample" volume of bodily fluid. The terms "pre-sample," "first," and / or "initial" may be used interchangeably to describe and / or refer to a quantity, portion, or volume of bodily fluid that is transferred, diverted, and / or isolated prior to obtaining a "sample" volume. In some embodiments, the terms "pre-sample," "first," and / or "initial" may refer to a predetermined, defined, desired, or given volume, portion, or amount of bodily fluid. For example, in some embodiments, the predetermined and / or desired pre-test volume of bodily fluid can be about 0.1 milliliters (mL), about 0.2 mL, about 0.3 mL, about 0.4 mL, about 0.5 mL, about 1.0 mL, about 2.0 mL, about 3.0 mL, about 4.0 mL, about 5.0 mL, about 10.0 mL, about 20 mL, about 50 mL, and / or any volume or fraction of a volume therebetween. In other embodiments, the pre-test volume can be greater than 50 mL or less than 0.1 mL. In some particular embodiments, the predetermined and / or desired pre-test volume can be between about 0.1 mL and about 5.0 mL. In other embodiments, the pre-test volume can be, for example, a drop of bodily fluid, several drops of bodily fluid, or the combined volume of any number of lumens that form a flow path (or a portion thereof) from, for example, a source of bodily fluid to an initial collection chamber, portion, reservoir, etc. (e.g., an isolation chamber).

[0027] On the other hand, when used in the context of a volume of bodily fluid, the terms "sample," "second," and / or "subsequent" refer to a volume, portion, or amount of bodily fluid that is a random volume or a predetermined or desired volume of collected bodily fluid after transferring, diverting, isolating, and / or separating a pre-test volume of bodily fluid. For example, in some embodiments, the desired test volume of bodily fluid can be from about 10 mL to about 60 mL. In other embodiments, the desired test volume of bodily fluid can be less than 10 mL or more than 60 mL. In some embodiments, for example, the test volume can be based at least in part on one or more tests, chemical analyses, analyses, and / or processes to be performed on the test volume.

[0028] The embodiments described herein can be configured to selectively transfer bodily fluid to one or more fluid collection device(s). In some embodiments, the fluid collection device may include, but is not limited to, any suitable vessel, container, reservoir, bottle, adapter, dish, vial, syringe, device, diagnostic and / or testing machine, and / or the like. As a specific example, in some instances, a test volume can be transferred to a sample reservoir using any of the embodiments and / or methods described herein, such as any of those detailed in U.S. Patent No. 8,197,420, entitled "Systems and Methods for Parenterally Procuring Bodily-Fluid Samples with Reduced Contamination," filed December 13, 2007 (the "'420 Patent"), the disclosure of which is incorporated by reference in its entirety.

[0029] In some embodiments, the sample reservoir may be a sample bottle or culture bottle, such as, for example, an aerobic or anaerobic culture bottle. In this manner, the culture bottle may receive a bodily fluid sample, which may then be tested (e.g., via an in vitro diagnostic (IVD) test, and / or any other suitable test) for the presence of, for example, gram-positive bacteria, gram-negative bacteria, yeast, fungi, and / or any other suitable organisms. In some examples, the culture bottle may receive a bodily fluid sample, and the culture medium (provided therein) may be tested for the presence of any suitable organism. If such testing of the culture medium produces a positive result, the culture medium may then be tested using a PCR-based system to identify the specific organism. Additionally, as described in more detail herein, in some examples, diverting a pre-test or initial volume of bodily fluid may reduce and / or substantially eliminate contaminants in the bodily fluid sample that may otherwise lead to inaccurate test results.

[0030] Any of the sample containers, reservoirs, bottles, dishes, vials, etc. described herein may be empty of contents prior to receiving a test volume of bodily fluid, or may contain, for example, any suitable additives, culture media, substances, enzymes, oils, fluids, and / or the like. For example, in some embodiments, the sample reservoir may contain at least an aerobic or anaerobic culture medium (e.g., a nutrient-rich and / or environmentally controlled medium to promote growth, and / or other suitable medium(s)), which culture medium occupies at least a portion of the internal volume defined by the sample reservoir. In some embodiments, the sample reservoir may contain any suitable additives, such as, for example, heparin, citrate, ethylenediaminetetraacetic acid (EDTA), oxalate, SPS, and / or the like, which likewise occupy at least a portion of the internal volume defined by the sample reservoir. In other embodiments, the sample reservoir may be any suitable container used to collect a specimen.

[0031] While the term "culture medium" can be used to describe a substance configured to react with organisms (microorganisms such as bacteria) in a bodily fluid, and the term "additive" can be used to describe a substance configured to react with a portion of the bodily fluid (e.g., constituent cells of blood, serum, synovial fluid, etc.), it should be understood that the sample reservoir can include any suitable substance, liquid, solid, powder, lyophilized compound, gas, etc. Furthermore, when referring to an "additive" in the sample reservoir, it should be understood that the additive can be a medium, such as an aerobic culture medium and / or an anaerobic culture medium, contained in a culture bottle, an additive contained in a culture bottle such as those described above and / or any other suitable reservoir, and / or any suitable substance or combination of substances. That is, the embodiments described herein can be used with any suitable fluid reservoir containing any suitable substance, and the like. Additionally, any of the embodiments and / or methods described herein can be used to transfer a volume of bodily fluid to a reservoir (and the like) that does not contain culture medium, additive, and / or any other substance prior to receiving a flow of bodily fluid.

[0032] Although some of the embodiments are described herein as being used to obtain bodily fluids for one or more culture sample tests, it should be understood that the embodiments are not limited to such use. Any of the embodiments and / or methods described herein may be used to transfer a flow of bodily fluid to any suitable device in fluid communication therewith. Thus, although specific examples are described herein, the devices, methods, and / or concepts are not intended to be limited to such specific examples.

[0033] The embodiments and / or portions thereof described herein may be formed or constructed of one or more biocompatible materials. In some embodiments, the biocompatible material may be selected based on one or more properties of the material of construction, such as, for example, stiffness, toughness, durometer hardness, bioresponsiveness, etc. Examples of suitable metals include pharmaceutical grade stainless steel, gold, titanium, nickel, iron, platinum, tin, chromium, copper, and / or alloys thereof. The polymeric material may be biodegradable or non-biodegradable. Examples of suitable biodegradable polymers include polylactides, polyglycolides, polylactide-co-glycolides (PLGA), polyanhydrides, polyorthoesters, polyetheresters, polycaprolactones, polyesteramides, poly(butyric acid), poly(valeric acid), polyurethanes, and / or mixtures and copolymers thereof. Examples of non-biodegradable polymers include nylon, polyesters, polycarbonates, polyacrylates, ethylene-vinyl acetate and other acyl-substituted cellulose acetate polymers, non-degradable polyurethanes, polystyrene, polyvinyl chloride, polyvinyl fluoride, poly(vinylimidazole), chlorosulfonated polyolefins, polyethylene oxide, and / or mixtures and copolymers thereof.

[0034] The embodiments and / or portions thereof described herein may include components formed of one or more parts, features, structures, etc. When referring to such components, it should be understood that the components may be formed by a singular part having any number of areas, regions, portions, and / or properties, or may be formed by multiple parts or features. For example, when referring to a structure such as a wall or a chamber, the structure may be considered a singular structure having multiple parts, or multiple individual substructures that are joined to form the structure, etc. Thus, an integrally constructed structure may include, for example, a set of substructures. Such a set of substructures may include multiple parts that are continuous or discontinuous with each other. A set of substructures may also be made from multiple items or components that are manufactured separately and later joined together (e.g., via welding, adhesives, or any suitable method).

[0035] Referring now to the drawings, FIG. 1 is a schematic diagram of a fluid control device 100, according to one embodiment. In general, the fluid control device 100 (also referred to herein as a "control device" or "device") is configured to collect bodily fluid from a patient. A first portion or amount of the collected bodily fluid (e.g., an initial amount) is isolated from a second portion or amount of the collected bodily fluid (e.g., a subsequent amount), after which the bodily fluid may be used for additional testing, discarded, and / or reinjected into the patient. In this manner, contaminants and the like may be sequestered within the first portion or amount, separate from the second portion or amount, which is substantially free of contaminants. The second portion or amount of the bodily fluid may then be used as a biological sample in one or more tests (e.g., blood culture tests, etc.) for medical diagnostic and / or therapeutic purposes, as described in more detail herein. The first portion or amount of the bodily fluid may be discarded as waste, or may be used in any suitable test that is unlikely to produce erroneous, inaccurate, abnormal, inconsistent, and unreliable results as a result of potential contaminants contained therein. In another example, the first portion or amount of bodily fluid may be reinjected into the patient.

[0036] The control device 100 includes a housing 130 having and / or forming an inlet 131, at least one outlet 136, and an isolation chamber 134. The inlet 131 is configured to fluidly couple to a lumen containing device, which can fluidly connect the housing 130 to a bodily fluid source. For example, the housing 130 can be coupled to and / or include a lumen containing device (e.g., a butterfly needle, an intravenous (IV) catheter, a peripherally inserted central catheter (PICC), a syringe, a sterile tube, an intermediate lumen containing device, and / or a bodily fluid transfer device, etc.) in fluid communication with the inlet 131 and configured to be percutaneously placed in a patient. Thus, as described in more detail herein, bodily fluids can be transferred from a patient and / or other bodily fluid sources to the housing 130 via the inlet 131. The outlet(s) 136 can be in fluid communication with a fluid collection device 180 (e.g., a fluid or sample reservoir, a syringe, a vacuum vessel, etc.). As such, as described in further detail herein, the control device 100 can be used and / or operated to selectively transfer a volume of bodily fluid from a bodily fluid source through the inlet 131, the housing 130, and the outlet(s) 136 to the fluid collection device 180.

[0037] The housing 130 defines one or more fluid flow paths 133 between the inlet 131 and the isolation chamber 134 and / or one or more fluid flow paths 154 between the inlet 131 and the outlet 136. The housing 130 of the device 100 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, the housing 130 may have a size based at least in part on a volume of bodily fluid to be at least temporarily stored, for example, in the isolation chamber 134. As described in more detail herein, the control device 100 and / or the housing 130 may be configured to transition between operational modes such that bodily fluid flows through at least one of the fluid flow paths 133 and / or 154. Additionally, the control device 100 and / or the housing 130 may be configured to transition automatically (e.g., based on pressure differential, time, electronically, saturation of a membrane, absorbent and / or barrier material, etc.) or via intervention (e.g., user intervention, mechanical intervention, etc.).

[0038] The isolation chamber 134 is disposed in at least temporary fluid communication with the inlet 131 via the fluid flow path(s) 133. As described in further detail herein, the isolation chamber 134 is configured to (1) receive a flow and / or volume of bodily fluid from the inlet 131 and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) the flow and / or volume of bodily fluid therein. The isolation chamber 134 can have any suitable arrangement, such as, for example, those described herein with respect to certain embodiments. However, it should be understood that the control device 100 and / or the housing 130 can have the isolation chamber 134 in any suitable arrangement and are not intended to be limited to those shown and described herein. For example, in some embodiments, the isolation chamber 134 can be at least partially formed by the housing 130. In other embodiments, the isolation chamber 134 can be a reservoir located and / or provided in a portion of the housing 130. In other embodiments, the isolation chamber 134 can be formed and / or defined by a portion of the fluid flow path 133. That is, housing 130 can define one or more lumens and / or can include one or more lumen-defining device(s) configured to receive a flow of bodily fluid from inlet 131, thereby defining a fluid flow path 133. In such embodiments, at least a portion of the lumen and / or a portion of the lumen-defining device(s) can form and / or define isolation chamber 134.

[0039] The isolation chamber 134 can have any suitable volume and / or fluid capacity. For example, in some embodiments, the isolation chamber 134 can have a volume and / or fluid capacity of about 0.25 mL to about 5.0 mL. In some embodiments, the isolation chamber 134 can have a volume measured by the amount of bodily fluid configured to be transferred into the isolation chamber 134 (e.g., an initial or first amount of bodily fluid). For example, in some embodiments, the isolation chamber 134 can have a volume sufficient to accommodate an initial volume of bodily fluid as small as a microliter or less of bodily fluid (e.g., as small as 20 drops of bodily fluid, 10 drops of bodily fluid, 5 drops of bodily fluid, 1 drop of bodily fluid, or any suitable volume therebetween). In other embodiments, the isolation chamber 134 can have a volume sufficient to accommodate an initial volume of bodily fluid up to, for example, about 5.0 mL, 10.0 mL, 15 mL, 20 mL, 30 mL, 40 mL, 50 mL, or more. In some embodiments, the isolation chamber 134 can have a volume equal to a fraction and / or a plurality of the volumes of at least some of the lumen(s) that fluidly connect the isolation chamber 134 to a source of bodily fluid.

[0040] Although not shown in FIG. 1 , in some embodiments, the isolation chamber 134 can include any suitable arrangement, configuration, and / or feature and / or can be formed of one or more materials configured to interact with a portion of the bodily fluid transferred into the isolation chamber 134. For example, in some embodiments, the housing 130 can include an absorbent and / or hydrophilic material disposed within the isolation chamber 134. Thus, as described in further detail herein, when the bodily fluid is transferred to the isolation chamber 134, the absorbent and / or hydrophilic material can absorb, attract, hold, spread, and / or otherwise interact with at least a portion of the bodily fluid, thereby isolating and / or retaining at least an initial portion of the bodily fluid within the isolation chamber 134. In other embodiments, the isolation chamber 134 can include and / or be formed of an expandable or contractible material configured to transition from a first state (e.g., while the initial portion of the bodily fluid is being transferred into the isolation chamber 134) to a second state (e.g., after the initial portion of the bodily fluid is transferred into the isolation chamber 134). In some embodiments, forces associated with and / or resulting from such expanding or contracting materials may be operable to transition the housing 130 and / or device 100 from a first state, position, configuration, etc. to a second state, position, configuration, etc. In some embodiments, the isolation chamber 134 and / or any other suitable portion of the housing 130 may include one or more chemicals, compounds, and / or the like configured to chemically interact with bodily fluid transferred through a portion of the housing 130, which portion of the housing 130 may be operable (e.g., via force or other suitable means) to transition the control device 100 and / or housing 130 between the first and second states.

[0041] In some embodiments, the control device 100 and / or the housing 130 can include and / or define a flow controller 120 configured to selectively control the flow of a fluid (e.g., gas or liquid) through a portion of the control device 100. For example, in some embodiments, the flow controller 120 can control the flow of bodily fluid through the control device 100 (or the housing 130) and / or otherwise selectively control the flow of bodily fluid through at least one of the fluid flow paths 133 and / or 154. The flow controller 120 can be, for example, a valve, a membrane, a diaphragm, a restrictor, a vent, a selectively permeable member (e.g., a fluid-impermeable barrier or seal that at least selectively allows the passage of air or gas therethrough), a port, a junction, an actuator, and / or the like, or any suitable combination thereof. In some embodiments, the flow controller 120 can be configured to selectively control (at least in part) the flow of fluid into and / or out of the isolation chamber 134 and / or any other suitable portion of the housing 130. In the present context, for example, the fluid flow can be a liquid, such as water, oil, dampening fluid, bodily fluids, and / or other suitable liquids, and / or a gas, such as air, oxygen, carbon dioxide, helium, nitrogen, ethylene oxide, and / or any other suitable gas. For example, in some embodiments, the walls or structure of the housing 130 can define openings, apertures, ports, orifices, and / or the like that are in fluid communication with the isolation chamber 134. In such embodiments, the flow controller 120 can be, for example, a semi-permeable member or membrane disposed in or around the opening that can restrict or substantially prevent the flow of a fluid (e.g., bodily fluids such as blood) through the opening while selectively allowing the flow of air or gas through the opening.

[0042] In some embodiments, one or more flow controllers 120 or the like can be configured to facilitate displacement of air (or other fluid) through one or more portions of the control device 100, and in some examples, the control device 100 can create a pressure differential across one or more portions of the control device 100 or can create and / or enable equalization of pressure across one or more portions of the housing 130. In some embodiments, the control device 100 can be configured to selectively transfer a volume of bodily fluid to the isolation chamber 134 or to the outlet 136 based at least in part on a pressure differential between two or more portions of the control device 100. In some embodiments, the pressure differential can be created by fluidly coupling the outlet 136 to a fluid collection device 180, which can define and / or be configured to generate a negative pressure (e.g., a vacuum reservoir, a syringe, a pressure-filled canister, and / or other source or potential energy that creates a vacuum or pressure differential). In other embodiments, the pressure differential can result from a change in volume and / or temperature. In still other embodiments, the pressure differential may arise from at least a portion of the control device 100, the housing 130, and / or other portions of the vacuum and / or filled flow path (e.g., the isolation chamber 134 and / or other suitable portions). In some embodiments, the pressure differential may be established automatically or through direct or indirect intervention (e.g., by a user).

[0043] Additionally, the flow of fluids (e.g., gases and / or liquids) resulting from the pressure differential can be selectively controlled via, for example, one or more flow controllers 120 that can transition between one or more operating conditions to control the flow of fluids. In some embodiments, for example, the flow controllers 120 can be actuators, etc., configured to transition between one or more operating conditions or states to establish fluid communication between one or more portions of the control device 100 and / or isolate one or more portions of the control device 100 (e.g., isolation chamber 134). In some embodiments, the flow controllers 120 can be members or devices formed of absorbent materials configured to selectively allow the flow of fluids therethrough. For example, such absorbent materials can be transitioned from a first state in which the material allows the flow of gases (e.g., air) therethrough but prevents the flow of liquids (e.g., bodily fluids) therethrough to a second state in which the material substantially prevents the flow of gases and liquids therethrough. In other embodiments, the flow controllers 120 can include one or more valves, membranes, diaphragms, and / or the like. In some embodiments, the flow controller 120 may include any suitable combination of devices, components, and / or features. It should be understood that the flow controllers included in the embodiments described herein are provided by way of example and not limitation. Thus, although a particular flow controller is described herein, it should be understood that the flow of fluid may be controlled through the control device 100 by any suitable means.

[0044] The outlet(s) 136 are in and / or configured to be in fluid communication with the fluid flow paths 133 and / or 154. As shown in FIG. 1, the outlet 136 may be any suitable outlet, opening, port, stopcock, stop, seal, coupler, valve (e.g., one-way, check valve, duckbill valve, and / or the like), etc., and is configured to be fluidly coupled to a fluid collection device 180 (e.g., a fluid reservoir, a culture sample bottle, a syringe, a container, a vial, a dish, a receptacle, a pump, an adapter, and / or any other suitable collection or transfer device). In some embodiments, the outlet 136 may be integrally formed with the fluid collection device 180. In other embodiments, the outlet 136 may be at least temporarily coupled to the fluid collection device 180 via adhesives, resistance fits, mechanical fasteners, threaded connections, a perforation or puncture arrangement, any number of mating recesses, and / or any other suitable connections or combinations thereof. Similarly stated, the outlet 136 may be physically (e.g., mechanically) and / or fluidly coupled to the fluid collection device 180 such that an interior volume defined by the fluid collection device 180 is in fluid communication with the outlet 136. In yet other embodiments, the outlet 136 may be operably coupled to the fluid collection device 180 via an intervening structure (not shown in FIG. 1 ), such as a flexible sterile tube. In some embodiments, the outlet 136 may be positioned such that the outlet 136 is physically and / or fluidly sealed prior to coupling to the fluid collection device 180. In some embodiments, the outlet 136 may be transitioned from a sealed configuration to an unsealed configuration upon coupling to the fluid collection device 180 and / or in response to a negative pressure differential between the environment within the outlet 136 and / or the housing 130 and the environment within the fluid collection device 180.

[0045] Fluid collection device 180 may be any suitable device for at least temporarily containing a bodily fluid, such as, for example, any of those described in detail above. For example, in some embodiments, fluid collection device 180 may be a single-use disposable collection tube(s), a syringe, a vacuum-based collection tube(s), an intermediate bodily fluid transfer device, and / or the like. In some embodiments, fluid collection device 180 may be substantially similar or identical to known sample containers, such as, for example, a Vacutainer® (manufactured by BD), BacT / ALERT® SN or BacT / ALERT® FA (manufactured by Biomerieux, Inc.), and / or any suitable reservoir, vial, microvial, microliter vial, nanoliter vial, container, microcontainer, nanocontainer, and / or the like. In some embodiments, as described in more detail herein, the fluid collection device 180 may be a sample reservoir including a vacuum seal that maintains a negative pressure condition (vacuum condition) inside the sample reservoir, which may facilitate collection of bodily fluid from the patient, through the control device 100, and into the sample reservoir via vacuum or suction. In embodiments in which the fluid collection device 180 is a vacuum container, or the like, a user may couple the fluid collection device 180 to the outlet 136 to initiate a flow of bodily fluid from the patient, such that a first or initial portion of the bodily fluid is transferred into and isolated by the isolation chamber 134, and such that a subsequent portion or volume of the bodily fluid is bypassed and / or otherwise diverted from the isolation chamber 134 and flows into the fluid collection device 180, as described in more detail herein.

[0046] Although the control device 100 and / or the outlet 136 of the housing 130 are described above as being fluidly coupled to and / or otherwise fluidly accessible to the fluid collection device 180, in other embodiments, the control device 100 can be used in conjunction with any suitable bodily fluid collection device and / or system. For example, in some embodiments, the control device 100 described herein can be used with any suitable fluid transfer device, such as those described in U.S. Patent Publication No. 2015 / 0342510, entitled "Sterile Bodily-Fluid Collection Device and Methods," filed June 2, 2015 (herein referred to as the "'510 publication"), the disclosure of which is incorporated herein by reference in its entirety. More specifically, the control device 100 can be used in a "one-piece" or pre-assembled device (e.g., such as that described in the '510 publication) to receive and isolate an initial volume of bodily fluid to reduce and / or remove contaminants in a subsequent volume of bodily fluid.

[0047] As described above, device 100 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as those present on the skin, and / or the like. For example, in some examples, a user, such as a doctor, physician, nurse, phlebotomist, technician, etc., can operate device 100 to establish fluid communication between inlet 131 and a bodily fluid source (e.g., a patient's blood vessel, cerebrospinal fluid (CSF) from the spinal cavity, urine collection, and / or the like). As a specific example, in some examples, inlet 131 can be coupled to and / or include a needle or the like that can be operated to pierce the patient's skin and insert at least a portion of the needle into the patient's blood vessel, thereby enabling inlet 131 to communicate fluidly with the bodily fluid source (e.g., blood vessel, IV catheter, PICC, etc.).

[0048] In some embodiments, once the inlet 131 is placed in fluid communication with a bodily fluid source (e.g., a portion of a patient), the outlet 136 may be fluidly coupled to a fluid collection device 180. As discussed above, in some embodiments, the fluid collection device 180 may be any suitable reservoir, container, and / or device configured to receive a volume of bodily fluid. For example, the fluid collection device 180 may be a vacuum reservoir or container that defines a negative pressure and / or may be a syringe that can be operated to generate a negative pressure. In some examples, coupling the outlet 136 to the fluid collection device 180 selectively exposes at least a portion of the fluid flow paths 133 and / or 154 to a negative pressure, thereby creating a negative pressure differential that is operable to draw bodily fluid from a bodily fluid source (e.g., a patient), through the inlet 131, and into the housing 130.

[0049] In some embodiments, the housing 130 is positioned such that when a volume of bodily fluid is transferred to and / or through the inlet 131, an initial portion of the volume of bodily fluid (also referred to herein as an “initial volume” or “first volume”) flows from the inlet 131 through at least a portion of the fluid flow path 133 and into the isolation chamber 134. That is, in some embodiments, the control device 100 and / or the housing 130 may be in a first or initial state in which an initial portion or volume of bodily fluid can flow into or through at least a portion of the fluid flow path 133 and into the isolation chamber 134. For example, in some embodiments, the initial state of the control device 100 and / or the housing 130 may be in a state in which one or more flow controllers 120 (e.g., valves, membranes, diaphragms, restrictors, vents, air permeable and fluid impermeable barriers, ports, actuators, and / or the like, or combinations thereof) are in a first state in which the fluid flow path 133 is exposed to a negative pressure differential through the isolation chamber 134. In other words, the negative pressure within or generated by the fluid collection device 180 can create a negative pressure (or negative pressure differential) within at least a portion of the isolation chamber 134 that is operable to draw an initial flow of bodily fluid into the isolation chamber 134 when the one or more flow controllers 120 are in a first or initial state.

[0050] For example, in some embodiments, the flow controller 120 may be a valve (e.g., a one-way valve, a check valve, a duckbill valve, an umbrella valve, and / or the like), a selectively permeable member (e.g., a fluid-impermeable barrier or seal that allows at least selective passage of gas or air), an actuator including a selectively permeable membrane, a diaphragm, and / or the like, at least temporarily fluidly coupled to a flow path (e.g., at least a portion of the fluid flow path 154) between the fluid collection device 180 and the isolation chamber 134. In some embodiments, the above examples of flow controller 120 may be known commercially available components used in medical devices, for example, to control the flow of fluids and air, while in other embodiments, the flow controller 120 may be a custom, unique, and / or custom-made component integral to the device 100. When the flow controller 120 is in a first or initial state, in response to a negative pressure in the fluid collection device 180, the flow controller 120 may allow the flow of fluid therethrough. In some embodiments, the flow controller 120, or a portion or component thereof, is configured to allow only the flow of air or gas through the flow controller 120, and is configured to limit and / or substantially prevent the flow of liquid (e.g., bodily fluid) through the flow controller 120. As such, when the flow controller 120 is in a first or initial state that does not allow an initial portion of the bodily fluid to flow into the fluid flow passages 154 and / or otherwise out of the isolation chamber 134, the fluid collection device 180 can create a negative pressure differential within the isolation chamber 134 that is operable to draw an initial portion and / or amount of the bodily fluid into the isolation chamber 134.

[0051] Although not shown in FIG. 1 , in some embodiments, the control device 100 and / or the housing 130 can include members, devices, mechanisms, features, etc. configured to regulate the amount of negative pressure to which the isolation chamber 134 is exposed. For example, in some embodiments, the housing can include a valve, a membrane, a porous material, a restrictor, an orifice, and / or any other suitable members, devices, and / or features configured to regulate pressure. In some embodiments, regulating and / or controlling the amount of pressure to which the isolation chamber 134 is exposed can regulate the amount of pressure exerted on the patient's bodily fluids and / or within the blood vessels. In some examples, such pressure regulation can, for example, reduce the likelihood of hemolysis of a blood sample and / or collapsing a blood vessel (e.g., particularly important for frail patients requiring microbiological and / or other diagnostic tests associated with the use of the control device 100). In addition, regulating the negative pressure can, for example, at least partially control the rate at which the control device 100 transitions between a first configuration or state and a second configuration or state. In some embodiments, regulating the negative pressure can act like a timer. For example, the time from the introduction of the negative pressure differential until the control device 100 transitions from the first state to the second state may be known, predetermined, calculated, and / or controlled. Thus, in some examples, the amount or volume of bodily fluid transferred into the isolation chamber 134 may be at least partially controlled by adjusting the negative pressure (i.e., the volume of the initial amount of bodily fluid may be controlled).

[0052] As noted above, the initial portion and / or amount of bodily fluid may be any suitable amount of bodily fluid. For example, in some instances, the control device 100 and / or housing 130 may remain in the first state until a predetermined and / or desired volume of bodily fluid (e.g., an initial volume) has been transferred to the isolation chamber 134. In some embodiments, the initial volume may be related to and / or based at least in part on the volume of the isolation chamber 134. In other embodiments, the initial volume may be related to and / or based at least in part on the amount or volume of bodily fluid that may be absorbed by an absorbent material, a swelling material, a hydrophilic material, a wicking material, and / or other suitable material provided within the isolation chamber 134. In other embodiments, the initial volume of bodily fluid may be related to and / or based at least in part on the amount or volume of bodily fluid that may be transferred into the isolation chamber 134 within a predetermined time. In yet other embodiments, the initial volume can be related to and / or based at least in part on an amount or volume of bodily fluid that is sufficient to fully wet or saturate a semi-permeable member or membrane configured to selectively expose the isolation chamber 134 to a negative pressure of the fluid collection device 180 (i.e., a flow controller 120, such as an air permeable and liquid impermeable member or membrane). In other words, in some embodiments, the initial volume of bodily fluid can be a volume sufficient to transition one or more flow controllers 120 to a second state (e.g., a saturated or fully wet state). In still other embodiments, the control device 100 and / or the housing 130 can be configured to transfer a volume of bodily fluid (e.g., an initial volume) into the isolation chamber 134 until a pressure differential between the isolation chamber 134 and the fluid flow path 133 and / or the bodily fluid source is substantially in equilibrium and / or is otherwise reduced below a desired threshold.

[0053] After the initial volume of bodily fluid has been transferred and / or diverted into the isolation chamber 134, the initial volume is sequestered, separated, held, contained, isolated, etc. within the isolation chamber 134. For example, in some embodiments, one or more flow controllers 120 may be operable to transition from a first state to a second state such that the initial portion of the bodily fluid within the isolation chamber 134 is sequestered and / or held. As described in more detail herein, in some instances, contaminants such as microorganisms present on the skin that are expelled during venipuncture, other external sources of contamination, colonization of catheters and PICC lines used to collect the sample, etc. may be entrained and / or contained within the initial volume of bodily fluid and thus isolated within the isolation chamber 134 as the initial volume is sequestered therein.

[0054] Once the initial volume has been transferred and / or diverted into the isolation chamber 134, the device 100 may transition to a second state in which a subsequent volume(s) of bodily fluid may flow through at least a portion of the fluid flow paths 133 and / or 154 from the inlet 131 to the outlet 136. In some embodiments, the control device 100 and / or the housing 130 may passively and / or automatically transition (e.g., without user intervention) from the first state to the second state once the initial volume of bodily fluid is sequestered within the isolation chamber 134. For example, in some embodiments, filling the isolation chamber 134 to capacity and / or completely saturating, wetting, and / or impregnating an absorbent or similar material provided between the isolation chamber 134 and the fluid collection device 180 may cause further transfer of bodily fluid into the isolation chamber 134 to be limited and / or substantially prevented due to removal of negative pressure or diverting. In other embodiments, the control device 100 and / or the housing 130 may be transitioned manually or at least in response to indirect interaction by a user. For example, in some embodiments, a user may transition the control device 100 and / or the housing 130 from a first state to a second state by actuating an actuator or the like (e.g., actuating the flow controller 120 or a portion thereof). In still other embodiments, at least a portion of an initial volume of bodily fluid may transition the control device 100 and / or the housing 130 from a first state to a second state. For example, the control device 100 may include a flow controller 120 that is and / or includes a bodily fluid-activated switch, a valve, a port, and / or the like. In other embodiments, the volume of bodily fluid may displace and / or replace one or more of the flow controllers 120 (e.g., an actuator, etc.), which may, for example, open ports, flow paths, and / or outlets. In yet other embodiments, a user may manipulate such flow controller 120 (e.g., a switch, valve, port, actuator, etc.) to transition control device 100 and / or housing 130 from a first state to a second state.

[0055] Once the fluid collection device 180 is fluidly coupled to the outlet 136, and once the control device 100 and / or housing 130 are in the second state (e.g., an initial volume of bodily fluid is isolated within or by the isolation chamber 134), any subsequent volume(s) of bodily fluid can flow from the inlet 131, through at least one of the fluid flow paths 133 and / or 154, through the outlet 136, and into the fluid collection device 180. Thus, as described above, by isolating the initial volume of bodily fluid in the isolation chamber 134 prior to collecting or obtaining a test volume of the one or more bodily fluids, the amount of contaminants in the one or more test volumes is reduced and / or substantially eliminated. Further, in some embodiments, the control device 100 and / or housing 130 are arranged such that the control device 100 and / or housing 130 cannot transition to the second state prior to the control device 100 and / or housing 130 collecting and isolating the initial volume within the isolation chamber 134.

[0056] Figures 2-5 show a fluid control device 200 according to one embodiment. The fluid control device 200 may be similar, at least in form and / or function, to the fluid control device 100 described above with reference to Figure 1. Accordingly, portions of the fluid control device 200 that may be similar to portions of the fluid control device 100 will not be described in further detail herein.

[0057] 2-5, fluid control device 200 (also referred to herein as a "control device" or "device") includes a housing 230 having an inlet 231, an outlet 236, and an actuator 250. As described above with reference to control device 100, inlet 231 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen-containing device such as a needle, IV catheter, PICC line, etc.). Outlet 236 is configured to be fluidly coupled to a fluid collection device, such as, for example, a sample reservoir, a syringe, and / or other intermediate bodily fluid transfer device or container (e.g., a transfer device similar to those described in the '510 publication), and / or the like.

[0058] As described above with reference to the housing 130, the housing 230 defines one or more fluid flow paths 233 between the inlet 231 and the isolation chamber 234 and / or one or more fluid flow paths 254 between the inlet 231 and the outlet 236. The housing 230 of the device 200 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, the housing 230 may be substantially similar, at least in form and / or function, to the housing 130 described above with reference to FIG. 1. The isolation chamber 234 of the housing 230 is positioned in at least temporary fluid communication with the inlet 231 via the fluid flow path(s) 233. Additionally, as described in more detail herein, the isolation chamber 234 may be selectively placed in fluid communication with the fluid flow paths 254 such that at least air or gas may be transferred therebetween.

[0059] As described in further detail herein, the isolation chamber 234 is configured to (1) receive a flow and / or volume of bodily fluid from the inlet 231 and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) the flow and / or volume of bodily fluid therein. The isolation chamber 234 can have any suitable shape, size, and / or configuration. For example, in some embodiments, the isolation chamber 234 can have any suitable size, volume, and / or fluid capacity, such as, for example, those described above with reference to the isolation chamber 134. In the embodiment shown in FIGS. 2-5, the isolation chamber 234 can be at least partially formed by the housing 230, which defines a lumen or flow path. In some embodiments, at least a portion of the fluid flow path 233 can extend through a portion of the housing 230 to form and / or define at least a portion of the isolation chamber 234. As shown in FIGS. 2-5, the isolation chamber 234 and / or the portion of the fluid flow path 233 that forms the isolation chamber 234 can have a serpentine configuration, etc. In other embodiments, the isolation chamber 234 can have any suitable configuration. For example, in some embodiments, the housing can include an isolation chamber formed by a flexible tube or the like, which can be arranged in any suitable shape and / or configuration.

[0060] In some embodiments, the housing 230 and / or the isolation chamber 234 can include, form, and / or define a flow controller 242. The flow controller 242 can be, for example, a valve, a membrane, a septum, a restrictor, a vent, a selectively permeable member (e.g., a fluid-impermeable barrier or seal that allows at least the selective passage of gas or air, such as a blood barrier, and / or the like), a port, etc., configured to selectively control (at least in part) the flow of fluid into and / or out of the isolation chamber 234 and / or any other suitable portion of the housing 230 (collectively referred to herein as a "flow controller"). More specifically, in the embodiment illustrated in Figures 2-5, the flow controller 242 is a selectively permeable fluid barrier (e.g., a blood barrier) that includes and / or is formed of a porous material configured to selectively allow the flow of gas but prevent the flow of liquid therethrough.

[0061] The flow controller 242 is positioned within the housing 230 to selectively allow fluid communication between the isolation chamber 234 and the fluid flow path 254. Thus, as described in further detail herein, by configuring the flow controller 242 as a semi-permeable member, the flow controller 242 can be configured to at least temporarily transfer gas or air between the fluid flow path 254 and the isolation chamber 234, and can be configured to substantially prevent the flow of liquid between the fluid flow path 254 and the isolation chamber 234.

[0062] The outlet 236 of the housing 230 is configured to be in fluid communication with and / or in fluid communication with the fluid flow paths 233 and / or 254. As shown in FIGS. 2-5, the outlet 236 can be any suitable outlet, opening, port, stop, seal, coupler, etc. configured to be fluidly coupled to a fluid collection device, such as a sample reservoir, syringe, container, and / or other sample vessel. In some embodiments, the outlet 236 can be integrally formed with or at least temporarily coupled to a fluid collection device, as described above with reference to the outlet 136 of the housing 130. The fluid collection device can be any suitable reservoir, container, and / or device for containing bodily fluids, such as, for example, any of those detailed above with reference to the fluid collection device 180. More specifically, in some embodiments, the outlet 236 can be configured to be coupled to a vacuum sample reservoir. Thus, a user can couple the sample reservoir to the outlet 236 to initiate a flow of bodily fluid from the patient, such that a first or initial portion of the bodily fluid is transferred into and isolated by the isolation chamber 234, and such that any subsequent portions or volumes of bodily fluid are bypassed and / or otherwise diverted away from the isolation chamber 234 and flow into the sample reservoir.

[0063] As shown in FIGS. 3-5, the housing 230 includes and / or is coupled to an actuator 250 configured to selectively control the flow of bodily fluid through the housing 230. More specifically, the actuator 250 is disposed between a portion of the fluid flow path 233 and a portion of the fluid flow path 254, for example. Although the actuator 250 is shown in FIGS. 3-5 as being positioned at a distance, away from, and / or downstream from the junction between the fluid flow path 233 and the isolation chamber 234, in other embodiments, the actuator 250 may be disposed at any suitable location within the housing 230. For example, in some embodiments, the actuator 250 may be positioned at and / or form at least a portion of the junction between the fluid flow path 233, the isolation chamber 234, and the fluid flow path 254.

[0064] Actuator 250 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, actuator 250 may be any suitable member or device configured to transition between a first state and a second state. In the embodiment shown in FIGS. 2-5, actuator 250 is configured to separate, isolate, separate, and / or otherwise impede fluid communication between fluid flow channel 233 and fluid flow channel 254 when in a first state, and is configured to position fluid flow channel 233 in fluid communication with fluid flow channel 254 when in a second state. In some embodiments, for example, actuator 250 may be a valve, plunger, seal, membrane, flap, plate, and / or the like. For example, as shown in FIG. 5, actuator 250 may include one or more seals 265 configured to selectively allow fluid communication between flow channels 233 and 254 when actuator 250 is transitioned (e.g., pressed, rotated, moved, activated, switched, slid, etc.) from a first state to a second state.

[0065] Although actuator 250 is specifically shown in FIGS. 2-5 and described above, in other embodiments, control device 200 may include any suitable actuator or device configured to selectively allow fluid communication between fluid flow paths 233 and 254. Thus, while specifically shown in FIGS. 2-5, it should be understood that control device 200 is presented by way of example only and not limitation. For example, while actuator 250 is shown in FIGS. 2-5 as being provided at a given location, in other embodiments, actuator 250 may be located at any suitable location along housing 230. By way of example, in some embodiments, actuator 250 may be provided at a junction between fluid flow path 233, isolation chamber 234, and inlet 231. In such embodiments, when actuator 250 is in a first state, bodily fluid flow may flow directly from inlet 231 into isolation chamber 234, and when actuator 250 is in a second state, bodily fluid may flow directly from inlet 231 into fluid flow path 254. In other words, when the actuator 250 is in the first state, the actuator 250 can form a portion of the isolation chamber 234 such that bodily fluid flows directly from the inlet into the isolation chamber 234. When the actuator 250 is actuated, positioned, and / or transitioned to the second state, for example, the actuator 250 can allow bodily fluid to flow directly from the inlet 231 into the fluid flow path 233. In such an embodiment, the actuator 250 can prevent the formation of a junction between the inlet 231, the isolation chamber 234, and the fluid flow path 233. Additionally, when in the second state, the actuator 250 can be operable to at least partially isolate the isolation chamber 234 from the inlet 231 and / or the fluid flow path 233.

[0066] Additionally, the actuator 250 may be actuated and / or transitioned in any suitable manner. For example, in some embodiments, the actuator 250 may transition between a first state and a second state in response to manual actuation by a user (e.g., application of a manual force to a button, slider, switch, rotating member, etc.). In other embodiments, the actuator 250 may be configured to automatically transition between a first state and a second state in response to a pressure differential (or lack thereof), a change in potential or kinetic energy, a change in composition or configuration (e.g., a portion of the actuator may at least partially degrade or deform), and / or the like. In still other embodiments, the actuator 250 may be mechanically and / or electrically actuated or transitioned based on a predetermined time, volumetric flow rate, flow rate, etc. While examples of actuators and / or ways in which the actuators may transition are provided herein, it should be understood that they are presented by way of example only and not limitation. Thus, the control device 200 may include any suitable actuator configured to transition in any suitable manner.

[0067] As discussed above, device 200 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as those present on the skin, and / or the like. For example, in some instances, a user, such as a doctor, physician, nurse, phlebotomist, technician, etc., can manipulate device 200 to establish fluid communication between inlet 231 and a bodily fluid source (e.g., a patient's blood vessel). Once inlet 231 is positioned in fluid communication with a bodily fluid source (e.g., a portion of a patient), outlet 236 can be fluidly coupled to a fluid collection device. As discussed above, in the embodiment shown in FIGS. 2-5, the fluid collection device can be, for example, a vacuum reservoir or container that defines a negative pressure, and / or any other suitable negative pressure source.

[0068] By coupling the outlet 236 to the fluid collection device, at least a portion of the fluid flow path 254 is selectively exposed to a negative pressure in the fluid collection device. As described above, the flow controller 242 is in fluid communication with the fluid flow path 254 and the isolation chamber 234. Thus, by coupling the outlet 236 to the fluid collection device, the isolation chamber is exposed to the negative pressure of the fluid collection device, thereby creating a negative pressure differential that is operable to draw bodily fluid from a bodily fluid source (e.g., a patient), through the inlet 231, and into the housing 230. As described above with reference to the control device 100, the housing 230 is arranged such that when a volume of bodily fluid is transferred to and / or through the inlet 231, an initial portion of the volume of bodily fluid (also referred to herein as an "initial volume" or "first volume") flows from the inlet 231, through at least a portion of the fluid flow path 233, and into the isolation chamber 234. That is, in some embodiments, the control device 200 and / or the housing 230 may be in a first or initial state in which an initial portion or volume of bodily fluid can flow into or through at least a portion of the fluid flow path 233 and into the isolation chamber 234.

[0069] As described above, when the flow controller 242 and the actuator 250 are in a first state, position, configuration, etc., the housing 230 and / or the control device 200 may be in an initial state. As such, the actuator 250 separates, separates, spaces, isolates, and / or otherwise prevents direct fluid communication between the fluid flow paths 233 and 254. Additionally, the inlet 231 is exposed to a negative pressure differential via the isolation chamber 234. In other words, the negative pressure within the fluid collection device may create a negative pressure (or negative pressure differential) within at least a portion of the isolation chamber 234 that is operable in drawing an initial flow of bodily fluid from the inlet 233 into the isolation chamber 234 when the housing 230 and / or the control device 200 are in a first or initial state.

[0070] When the flow controller 242 is in a first or initial state, as described above with reference to the housing 130, the flow controller 242 can allow the flow of a fluid (e.g., gas or air) therethrough in response to a negative pressure in a fluid collection device (e.g., a sample reservoir, a syringe, or other potential energy source used to generate the negative pressure). In some instances, it may be desirable to regulate and / or control the magnitude of the negative pressure differential. In the embodiment shown in FIGS. 2-5, for example, the housing 230 defines a restrictor flow path 232 that is disposed in fluid communication with the flow controller 242 and the fluid flow path 254. More specifically, the restrictor flow path 232 is a fluid flow path having a diameter that is at least smaller than the fluid flow path 254.

[0071] For example, in some embodiments, the restricted flow path 232 can have a diameter of about 0.0005 inches, about 0.001 inches, about 0.003 inches, about 0.005 inches, about 0.01 inches, about 0.1 inches, about 0.5 inches, or more. In other embodiments, the restricted flow path 232 can have a diameter of less than 0.0005 inches or greater than 0.5 inches. In some embodiments, the restricted flow path 232 can have a predetermined and / or desired length of about 0.01 inches, about 0.05 inches, about 0.1 inches, about 0.15 inches, about 0.2 inches, about 0.5 inches, or more. In other embodiments, the restricted flow path 232 can have a predetermined and / or desired length of less than 0.01 inches or greater than about 0.5 inches. Additionally, in some embodiments, the restricted flow path 232 can have any suitable combination of diameter and length to enable and / or provide desired flow characteristics through at least a portion of the control device 200.

[0072] In this embodiment, a restricted flow path 232 having a smaller diameter will result in a lower magnitude of negative pressure being applied through the isolation chamber than the magnitude of the negative pressure when the restricted flow path has a larger diameter. In some examples, the magnitude of the negative pressure can be adjusted to control the rate at which bodily fluid is transferred into the isolation chamber 234. For example, in some embodiments, the fluid collection device and / or other suitable negative pressure source may generate a negative pressure differential having a magnitude (e.g., a negative magnitude) of about 0.5 pounds per square inch (PSI), about 1.0 PSI, about 2.0 PSI, about 3.0 PSI, about 4.0 PSI, about 5.0 PSI, about 10 PSI, about 12.5 PSI, or about 14.7 PSI (e.g., about atmospheric pressure at sea level or substantially about atmospheric pressure). In some embodiments, a fluid collection device, such as a vacuum vessel, can have a predetermined negative pressure of about 12.0 PSI. Thus, by controlling the diameter and / or length of the restrictor flow path 232, the amount of negative pressure to which the isolation chamber 234 is exposed and / or the rate at which the negative pressure is applied can be controlled, reduced, and / or otherwise adjusted. In some examples, the use of the restrictor flow path 232 can result in a delay or build-up of negative pressure being applied on or within the isolation chamber.

[0073] Further, in this embodiment, the restricted flow path 232 is, for example, a gas flow path configured to accept a flow of gas or air rather than a flow of liquid (e.g., bodily fluid). In some embodiments, the diameter of the restricted flow path 232 may be small enough to restrict and / or prevent the flow of liquid therethrough. Additionally, the restricted flow path 232 disposed between the fluid flow path 254 and the flow controller 242 is positioned such that the flow of bodily fluids and / or any other liquids is substantially prevented by the flow controller 242 (e.g., a selectively permeable barrier or seal).

[0074] It should be understood that while pressure regulation is described above as being based on the diameter of the restriction passage 232 (i.e., a single restriction passage), this is presented merely as an example and not a limitation. Other means for regulating the amount of negative pressure to which the isolation chamber is exposed may include, for example, porous materials, valves, membranes, diaphragms, specific restrictions, vents, deformable members or passages, and / or any other suitable means. In other embodiments, the control device may include any suitable number of restriction passages, and each restriction passage may have substantially the same diameter or may have a variety of diameters. For example, in some embodiments, the control device may include up to 100 or more restriction passages. In such embodiments, each restriction passage may have a diameter of about 0.0005 inches to about 0.1 inches, about 0.0005 inches to about 0.05 inches, or about 0.0005 inches to about 0.01 inches. In some embodiments, the multiple restrictive flow paths can be configured to (1) selectively provide a flow path between the outlet 236 and the isolation chamber 234 that exposes the isolation chamber 234 to a negative pressure differential, and (2) act as a flow controller configured to selectively allow the passage of gas and / or air while substantially preventing the passage of liquids (e.g., bodily fluids).

[0075] In some embodiments, by adjusting and / or controlling the amount of pressure to which the isolation chamber 234 is exposed, the amount of pressure applied to the patient's bodily fluids and / or within the blood vessels can be adjusted. In some examples, such pressure adjustment can reduce the likelihood of hemolysis of a blood sample and / or collapsing a blood vessel, for example. In some examples, the ability to adjust and / or control the amount or magnitude of negative pressure allows the device 200 to be used with a wide range of patients who often have physiological difficulties, thereby requiring a negative pressure to facilitate collection of bodily fluids such as blood, without a sudden applied force causing flattening, collapse, invagination, and / or otherwise inhibiting patency and blood collection capabilities (the pressure difference between atmospheric pressure and the patient's blood vessel pressure is not sufficient to facilitate uniform and sufficiently strong flow).

[0076] As discussed in detail above with reference to the control device 100, the initial portion and / or amount of bodily fluid may be any suitable amount of bodily fluid. For example, in some examples, the initial volume may be related to and / or based at least in part on an amount or volume of bodily fluid that is sufficient to fully wet or saturate the flow controller 242. In other words, in some embodiments, the initial volume of bodily fluid may be a volume sufficient to transition the flow controller 242 to a second state (e.g., a saturated state or a fully wet state). In some embodiments, the flow controller 242 is placed in a sealing configuration when transitioned to the second state. That is, by saturating and / or fully wetting the flow controller 242 (e.g., a semi-permeable material), the flow controller 242 is placed in a sealing configuration in which the flow controller 242 substantially prevents the flow of liquids and gases therethrough. Thus, by transitioning the flow controller 242 to the second state, flow through the flow controller 242 between the restricted flow path 232 and the isolation chamber 234 is isolated, blocked, separated, distinct, spaced, and / or otherwise prevented.

[0077] After the initial volume of bodily fluid has been transferred and / or diverted to the isolation chamber 234, the control device 200 and / or the housing 230 can be transitioned to its second state or mode of operation to isolate, space, hold, contain, isolate, etc. the initial volume in the isolation chamber 234. For example, as described above, the flow controller 242 can be placed in a sealing configuration. Additionally, the actuator 250 can be actuated to transition from its first state to its second state to allow fluid communication between the fluid flow paths 233 and 254. As such, negative pressure that would otherwise be applied on or through the isolation chamber 234 is now applied on or through the fluid flow paths 233 and 254. In response, bodily fluid can flow from the inlet 231, through the fluid flow paths 233 and 254, through the outlet 236, and into the fluid collection device. In some embodiments, transitioning the flow controller 242 and the actuator 250 from their respective first states to their respective second states is operable to segregate and / or retain an initial portion of the bodily fluid within the segregation chamber 234. As described in further detail herein, in some instances, contaminants such as, for example, microorganisms present on the skin that are expelled during venipuncture may be entrained and / or contained within the initial volume of bodily fluid and thus segregated within the segregation chamber 234 as the initial volume is segregated therein.

[0078] With the fluid collection device fluidly coupled to outlet 236 and control device 200 and / or housing 230 in the second state (e.g., an initial volume of bodily fluid is isolated in or by isolation chamber 234), any subsequent volume(s) of bodily fluid can flow from inlet 231, through fluid flow paths 233 and 254, through outlet 236, and into the fluid collection device. Thus, as described above, by isolating the initial volume of bodily fluid in isolation chamber 234 prior to collecting or obtaining a test volume of one or more bodily fluids, the amount of contaminants in the one or more test volumes is reduced and / or substantially eliminated. Further, in some embodiments, control device 200 and / or housing 230 can be positioned such that control device 200 and / or housing 230 cannot transition to the second state prior to collecting and isolating the initial volume in isolation chamber 234.

[0079] Although the control device 200 is described above with reference to Figures 2-5 as including an actuator 250 configured to move between a first state and a second state (e.g., via a force applied by a user), in other embodiments, the control device may include any suitable member, device, mechanism, etc. configured to selectively establish fluid communication between two or more fluid-flow paths. For example, Figures 6-8 show a fluid control device 300, according to one embodiment. The fluid control device 300 may be similar in form and / or function to the fluid control device 100 described above with reference to Figure 1 and / or the fluid control device 200 described above with reference to Figures 2-5. Accordingly, portions of the fluid control device 300 that may be similar to portions of the fluid control devices 100 and / or 200 are not described in further detail herein.

[0080] As shown in Figures 6-8, fluid control device 300 (also referred to herein as a "control device" or "device") includes a housing 330 having an inlet 331 and an outlet 336, and containing or coupled to an actuator 350. As described above with reference to control devices 100 and / or 200, inlet 331 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen containing device such as a needle). Outlet 336 is configured to be fluidly coupled to a fluid collection device (not shown in Figures 6-8).

[0081] As described above with reference to housing 130 and / or 230, housing 330 defines one or more fluid flow paths 333, 354A, and 354B configured to selectively place in fluid communication inlet 331 with isolation chamber 334 and / or outlet 336. Housing 330 of device 300 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, housing 330 may be substantially similar in at least form and / or function to housings 130 and / or 230 described above. In some embodiments, housing 330 may have a size based at least in part on a volume of bodily fluid to be at least temporarily stored in isolation chamber 334, for example. Isolation chamber 334 of housing 330 is at least temporarily placed in fluid communication with inlet 331 via fluid flow path(s) 333. Additionally, as described in more detail herein, isolation chamber 334 may be selectively placed in fluid communication with fluid flow path 354A such that at least air or gas may be transferred therebetween.

[0082] As described in further detail herein, the isolation chamber 334 is configured to (1) receive a flow and / or volume of bodily fluid from the inlet 331 and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) the flow and / or volume of bodily fluid therein. The isolation chamber 334 can have any suitable shape, size, and / or configuration. For example, in some embodiments, the isolation chamber 334 can be substantially similar to the isolation chamber 234 described above with reference to FIGS. 2-5 and thus will not be described in further detail herein. Similarly, the housing 330 and / or the isolation chamber 334 include, form, and / or define a flow controller 342, which can be substantially similar to the flow controller 242 described above. Thus, as described in further detail herein, the flow controller 342 is positioned within the housing 330 to selectively allow fluid communication between the isolation chamber 334 and the fluid flow path 354A.

[0083] The outlet 336 of the housing 330 is configured to be in fluid communication with and / or fluidically disposed within the fluid flow paths 333, 354A and / or 354B. Additionally, the outlet 336 is configured to be fluidly coupled to a fluid collection device, such as, for example, a sample reservoir, a container, a vial, a negative pressure source, a syringe, and / or an intermediate control device and / or a transfer device (not shown in FIGS. 6-8). Each of the outlet 336 and the fluid collection device may be substantially similar to the outlet 236 and the fluid collection device, respectively, described above with reference to the control device 200. Accordingly, the outlet 336 and the fluid collection device will not be described in further detail herein.

[0084] As shown in FIGS. 6-8, the housing 330 includes and / or is coupled to an actuator 350 configured to selectively control the flow of bodily fluid through the housing 330. In some embodiments, the actuator 350 may be substantially similar in form and / or function to the actuator 250 described above with reference to FIGS. 2-5. However, in this embodiment, the actuator 350 is disposed as a plunger and includes a set of seals 365 disposed along an outer surface of the plunger. Additionally, as shown in FIG. 8, the actuator 350 has a substantially annular shape and is configured to at least temporarily receive and / or otherwise be disposed about a portion of the flow controller 342. As described above with reference to the actuator 250, the actuator 350 is configured to separate, isolate, separate, and / or otherwise impede fluid communication between the fluid flow path 333 and the fluid flow path 354B when in a first state, and is configured to place the fluid flow path 333 in fluid communication with the fluid flow path 354B when in a second state.

[0085] As discussed above, device 300 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as those present on the skin, and / or the like. For example, in some instances, a user, such as a doctor, physician, nurse, phlebotomist, technician, etc., can manipulate device 300 to establish fluid communication between inlet 331 and a source of bodily fluid (e.g., a patient's blood vessel). Once inlet 331 is in fluid communication with a source of bodily fluid (e.g., a portion of a patient), outlet 336 can be fluidly coupled to a fluid collection device. As discussed above, in the embodiment shown in FIGS. 6-8, the fluid collection device can be, for example, a vacuum reservoir, a syringe, and / or any container that defines a negative pressure.

[0086] By coupling the outlet 336 to the fluid collection device, at least a portion of the fluid flow paths 354A and 354B are selectively exposed to a negative pressure in and / or generated by the fluid collection device. The actuator 350 is arranged such that when in its first state, configuration, and / or position, the actuator 350 isolates the fluid flow path 354B from the fluid flow path 333, such that the fluid flow path 333 is not exposed to a negative pressure differential generated by the fluid collection device. As described above, the flow controller 342 is in fluid communication with the fluid flow path 354A and the isolation chamber 334. More specifically, the annular arrangement of the actuator 350 allows the flow controller 342 to be in fluid communication with the fluid flow path 354A (see, e.g., FIG. 8 ). Thus, by coupling the outlet 336 to the fluid collection device, the isolation chamber 334 is exposed to a negative pressure of the fluid collection device, thereby creating a negative pressure differential that is operable to draw bodily fluid from a bodily fluid source (e.g., a patient), through the inlet 331, and into the housing 330. As described above with reference to control devices 100 and 200, housing 330 is positioned such that when a volume of bodily fluid is transferred to and / or through inlet 331, an initial portion of the volume of bodily fluid (also referred to herein as the “initial volume” or “first volume”) flows from inlet 331 and into isolation chamber 334. That is, in some embodiments, housing 330 may be in a first or initial state in which an initial portion or volume of bodily fluid can flow from inlet 331 and into isolation chamber 334.

[0087] As described above, when the flow controller 342 and the actuator 350 are in a first state, position, configuration, etc., the housing 330 and / or the control device 300 may be in an initial state. As such, the actuator 350 separates, separates, separates, isolates, and / or otherwise prevents direct fluid communication between the fluid flow paths 333 and 354B. Additionally, the inlet 331 is exposed to a negative pressure differential via the isolation chamber 334. In other words, a negative pressure in or generated by the fluid collection device may create a negative pressure (or negative pressure differential) in at least a portion of the isolation chamber 334 that is operable in drawing an initial flow of bodily fluid from the inlet 331 and into the isolation chamber 334 when the housing 330 and / or the control device 300 are in a first or initial state. As described in detail above, in some instances, it may be desirable to regulate and / or control the magnitude of the negative pressure differential by any suitable means, such as those described herein.

[0088] As discussed in detail above with reference to control device 100 and / or 200, the initial portion and / or amount of bodily fluid may be any suitable amount of bodily fluid. For example, in some examples, the initial volume may be related to and / or based at least in part on an amount or volume of bodily fluid that is sufficient to fully wet or saturate flow controller 342. In other words, in some embodiments, the initial volume of bodily fluid may be a volume sufficient to transition flow controller 342 to a second state (e.g., a saturated state or a fully wet state). As discussed above with reference to flow controller 242, flow controller 342 is positioned in a sealing configuration when transitioning to the second state. Thus, by transitioning flow controller 342 to the second state, flow through flow controller 342 is isolated, blocked, separated, separate, spaced, and / or otherwise prevented.

[0089] After the initial volume of bodily fluid has been transferred and / or diverted to the isolation chamber 334, the control device 300 and / or the housing 330 can be transitioned to its second state or mode of operation to isolate, space, hold, contain, isolate, etc. the initial volume in the isolation chamber 334. As described above, the flow controller 342 is positioned in a sealing configuration, thus substantially preventing the flow of fluid therethrough. In this embodiment, the actuator 350 is arranged such that when the flow controller 342 is positioned in the sealing configuration, at least a portion of the negative pressure that would otherwise be applied through the flow controller 342 is instead applied to the actuator 350, thereby being sufficient to transition the actuator 350 from its first state to its second state. For example, in some embodiments, the negative pressure is operable to move the actuator 350 from a first position (e.g., the first state) to a second position (e.g., the second state), thereby establishing fluid communication between the fluid flow paths 333 and 354B.

[0090] More specifically, moving the actuator 350 to its second position (or otherwise transitioning the actuator 350 to its second state) moves and / or transitions the seal 365 relative to the fluid flow paths 333 and 354B to allow fluid communication therebetween. As such, negative pressure that would otherwise be applied on or through the isolation chamber 334 is now applied on or through the fluid flow paths 333 and 354B. In response, bodily fluid can flow from the inlet 331, through the fluid flow paths 333 and 354B, through the outlet 336, and into the fluid collection device. In some embodiments, transitioning the flow controller 342 and the actuator 350 from their respective first states to their respective second states is operable to isolate and / or retain an initial portion of the bodily fluid in the isolation chamber 334. As described in further detail herein, in some instances, contaminants, such as microorganisms present on the skin that are expelled during venipuncture, may be entrained and / or contained in the initial volume of bodily fluid and thus become isolated within the isolation chamber 334 when the initial volume is isolated therein.

[0091] With the fluid collection device fluidly coupled to the outlet 336 and the control device 300 and / or housing 330 in the second state (e.g., an initial volume of bodily fluid is isolated in or by the isolation chamber 334), any subsequent volume(s) of bodily fluid can flow from the inlet 331, through the fluid flow paths 333 and 354B, through the outlet 336, and into the fluid collection device. Thus, as described above, by isolating the initial volume of bodily fluid in the isolation chamber 334 prior to collecting or obtaining a test volume of one or more bodily fluids, the amount of contaminants in the one or more test volumes is reduced and / or substantially eliminated. Further, in some embodiments, the housing 330 can be positioned such that the housing 330 cannot transition to the second state before collecting and isolating the initial volume in the isolation chamber 334.

[0092] Figures 9-10 show a fluid control device 400, according to one embodiment. Fluid control device 400 may be similar, at least in form and / or function, to fluid control device 100 described above with reference to Figure 1, fluid control device 200 described above with reference to Figures 2-5, and / or fluid control device 300 described above with reference to Figures 6-8. Accordingly, portions of fluid control device 400 that may be similar to portions of fluid control devices 100, 200, and / or 300 will not be described in further detail herein.

[0093] 9 and 10, fluid control device 400 (also referred to herein as a "control device" or "device") includes a housing 430 having an inlet 431 and an outlet 436, and having and / or coupled to an actuator 450. As described above with reference to control devices 100, 200, and / or 300, inlet 431 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen containing device such as a needle). Outlet 436 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 9 and 10).

[0094] As described above, the housing 430 of the control device 400 is configured to (1) receive a flow and / or volume of bodily fluid from the inlet 431 and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) the flow and / or volume of bodily fluid within the isolation chamber 434. The housing 430 may be of any suitable shape, size, and / or configuration. In some embodiments, the housing 430 may have a size based at least in part on, for example, the volume of bodily fluid to be at least temporarily stored within the isolation chamber 434. For example, in the embodiment shown in FIGS. 9 and 10, the housing 430 is arranged (at least in part) as a syringe-like device or the like, as described in further detail herein.

[0095] The housing 430 defines fluid flow paths 433 and 454 in selective fluid communication with the outlet 436 and selectively receiving a flow of fluid (e.g., liquid and / or gas) therethrough. The outlet 436 of the housing 430 is configured to be in fluid communication with and / or fluidly disposed with the fluid flow paths 433 and / or 454. Additionally, the outlet 436 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 9 and 10 ). Each of the outlet 436 and the fluid collection device may be substantially similar to the outlet 236 and the fluid collection device, respectively, described above with reference to the control device 200. Accordingly, the outlet 436 and the fluid collection device will not be described in further detail herein.

[0096] The housing 430 includes and / or is coupled to an actuator 450 configured to selectively control the flow of bodily fluid through the housing 430. In this embodiment, the actuator 450 includes a first plunger 460 and a second plunger 461 configured to be movably disposed within the housing 430 and to at least partially define the isolation chamber 434. More specifically, the actuator 450 is configured to move between a first state ( FIG. 9 ) in which the inlet 431 is disposed in fluid communication with the isolation chamber 434 and a second state ( FIG. 10 ) in which the inlet 431 is disposed in fluid communication with the outlet 436 via the fluid flow passage 454. In this embodiment, when the actuator 450 and / or the housing 430 are in the first state, the inlet 431 is in fluid communication with a portion of the housing 430 defined between the first plunger 460 and the second plunger 461.

[0097] When in the first state, the first plunger 460 is positioned such that a damping chamber 437 is defined by the housing 430 on a side of the first plunger 460 opposite the isolation chamber 434. As shown, the damping chamber 437 is configured to be fluidly disposed with the fluid flow passage 433 via a port 435. The port 435 may be an opening, a valve, a membrane, a diaphragm, and / or any other suitable flow controller, etc., configured to at least selectively allow fluid communication between the fluid flow passage 433 and the damping chamber 437. Additionally, when the actuator 450 and / or the housing 430 are in the first state, the damping chamber 437 contains and / or accommodates a damping fluid 456, such as a gas (compressed or uncompressed) and / or a liquid (e.g., water, oil, a damping fluid, and / or any other suitable liquid).

[0098] When the actuator 450 and / or the housing 430 are in a first state, the second plunger 461 is disposed in a position within the housing 430 such that one or more seals 465 formed by or coupled to the second plunger 461 fluidly separate, separate, and / or isolate the inlet 431 from the fluid flow path 454. Additionally, the second plunger 461 and / or the seals 465 formed or coupled thereto fluidly isolate the fluid flow path 454 from the isolation chamber 434. Thus, when the actuator 450 and / or the control device 400 are in a first state, the inlet 431 is in fluid communication with the isolation chamber 434 and is fluidly isolated from the fluid flow paths 433 and 454 and the outlet 436 (see FIG. 9 ). As described in more detail herein, the actuator 450 and / or control device 400 can be configured to transition to a second state in which the isolation chamber 434 is isolated within the housing 430 and the inlet 431 is positioned in fluid communication with the fluid flow path 454 (see FIG. 10 ).

[0099] As discussed above, device 400 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as those present on the skin, and / or the like. For example, in some instances, a user, such as a doctor, physician, nurse, phlebotomist, technician, etc., can manipulate device 400 to establish fluid communication between inlet 431 and a source of bodily fluid (e.g., a patient's blood vessel). Once inlet 431 is positioned in fluid communication with a source of bodily fluid (e.g., a portion of a patient), outlet 436 can be fluidly coupled to a fluid collection device. As discussed above, in the embodiment shown in Figures 9 and 10, the fluid collection device can be, for example, a vacuum reservoir or container that defines a negative pressure.

[0100] As shown in FIG. 9 , the actuator 450 and / or the control device 400 may be in a first or initial state prior to coupling the outlet 436 to the fluid collection device. Thus, the fluid flow path 433 is in fluid communication with the damping chamber 437, and the fluid flow path 454 is fluidly isolated from the inlet 431 and the isolation chamber 434 (e.g., via the second plunger 461). As described above, by coupling the outlet 436 to the fluid collection device, at least a portion of the fluid flow paths 433 and 454 are exposed to a negative pressure within the fluid collection device. When the actuator 450 and / or the control device 400 is in the first state, the second plunger 461 isolates the housing 430 and / or the isolation chamber 434 from the negative pressure applied via the fluid flow path 454. Conversely, the negative pressure applied through the fluid flow path 433 may be operable in exerting at least a portion of the negative pressure on the damping chamber 437 (e.g., via the port 435). In some embodiments, for example, the port 435 can be transitioned from a closed configuration to an open configuration in response to negative pressure.

[0101] Negative pressure applied through the fluid flow path 433 is operable in transitioning the actuator 450 from a first state to a second state. For example, in some embodiments, the negative pressure differential draws damping fluid 456 from the damping chamber 437 and into the fluid flow path 433 or an auxiliary chamber, etc. Additionally, the negative pressure urges the first plunger 460 to transition and / or move from a first configuration or position to a second configuration or position relative to the housing 430. In some embodiments, the first plunger 460 can transition and / or move such that a volume of the housing 430 defined between the first plunger 460 and the second plunger 461 increases (i.e., the volume of the isolation chamber 434 increases). In some embodiments, the increase in the volume of the isolation chamber 434 creates a negative pressure therein, which may be operable in drawing an initial volume of bodily fluid through the inlet 431 and into the isolation chamber 434. In other words, the negative pressure of the fluid collection device indirectly creates a negative pressure differential between the inlet 431 and the isolation chamber 434 that is operable to draw an initial volume of bodily fluid into the isolation chamber 434 .

[0102] 10, movement of the first plunger 460 causes the second plunger 461 to move in a similar manner. For example, in some embodiments, the actuator 450 is arranged to move or transition the second plunger 461 from a first position and / or configuration to a second position and / or configuration after the first plunger 460 has moved a predetermined amount (and / or the volume of the isolation chamber 434 has increased a predetermined amount) and after an initial volume of bodily fluid has been drawn into the isolation chamber 434. As such, the actuator 450 is positioned in its second state in which the isolation chamber 434 is isolated from the inlet 431. In addition, the second plunger 461 and / or a seal 465 coupled thereto place the inlet 431 in fluid communication with the fluid flow path 454. Thus, any negative pressure that would otherwise be applied on or through the fluid flow path 433 is now applied on or through the fluid flow path 454. In response, bodily fluid can flow from inlet 431, through fluid flow path 454, through outlet 436 and into the fluid collection device.

[0103] In some embodiments, transitioning the actuator 450 from the first state to the second state is operable to isolate and / or retain an initial portion of the bodily fluid in the isolation chamber 434. As described in more detail herein, in some instances, contaminants, such as, for example, microorganisms present on the skin expelled during venipuncture, may be entrained and / or contained in the initial volume of bodily fluid and thus isolated within the isolation chamber 434 when the initial volume is isolated therein. Thus, as described above, by isolating the initial volume of bodily fluid in the isolation chamber 434 prior to collecting or obtaining one or more test volumes of the bodily fluid, the amount of contaminants in the one or more test volumes is reduced and / or substantially eliminated. Further, in some embodiments, the housing 430 may be positioned such that the housing 430 is unable to transition to the second state prior to collecting and isolating the initial volume in the isolation chamber 434.

[0104] As described above with reference to the control devices 100, 200, and / or 300, when the actuator 450 is in the first state, the control device 400 is configured to adjust the amount of negative pressure applied to the first plunger 460. Specifically, in this embodiment, the damping fluid 456 provided in the damping chamber 437 reduces the magnitude of the negative pressure applied to the first plunger 460. As such, the rate at which the actuator 450 and / or the control device 400 transition from the first state to the second state can be controlled. Furthermore, in some examples, the actuator 450 and / or the control device 400 can transition from the first state to the second state before receiving the initial volume of bodily fluid in the isolation chamber 434 by subjecting the housing 430 to a maximum negative pressure. As such, the amount of pressure can be adjusted to ensure that a desired volume of bodily fluid is transferred into the isolation chamber 434. It should be understood that while FIGS. 9 and 10 show the negative pressure being adjusted via the damping fluid 456, this is provided by way of example only and not by way of limitation. Any other suitable means of attenuating and / or regulating the magnitude of negative pressure may be used to control the transition of actuator 450 and / or housing 430.

[0105] Although the housing 430 is shown and described above in FIGS. 9 and 10 as being in a syringe-like configuration, including plungers 460 and 461, in other embodiments the housing may include any other suitable means for controlling fluid flow therethrough. For example, FIGS. 11 and 12 show a fluid control device 500, according to one embodiment. The fluid control device 500 may be similar, at least in form and / or function, to any of the fluid control devices 100, 200, 300, and / or 400. Thus, portions of the fluid control device 500 that may be similar to portions of the fluid control devices 100, 200, 300, and / or 400 will not be described in further detail herein. As shown in FIGS. 11 and 12, the fluid control device 500 (also referred to herein as the "control device" or "device") includes a housing 530 having an inlet 531 and an outlet 536 and coupled to an actuator 550. As described above with reference to control devices 100, 200, 300, and / or 400, inlet 531 is configured to be in fluid communication with a bodily fluid source and to receive bodily fluid therefrom (e.g., via a lumen containing device such as a needle). Outlet 536 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 11 and 12). Inlet 531, outlet 536, and fluid collection device may be substantially similar to those described above and therefore will not be described in further detail herein.

[0106] As described above, the housing 530 of the control device 500 is configured to (1) receive a flow and / or volume of bodily fluid from the inlet 531 and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) the flow and / or volume of bodily fluid within the isolation chamber 534. The housing 530 may be of any suitable shape, size, and / or configuration. In some embodiments, the housing 530 may have a size based at least in part on, for example, the volume of bodily fluid to be at least temporarily stored within the isolation chamber 534. For example, in the embodiment shown in FIGS. 11 and 12, the housing 530 may be configured substantially similarly to the housing 430 described above with reference to FIGS. 9 and 10. As described in more detail herein, the housing 530 may differ from the housing 430 by positioning the actuator 550, for example, as a diaphragm instead of one or more plungers.

[0107] The housing 530 defines a pair of fluid channels 533 and 554 in selective fluid communication with the outlet 536 and configured to selectively accept a flow of fluid (e.g., liquid and / or gas) therethrough. The housing 530 includes and / or is coupled to an actuator 550 configured to selectively control the flow of bodily fluid through the housing 530. In this embodiment, the actuator 550 includes a diaphragm 576 movably disposed within the housing 530 and configured to at least partially define the isolation chamber 534. More specifically, the actuator 550 is configured to transition between a first state ( FIG. 11 ) in which the inlet 531 is disposed in fluid communication with the isolation chamber 534 and a second state ( FIG. 12 ) in which the inlet 531 is disposed in fluid communication with the outlet 536 via the fluid channels 554.

[0108] 11, when actuator 550 and / or 500 is in a first state, inlet 531 is in fluid communication with a portion of housing 530 defined between diaphragm 576 and one or more seals 565. Further, as described above with reference to housing 430, diaphragm 576 is provided in the first state such that damping chamber 537 is defined by housing 530 on a side of diaphragm 576 opposite isolation chamber 534. Damping chamber 537 is configured to be fluidly disposed with fluid flow passage 533 via port 535. Port 535 may be an opening, a valve, a membrane, a diaphragm, and / or any other suitable flow controller, etc., configured to at least selectively establish fluid communication between fluid flow passage 533 and damping chamber 537. Additionally, when the actuator 550 and / or the control device 500 are in a first state, the damping chamber 537 includes and / or contains a damping fluid, such as a gas (compressed or uncompressed) and / or a liquid (e.g., water, oil, a damping fluid, and / or any other suitable liquid). As described above with reference to the control device 400, the arrangement of the damping chamber 537, the damping fluid, and the port 535 can be configured to regulate the amount of negative pressure applied to the diaphragm 576 when the actuator 550 is in a first state. Although FIGS. 11 and 12 show the negative pressure as being regulated via a damping fluid, it should be understood that this is provided by way of example only and not by way of limitation. Any other suitable means of damping and / or regulating the amount of negative pressure can be used to control the transition of the actuator 550 and / or 500.

[0109] As discussed above with reference to actuator 450, when actuator 550 and / or control device 500 is in a first state, one or more seals 565 are provided in a position within housing 530 such that one or more seals 565 fluidly separate, separate, and / or isolate inlet 531 from fluid flow path 554. Additionally, one or more seals 565 fluidly isolate fluid flow path 554 from isolation chamber 534. Thus, when actuator 550 and / or control device 500 is in a first state, inlet 531 is in fluid communication with isolation chamber 534 and is fluidly isolated from fluid flow paths 533 and 554 and outlet 536 (see FIG. 11 ). As described in more detail herein, housing 530 of actuator 550 and / or control device 500 can be configured to transition to a second state in which isolation chamber 534 is isolated within housing 530 and inlet 531 is disposed in fluid communication with fluid flow path 554 (see FIG. 12 ).

[0110] As described in detail above, device 500 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as those present on the skin and / or the like. For example, in some instances, a user can place inlet 531 in fluid communication with a source of bodily fluid (e.g., a portion of a patient) and fluidly couple outlet 536 to a fluid collection device. As shown in FIG. 11, actuator 550 and / or device 500 can be in a first or initial state prior to coupling outlet 536 to a fluid collection device. Thus, as described in detail above with reference to control device 400 in FIGS. 9 and 10, fluid flow path 533 is in fluid communication with dampening chamber 537, and fluid flow path 554 is fluidly isolated (e.g., via one or more seals 565) from inlet 531 and isolation chamber 534.

[0111] By coupling the outlet 536 to the fluid collection device, at least a portion of the fluid flow paths 533 and 554 are selectively exposed to a negative pressure in and / or generated by the fluid collection device. When the actuator 550 and / or the device 500 are in a first state, the one or more seals 565 isolate the housing 530 and / or the isolation chamber 534 from the negative pressure applied through the fluid flow path 554. Conversely, the negative pressure applied through the fluid flow path 533 may be operable in placing at least a portion of the negative pressure on the damping chamber 537 (e.g., via the port 535). In some embodiments, for example, the port 535 may be transitioned from a closed configuration to an open configuration in response to the negative pressure. The negative pressure applied through the fluid flow path 533 is operable in transitioning the actuator 550 from a first state to a second state. For example, in some embodiments, the negative pressure differential draws damping fluid from the damping chamber 537 into the fluid flow path 533. Additionally, the negative pressure may prompt the diaphragm 576 to transition, flip, move, switch, deform, etc. from a first configuration or state ( FIG. 11 ) to a second configuration or state ( FIG. 12 ). As described above with reference to actuator 450, transitioning the diaphragm 576 from the first state to the second state may increase the volume of the housing 530 defined between the diaphragm 576 and the one or more seals 565 (i.e., increase the volume of the isolation chamber 534), thereby creating a negative pressure therein that is operable to draw an initial volume of bodily fluid through the inlet 531 and into the isolation chamber 534.

[0112] 12, movement of the septum 576 similarly moves the one or more seals 565 such that the one or more seals 565 are disposed on the same side of the inlet 531 as the septum 576. Thus, the isolation chamber 534 is isolated within the housing 530. In addition, the one or more seals 565 move such that fluid communication is established between the inlet 531 and the fluid flow path 554. Thus, negative pressure that would otherwise be applied on or through the fluid flow path 533 is now applied on or through the fluid flow path 554. Accordingly, bodily fluid can flow from the inlet 531, through the fluid flow path 554, through the outlet 536, and into the fluid collection device, as described in detail above. In some embodiments, transitioning the actuator 550 from a first state to a second state is operable to isolate and / or retain an initial portion of the bodily fluid within the isolation chamber 534, the initial portion of the bodily fluid including, for example, contaminants such as microorganisms present on the skin that were expelled during venipuncture. Thus, as described above, by isolating an initial volume of bodily fluid in isolation chamber 534 prior to collecting or acquiring one or more test volumes of bodily fluid, the amount of contaminants in the one or more test volumes is reduced and / or substantially eliminated. Further, in some embodiments, control device 500 and / or housing 530 are arranged such that control device 500 and / or housing 530 cannot transition to the second state prior to collecting and isolating the initial volume in isolation chamber 534.

[0113] 13-15 illustrate a fluid control device 600, according to one embodiment. The fluid control device 600 may be similar, at least in form and / or function, to any of the fluid control devices 100, 200, 300, 400, and / or 500. As such, portions of the fluid control device 600 that may be similar to portions of the fluid control devices 100, 200, 300, 400, and / or 500 will not be described in further detail herein. As shown in FIGS. 13-15, the fluid control device 600 (also referred to herein as a "control device" or a "device") includes a housing 630 having an inlet 631 and an outlet 636 and coupled to an actuator 650. As described above with reference to the control devices 100, 200, 300, 500, and / or 500, the inlet 631 is in fluid communication with a source of bodily fluid and configured to receive fluid therefrom (e.g., via a lumen-containing device, such as a needle). The outlet 636 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 13-15). The inlet 631, the outlet 636, and the fluid collection device may be substantially similar to those described above, and therefore will not be described in further detail herein.

[0114] As described above, the housing 630 of the control device 600 is configured to (1) receive a flow and / or volume of bodily fluid from the inlet 631 and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) the flow and / or volume of bodily fluid within an isolation chamber 634 contained within and / or at least partially formed by the housing 630. The housing 630 may be of any suitable shape, size, and / or configuration. In some embodiments, the housing 630 may have a size based at least in part on the volume of bodily fluid to be at least temporarily stored within the isolation chamber 634, for example. For example, in the embodiment shown in FIGS. 13-15, the housing 630 may be configured substantially similarly to the housing 530 described above with reference to FIGS. 11 and 12. That is, the housing 630 includes an actuator 650 arranged as a diaphragm.

[0115] The housing 630 defines a pair of fluid flow paths 633 and 654 in selective fluid communication with the outlet 636 and configured to selectively accept a flow of fluid (e.g., liquid and / or gas) therethrough. The housing 630 includes and / or is coupled to an actuator 650 configured to selectively control the flow of bodily fluid through the housing 630. In this embodiment, the actuator 650 includes a diaphragm 676 movably disposed within the housing 630 and configured to at least partially define the isolation chamber 634. More specifically, as described in detail above with reference to the control device 500, the actuator 650 is configured to move between a first state in which the inlet 631 is disposed in fluid communication with the isolation chamber 634 and a second state in which the inlet 631 is disposed in fluid communication with the outlet 636 via the fluid flow paths 654.

[0116] 14 and 15, when the actuator 650 and / or 600 is in a first state, the inlet 631 is in fluid communication with a portion of the housing 630 defined between the diaphragm 676 and the one or more seals 665. Additionally, as described above with reference to the housing 530, the diaphragm 676 is provided in the first state such that a damping chamber 637 is defined by the housing 630 on a side of the diaphragm 676 opposite the isolation chamber 634. As shown, the damping chamber 637 is configured to be placed in fluid communication with the fluid flow passage 654 via the port 635 (such as those described above). Although not shown, as described in detail above with reference to the device 500, when the actuator 650 and / or control device 600 is in the first state, the damping chamber 637 can be configured to contain and / or accommodate a damping fluid, such as a gas (compressed or uncompressed) and / or a liquid (e.g., water, oil, a damping fluid, and / or any other suitable liquid), to adjust the amount of negative pressure applied to the diaphragm. Although described as regulating the negative pressure via a dampening fluid, it should be understood that this is provided by way of example only and not limitation, and any other suitable means of damping and / or regulating the magnitude of the negative pressure may be used to control the transition of actuator 650 and / or device 600.

[0117] As discussed above with reference to actuator 550, when actuator 650 and / or control device 600 is in a first state, seal 665 is disposed in housing 630 at a position such that seal 665 fluidly separates, separates, and / or isolates inlet 631 from fluid flow path 654. Additionally, seal 665 fluidly isolates fluid flow path 654 from isolation chamber 634. Thus, when actuator 650 and / or device 600 is in a first state, inlet 631 is in fluid communication with isolation chamber 634 and is fluidly isolated from fluid flow path 654 and outlet 636. Actuator 650 and / or device 600 can be configured to transition to a second state in which isolation chamber 634 is isolated within housing 630 and inlet 631 is disposed in fluid communication with fluid flow path 654. Thus, device 600 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms (e.g., microorganisms present on the skin and / or the like) in substantially the same manner as device 500 described above with reference to Figures 11 and 12. Accordingly, the function of device 600 will not be described in further detail herein.

[0118] 16-18 illustrate a fluid control device 700, according to one embodiment. The fluid control device 700 may be similar, at least in form and / or function, to any of the fluid control devices 100, 200, 300, 400, 500, and / or 600. As such, portions of the fluid control device 700 that may be similar to portions of the fluid control devices 100, 200, 300, 400, 500, and / or 600 will not be described in further detail herein. As shown in FIGS. 16-18, the fluid control device 700 (also referred to herein as a "control device" or "device") includes a housing 730 having an inlet 731 and an outlet 736 and including or coupled to an actuator 750. As described above with reference to control devices 100, 200, 300, 400, 500, and / or 600, inlet 731 is in fluid communication with a bodily fluid source and configured to receive bodily fluid therefrom (e.g., via a lumen containing device such as a needle). Outlet 736 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 16-18). Inlet 731, outlet 736, and fluid collection device may be substantially similar to those described above and therefore will not be described in further detail herein.

[0119] As described above, the housing 730 of the control device 700 is configured to (1) receive a flow and / or volume of bodily fluid from the inlet 731 and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) the flow and / or volume of bodily fluid within the isolation chamber 734. The housing 730 may be of any suitable shape, size, and / or configuration. In some embodiments, the housing 730 may have a size based at least in part on the volume of bodily fluid to be at least temporarily stored within the isolation chamber 734, for example. For example, in the embodiment illustrated in FIGS. 16-18, the housing 730 may be configured substantially similarly to the housings 530 and / or 630. That is, the housing 530 includes and / or is coupled to an actuator 750 arranged as a diaphragm.

[0120] The housing 730 defines a pair of fluid flow paths 733 and 754 in selective fluid communication with the outlet 736 (see, e.g., FIGS. 17A and 17B ) and configured to selectively accept a flow of fluid (e.g., liquid and / or gas) therethrough. The housing 730 includes and / or is coupled to an actuator 750 configured to selectively control the flow of bodily fluid through the housing 730. In this embodiment, the actuator 750 includes a diaphragm 776 movably disposed within the housing 730 and configured to at least partially define the isolation chamber 734. More specifically, as described in detail above with reference to the control device 500, the actuator 750 is configured to move between a first state in which the inlet 731 is disposed in fluid communication with the isolation chamber 734 and a second state in which the inlet 731 is disposed in fluid communication with the outlet 736 via the fluid flow paths 754.

[0121] In the embodiment shown in FIGS. 16-18, when the actuator 750 and / or device 700 is in a first state, the inlet 731 is in fluid communication with an isolation chamber 734 formed by a portion of the housing 730 defined between a diaphragm 776 and a flow controller 742 (e.g., a selectively permeable fluid barrier or seal, and / or any other flow controller such as any of those described above). Additionally, the diaphragm 776 is disposed in the first state such that the fluid flow path 733 is in fluid communication with the isolation chamber 734. As discussed above with reference to the actuator 550, when the actuator 750 and / or control device 700 is in the first state, the diaphragm 776 and / or seal 765 are disposed in a position within the housing 730 such that the diaphragm 776 and / or seal 765 fluidly separate, separate, and / or isolate the inlet 731 from the fluid flow path 754. Additionally, diaphragm 776 and / or seal 765 fluidly isolate fluid flow path 754 from isolation chamber 734. Thus, when actuator 750 and / or device 700 is in the first state, inlet 731 is in fluid communication with isolation chamber 734 and is fluidly isolated from fluid flow path 754.

[0122] For example, as described above with reference to control device 200, when actuator 750 and / or device 700 are in a first state, a negative pressure differential in isolation chamber 734 may be created by coupling a fluid collection device to outlet 736. More specifically, fluid flow path 733 may be in fluid communication with outlet 736 and flow controller 742. When flow controller 742 is in a first state, flow controller 742 may allow gas or air to pass therethrough. Thus, a negative pressure differential in isolation chamber 734 may be created by coupling a fluid collection device to outlet 736.

[0123] 18, as described in detail above with reference to device 600, the actuator 750 and / or control device 700 can be configured to transition to a second state in which the isolated chamber 734 is isolated within the housing 730 and the inlet 731 is disposed in fluid communication with the fluid flow path 754. More specifically, an initial volume of bodily fluid can be transitioned into the isolated chamber 734, which can saturate, wet, and / or otherwise transition the flow controller 742 from a first or open state to a second or closed state. In some embodiments, the transition of the flow controller 742 from the first state to the second state can be operable to isolate the fluid flow path 733 from the outlet 736. As such, negative pressure applied through the fluid flow path 754 can be operable to transition, switch, flip, move, deform, and / or otherwise reconfigure the diaphragm 776 such that the actuator 750 is in its second state. Thus, as described in detail above, the negative pressure of the fluid collection device can draw bodily fluid from the inlet 731, through the housing 730 (bypassing the isolation chamber 734), through the fluid flow path 754 and the outlet 736, and into the fluid collection device. Thus, device 700 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms (e.g., microorganisms present on the skin and / or the like) in substantially the same manner as one or more of control devices 100, 200, 300, 400, 500, and / or 600 described in detail above. Accordingly, the function of device 700 will not be described in further detail herein.

[0124] In some embodiments, any of the control devices 100, 200, 300, 400, 500, 600, and / or 700 may be formed from any suitable components that may be manufactured, assembled, sterilized, and packaged as an assembly or integrated device. In such embodiments, for example, a user may open a package containing such an assembly or integrated device and use the device as described above with reference to the control devices 100, 200, 300, 400, 500, 600, and / or 700. In some embodiments, any of the control devices may be formed in whole or at least in part integrally.

[0125] In some embodiments, any control device may be physically coupled, attached, formed, and / or otherwise connected to a fluid collection device (e.g., a sample reservoir, a syringe, a blood culture bottle, a collection vial, a fluid transfer container, and / or other suitable reservoir, collection device, and / or transfer device) during the manufacturing process. This may be done prior to sterilization so that the collection path(s) and connection interface(s) (e.g., where the control device couples to the fluid collection device) remain within a sterile environment that is free of touch point contamination from external sources, a closed system mechanical diversion device. In this way, in order for a user to transfer a test volume to a fluid collection device, the user is first forced to isolate, space out, and / or separate at least a portion of the initial bodily fluid volume or flow. In some embodiments, coupling, connection, and / or attachment of the fluid control device to the fluid collection device may allow access to the fluid collection device by removing the control device after use (physically disconnecting, removing with a specific "key", and / or other techniques used to separate the control device from the fluid collection device), which may then be positioned in an incubator and / or any other type of analytical machine, accessed for analysis, and / or otherwise further processed. In some embodiments, such an uncoupled state may be blocked, limited, and / or substantially prevented prior to use, and unblocked or allowed after use. In other embodiments, the fluid control device and the fluid collection device may be permanently coupled and / or formed integrally (at least in part) to prevent such uncoupling.

[0126] Although described above as being combined and / or assembled, e.g., during manufacture, in other embodiments, the control device may include one or more modular components that a user may select based on desired use, preferences, patient, etc. In such embodiments, a user may combine one or more modular components (packaged together or packaged separately) to form a desired fluid control device. For example, FIGS. 19-25 show a modular fluid control device 800, according to one embodiment. The fluid control device 800 may be similar, at least in form and / or function, to the fluid control devices described herein. More specifically, portions of the fluid control device 800 may be similar and / or substantially the same as corresponding portions of the fluid control device 200 as described above with reference to FIGS. 2-5. Accordingly, such portions of the fluid control device 800 are not described in further detail herein.

[0127] Fluid control device 800 (also referred to herein as a "control device" or "device") includes a housing 830 and an actuator 850. As discussed above, control device 800 can be at least partially integrally formed or pre-assembled during manufacturing. In other embodiments, control device 800 can be at least partially modular such that a user can physically and fluidly couple housing 830 and actuator 850 to form control device 800. Housing 830 of device 800 can be of any suitable shape, size, and / or configuration. For example, in the embodiment shown in FIGS. 19-25, housing 830 can be, for example, relatively thin and substantially rectangular. In some embodiments, a portion of housing 830 can be substantially similar, at least in form and / or function, to housing 230 described above with reference to FIGS. 2-5. Thus, although such portions have been identified, similar components, features, and / or functions are not described in further detail herein.

[0128] 19 and 20, the housing 830 forms and / or defines an isolation chamber 834 in selective fluid communication with a first port 845 and a second port 846. The first port 845 and the second port 846 are at least fluidly coupled to a portion of the actuator 850 and configured to allow selective fluid flow between the housing 830 and the actuator 850. As described in further detail herein, the isolation chamber 834 is configured to (1) receive a selective flow and / or volume of bodily fluid from a portion of the actuator 850 via the first port 845, and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) a flow and / or volume of bodily fluid within the isolation chamber 834 (e.g., an initial or first flow and / or volume of bodily fluid or any portion thereof). The isolation chamber 834 can have any suitable shape, size, and / or configuration. For example, in some embodiments, isolation chamber 834 can have any suitable size, volume, and / or fluid capacity, such as, for example, those described above with reference to isolation chamber 134. In the embodiment shown in Figures 19-25, isolation chamber 834 can be, for example, a fluid flow path extending through and / or defined by at least a portion of housing 830. For example, in some embodiments, isolation chamber 834 can be substantially similar, at least in form and / or function, to isolation chamber 234 described above with reference to Figures 2-5, and thus will not be described in further detail herein.

[0129] 20, the housing 830 includes and / or defines a flow controller 842 and a restricted flow path 832. The flow controller 842 may be, for example, a valve, membrane, diaphragm, restrictor, vent, selectively permeable member, port, etc., configured to selectively control (at least in part) the flow of fluid into and / or out of the isolation chamber 834 and / or any other suitable portion of the housing 830. For example, the flow controller 842 may be a selectively permeable fluid barrier (e.g., a blood barrier) including and / or formed of a porous material configured to selectively allow the flow of gases but prevent the flow of liquids therethrough. In some embodiments, the flow controller 842 may be substantially similar to the flow controller 242 described in detail above with reference to FIGS. 2-5, and therefore will not be described in further detail herein.

[0130] As shown, the housing 830 defines a restrictive flow path 832 that is in fluid communication with the second port 846 and is positioned between the second port 846 and the flow controller 842 (or a portion of the housing 830 that receives or houses the flow controller 842). As described above with reference to the restrictive flow path 232 shown in FIGS. 2-5, the restrictive flow path 832 is a fluid flow path having a smaller diameter than one or more other flow paths defined by the housing 830 and / or the actuator 850, for example. For example, in some embodiments, the restrictive flow path 832 can have a diameter of about 0.0005 inches to about 0.5 inches and a length of about 0.01 inches to about 0.5 inches, as described above with reference to the restrictive flow path 232. As described above, the smaller diameter of the restrictive flow path 832 results in a lower magnitude of negative pressure being applied through the isolation chamber 834 than the magnitude of negative pressure when the restrictive flow path 832 has a larger diameter. In other words, the restrictive flow path 832 can be configured to regulate the amount of negative pressure to which the isolation chamber 834 is exposed. In some examples, the amount of negative pressure can be adjusted to control the rate at which bodily fluid is transferred into the isolation chamber 834. Additionally, in this embodiment, the restricted flow path 832 can be a gas flow path configured to accept a flow of gas or air, rather than a flow of liquid (e.g., bodily fluid), for example, and can allow a negative pressure differential sufficient to adequately collect an initial amount of bodily fluid and / or transition at least a portion of the control device 800 to the second state, while limiting and / or substantially preventing a portion of the initial or first volume of bodily fluid from being drawn through the isolation chamber 834 and second port 846.

[0131] As shown in FIGS. 19-24, actuator 850 includes a body 851 and an actuator rod 862. Body 851 of actuator 850 includes an inlet 852 and an outlet 853. Inlet 852 and outlet 853 may be substantially similar, at least in form and / or function, to inlet 231 and outlet 236 described above with reference to FIGS. 2-5. Thus, inlet 852 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen-containing device, such as a needle, IV catheter, PICC line, etc.). Outlet 853 is configured to be fluidly coupled to a fluid collection device 880, such as, for example, a sample reservoir, syringe, and / or other intermediate bodily fluid transfer device, adapter, or reservoir (see, for example, FIG. 25), such as, for example, a transfer device similar to those described in the '510 publication.

[0132] 21 , the body 851 of the actuator 850 includes and / or defines a first port 858 and a second port 859. The first port 858 is in fluid communication with the inlet 852, and the second port 859 is in fluid communication with the outlet 853. Further, the first port 858 and the second port 859 are configured to be at least fluidly coupled to the first port 845 and the second port 846, respectively, of the housing 830. As described in further detail herein, the actuator 850 can be transitioned between a first mode or state of operation and a second mode or state of operation to selectively control the flow of fluid through the ports 858 and 859 of the actuator 850 and the ports 845 and 846 of the housing 830, thereby selectively controlling the flow of bodily fluids into and / or out of the isolation chamber 834 of the housing 830.

[0133] In some embodiments, the arrangement of ports 858 and 859 of actuator 850 and ports 845 and 846 of housing 830 may enable and / or otherwise provide a means of physically coupling housing 830 to actuator 850 and fluidically coupling housing 830 to actuator 850. For example, in some embodiments, ports 858 and 859 of actuator 850 and ports 845 and 846 of housing 830 may form a friction fit, press fit, interference fit, and / or the like. In other embodiments, ports 858 and 859 of actuator 850 may be coupled to ports 845 and 846 of housing 830, respectively, via adhesives, mechanical fasteners, elastic couplings, gaskets, O-ring(s), and / or any other suitable coupling means. In yet other embodiments, ports 858 and 859 of actuator 850 may be physically and fluidly coupled to ports 845 and 846, respectively, of housing 830 via intervening structures, such as, for example, one or more sterile, flexible tube(s). Thus, device 800 may be and / or have a modular configuration in which housing 830 may be at least fluidly coupled to actuator 850, for example.

[0134] In some embodiments, such a modular configuration may allow a user to select a housing (or actuator) having one or more desired characteristics based on, for example, the intended purpose and / or use of the assembled device. In other embodiments, the modular arrangement may enable and / or facilitate the combination and / or assembly of one or more components having desired characteristics during manufacturing. For example, in some instances, it may be desirable to select a housing that includes and / or defines an isolation chamber having a particular or desired volume. As a specific example, when using the device to acquire bodily fluids from pediatric and / or critically ill patients (for example), it may be desirable to select a housing that defines and / or includes an isolation chamber having a smaller volume than would be selected when using the device to acquire bodily fluids from an apparently healthy adult patient. Thus, such a modular configuration may allow a user (e.g., a doctor, physician, nurse, technician, phlebotomist, etc.) to select a housing or actuator having one or more desired characteristics based on, for example, the intended use of the device. In other instances, the modular arrangement may enable or facilitate the assembly of a housing or actuator having one or more desired characteristics during manufacturing without significant changes to one or more manufacturing processes.

[0135] An actuator rod 862 of the actuator 850 is movably disposed within a portion of the body 851. The actuator rod 862 includes a first end 863 and a second end 864, at least one of which extends over the body 851 of the actuator 850 with the actuator rod 862 disposed within the body 851 (see, for example, FIGS. 23 and 24). A portion of the actuator rod 862 includes and / or is coupled to a set of seals 865. The seals 865 can be, for example, O-rings, elastic overmolding, protruding or raised features or fittings, and / or the like. The actuator 862 and the body 851 of the actuator 850 can be arranged such that an inner portion of the seals 865 forms a fluid-tight seal with a surface of the actuator rod 862 and an outer portion of the seals 865 forms a fluid-tight seal with an inner surface of the body 851. In other words, the seals 865 form one or more fluid-tight seals between the actuator rod 862 and the inner surface of the body 851. As shown in Figures 23 and 24, the actuator rod 862 includes and / or is coupled to three seals 865 that form and / or define a first fluid flow path 833 within the body 851 of the actuator 850 and a second fluid flow path 854 within the body 851 of the actuator 850.

[0136] The actuator rod 862 is configured to be moved or transitioned relative to the body 851 between a first position or configuration and a second position or configuration. For example, in some examples, a force can be applied to a first end 863 of the actuator rod 862 to position the actuator rod 862 in its first position and / or configuration, as shown in FIG. 23 . The force applied to the first end 863 of the actuator rod 862 can originate from any suitable source. For example, a user can generate the force with their own hand or finger, a syringe, a positive or negative pressure source, and / or any other external energy source. When in the first position and / or configuration, the inlet 852 of the actuator 850 is in fluid communication with the first fluid flow path 833 and the outlet 853 of the actuator 850 is in fluid communication with the second fluid flow path 854. In some examples, a force can be applied to a second end 864 of the actuator rod 862 to position the actuator rod 862 in its second position and / or configuration, as shown in FIG. 24 . When in the second position and / or configuration, each of the inlet 852 and outlet 853 of the actuator 850 is in fluid communication with the second fluid flow path 854, while the first fluid flow path is isolated, separated, and / or otherwise not in fluid communication with the inlet 852 and outlet 853. Although not shown, the first port 858 of the actuator 850 is in fluid communication with the first fluid flow path 833, and the second port 859 of the actuator 850 is in fluid communication with the second fluid flow path 854. Thus, as described in more detail herein, moving and / or transitioning the actuator rod 862 (or actuator 850 in general) between the first and second positions may be operable in selectively controlling the flow of fluid (e.g., bodily fluid) between the inlet 852 of the actuator 850 and the housing 830, or between the inlet 852 of the actuator 850 and the outlet 853 of the actuator 850.

[0137] As described above, device 800 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as those present on the skin, microorganisms external to the bodily fluid source, and / or the like. For example, in some instances, a user, such as a doctor, physician, nurse, phlebotomist, technician, etc., can manipulate device 800 to establish fluid communication between inlet 852 and a bodily fluid source (e.g., a patient's blood vessel). Once inlet 852 is positioned in fluid communication with a bodily fluid source (e.g., a portion of a patient), outlet 853 can be fluidly coupled to fluid collection device 880. In the embodiment shown in FIGS. 19-25, fluid collection device 880 can be, for example, a syringe (as shown in FIG. 25) and / or any other suitable container or device configured to define or generate a negative pressure or energy source.

[0138] For example, as described in detail above with reference to device 200, by coupling outlet 853 to fluid collection device 880, at least a portion of control device 800 is selectively exposed to negative pressure within and / or generated by fluid collection device 880. More specifically, in the embodiment shown in FIGS. 19-25, by coupling outlet 853 to fluid collection device 880, outlet 853 and second fluid flow path 854 of actuator 850 are exposed to negative pressure within and / or generated by fluid collection device 880. In addition, second port 859 of actuator 850 is in fluid communication with second fluid flow path 854 and second port 846 of housing 830. Second port 846 of housing 830 is thereby in selective fluid communication with isolation chamber 834 via flow controller 842 and restriction flow path 832. For example, device 800 and / or flow controller 842 may be in a first operational state or first mode in which flow controller 842 allows the flow of gas (e.g., air) through flow controller 842, while restricting and / or preventing the flow of liquid (e.g., bodily fluids such as blood) through flow controller 842. Thus, by coupling fluid collection device 880 to outlet 853, a negative pressure differential is created between fluid collection device 880 (and / or any suitable negative pressure source) and isolation chamber 834.

[0139] As discussed above, the control device 800 may be in a first state or initial state when the flow controller 842 and / or the actuator 850 are in a first state, position, configuration, etc. As such, the actuator rod 862 may be in its first position and / or configuration in which the first fluid flow path 833 is in fluid communication with the inlet 852. Additionally, the first port 858 of the actuator 850 and the first port 845 of the housing 830 allow fluid communication between the isolation chamber 834 and the first fluid flow path 833. Thus, when the actuator 850 and / or control device 800 are in a first or initial state (e.g., when the actuator rod 862 is in its first state, position, and / or configuration), the negative pressure within the fluid collection device 880 can create a negative pressure (or negative pressure differential) within at least a portion of the isolation chamber 834 that is operable to draw an initial flow, portion, amount, or volume of bodily fluid from the inlet 852, through the first fluid flow path 833, and into the isolation chamber 834. In some examples, the arrangement of the flow controller 842 and / or the restrictor flow path 832 can be configured to restrict, limit, control, and / or otherwise regulate the amount or magnitude of negative pressure applied on or through the isolation chamber 834, as described in detail above with reference to device 200.

[0140] As described in detail above with reference to the control device 100, the initial portion and / or amount of bodily fluid may be any suitable amount of bodily fluid. For example, in some examples, the initial volume may be related to and / or based at least in part on an amount or volume of bodily fluid that is sufficient to fully wet or saturate the flow controller 842. In other words, in some embodiments, the initial volume of bodily fluid may be a volume sufficient to transition the flow controller 842 from a first state to a second state (e.g., a saturated state or a fully wet state). In some embodiments, the flow controller 842 is positioned in a sealing configuration when transitioning to the second state. That is, by saturating and / or fully wetting the flow controller 842 (e.g., a semi-permeable material), the flow controller 842 is positioned in a sealing configuration in which the flow controller 842 substantially prevents the flow of liquids and gases therethrough. Thus, by transitioning the flow controller 842 to the second state, flow through the flow controller 842 between the restrictor flow path 832 and the isolation chamber 834 is isolated, blocked, separated, separate, spaced apart, and / or otherwise prevented.

[0141] After transferring and / or diverting the initial volume of bodily fluid to the isolation chamber 834, the control device 800 and / or the actuator 850 can be transitioned to its second state or mode of operation to isolate, space, hold, contain, isolate, etc. the initial volume in the isolation chamber 834. For example, the actuator 850 can be actuated to transition from its first state to its second state, for example, by application of a force to the second end 864 of the actuator rod 862. Thus, the actuator rod 862 is moved and / or transitioned to its second state, position, and / or configuration that isolates and / or separates the first fluid flow path 833 from the inlet 852. The initial volume of bodily fluid is isolated in the isolation chamber 834 by the flow controller 842 in a sealing configuration in response to the initial volume of bodily fluid provided in the isolation chamber 834, and by the initial fluid flow path 833 isolated and / or separated from the inlet 852. As described in detail above, in some instances, contaminants, such as microorganisms present on the skin that are expelled during venipuncture, may be entrained and / or contained in the initial volume of bodily fluid and thus become isolated within the isolation chamber 834 when the initial volume is isolated therein.

[0142] 24, by moving and / or transitioning the control device 800 and / or actuator 850 to its second state or configuration, fluid communication is established between the inlet 852 and the outlet 853 via the second fluid flow path 854. As such, negative pressure that would otherwise be applied on or through the isolation chamber 834 is now applied on or through the fluid flow path 854. In response, bodily fluid can flow from the inlet 852, through the fluid flow path 854, through the outlet 853, and into the fluid collection device 880. Thus, as described above, by isolating an initial volume of bodily fluid in the isolation chamber 834 prior to collecting or acquiring one or more test volumes of bodily fluid, the amount of contaminants in the one or more test volumes is reduced and / or substantially eliminated. Further, in some embodiments, the control device 800 can be positioned such that the control device 800 cannot transition to the second state before the control device 800 has collected and isolated the initial volume in the isolation chamber 834, thereby reducing the likelihood of contaminants being transferred to the fluid collection device 880.

[0143] In some examples, it may be desirable to isolate the negative pressure source (e.g., a negative pressure source) of the fluid collection device 880 from the inlet 853, such as when it is desirable to collect multiple samples of bodily fluid using multiple fluid collection devices 880 (e.g., syringes). For example, in some examples, after filling the fluid collection device 880, a user may use the actuator 850 to apply a force to the first end 863 of the actuator rod 862 to move and / or transition the actuator rod 862 from its second position and / or configuration toward its first position and / or configuration. As such, the second fluid flow path 854 is not disposed in fluid communication between the inlet 852 and the outlet 853. Additionally, the flow controller 842 may be configured to control the flow of the fluid from the outlet 853 to the outlet 853. The port 853 may remain in a sealed state or configuration (e.g., fully saturated, wetted, and / or otherwise impeding flow therethrough) such that the port 853 is substantially isolated or separated from the remainder of the control device 800. In some examples, the user may then remove the filled fluid collection device 880 (e.g., a syringe) and couple a new fluid collection device 880 (e.g., a syringe) to the outlet 853. As described above, with the new fluid collection device 880 coupled to the outlet 853, the user may apply a force, for example, to the second end 864 of the actuator rod 862 to move and / or transition the actuator rod 862 back to the second position, state, and / or configuration.

[0144] Although the fluid collection device 880 coupled to the device 800 is shown in FIG. 25 as being a syringe, in other embodiments the control device may be physically and / or fluidly coupled to any suitable collection device. For example, FIG. 26 illustrates a fluid control device 900. As described above with reference to the control device 800, the fluid control device 900 includes a housing 930 and an actuator 950, which may be arranged, for example, in a modular configuration. The actuator 950 includes an inlet 952 configured to be in fluid communication with a source of bodily fluid and an outlet 953 configured to be coupled to the fluid collection device 980. In the embodiment illustrated in FIG. 26, the fluid collection device 980 is a transfer adapter configured to be coupled to one or more reservoirs, such as, for example, a vacuum vessel, a sample bottle, a culture bottle, etc. In such an embodiment, the reservoir may be sealed prior to being coupled to the transfer adapter (i.e., the fluid collection device 980), and once coupled, the seal may be pierced, displaced, deformed, and / or otherwise unsealed to expose the outlet 953 to a negative pressure within the reservoir. Thus, the fluid control device 900 can function substantially similarly to the control device 800 described above with reference to Figures 19-25.

[0145] Although the fluid control device 800 is shown as including an actuator rod 862 including a first end 863 and a second portion 864 that can be transitioned between its first and second configurations, states, and / or positions upon application of a force, in other embodiments, the control device can include an actuator having any suitable configuration. For example, as shown in FIG. 26, the fluid control device 900 includes an actuator rod 962 having only a single end that extends beyond the body 951 of the actuator 950. In such embodiments, the device 900 can be used to fill a fluid collection device, such as, for example, a sample reservoir, container, vial, etc., and if it is desired to collect more than one sample, a user can, for example, disconnect the inlet 952 from the lumen containing device and / or any suitable device that otherwise places the inlet 952 in fluid communication with a source of bodily fluid. Once disconnected, a user can couple the inlet of a new control device 900 to the lumen containing device and / or the like, and one or more additional samples can be collected in a manner similar to that described above with reference to the control device 800.

[0146] As mentioned above, some fluid control devices described herein may be and / or have a modular configuration in which one or more components may be combined to collectively form a fluid control device having a desired set of properties, etc. For example, the fluid control device 800 shown in FIGS. 19-25 includes a housing 830 and an actuator 850 in one modular arrangement. However, it should be understood that the control device may have any suitable modular arrangement. For example, FIG. 27 illustrates a modular fluid control device 1000, according to one embodiment. The fluid control device (also referred to herein as a "device") includes a housing 1030 that forms and / or defines a segregation chamber 1034 and an actuator 1050 that forms and / or has an inlet 1052 and an outlet 1053. The device 1000 may be substantially similar to the control device 800 described in detail above, but may be arranged such that the housing 1030 is provided at a different position and / or orientation relative to the actuator 1050. In some embodiments, the arrangement may be altered to, for example, increase usability, visibility, and / or the like, and / or otherwise allow for a more compact design.

[0147] As another example, FIG. 28 illustrates a modular fluid control device 1100, according to one embodiment. The fluid control device (also referred to herein as a "device") includes a housing 1130 that forms and / or defines a segregation chamber 1134, and an actuator 1150 that forms and / or has an inlet 1152 and an outlet 1153. The device 1100 may be substantially similar to the control device 800 described in detail above, but may be arranged such that the housing 1130 is provided at a different position and / or orientation relative to the actuator 1150. Additionally, as shown in FIG. 28, the actuator 1150 may be arranged such that the inlet 1152 and the outlet 1153 are provided in a substantially perpendicular position relative to one another. As discussed above, in some embodiments, the arrangement may be changed to, for example, enhance usability, visibility, and / or the like, and / or otherwise allow for a more compact design. While examples of modular fluid control devices are illustrated herein, it should be understood that such embodiments are presented by way of example and not limitation. Thus, while particular locations and / or orientations may be described herein, the devices and / or concepts described herein are not intended to be limited to those shown herein.

[0148] Although the housings 230, 330, 830, 930, 1030, and 1130 are shown and described herein as including and / or defining isolation chambers arranged in a serpentine configuration, in other embodiments, any other suitable portion of the housing and / or control device can include and / or define isolation chambers having any suitable configuration. For example, FIGS. 29-34 show a fluid control device 1200, according to one embodiment. The fluid control device 1200 can be similar, at least in form and / or function, to the fluid control devices described herein. More specifically, portions of the fluid control device 1200 can be similar and / or substantially the same as corresponding portions of the fluid control devices 200, 300, 800, 900, 1000, and / or 1100 described above. Accordingly, such portions of the fluid control device 1200 are not described in further detail herein.

[0149] Fluid control device 1200 (also referred to herein as "control device" or "device") includes a housing 1230 and an actuator 1250. As described above with reference to control device 800, control device 1200 can be arranged in a modular configuration such that housing 1230 and actuator 1250 can be physically and fluidly coupled to form control device 1200. In other embodiments, control device 1200 need not be modular. That is, in some embodiments, control device 1200 can be assembled during manufacture and delivered to a supplier and / or end user as an assembled device. In other embodiments, control device can be integrally formed and / or coupled to a fluid collection device in any suitable manner, as described in detail above.

[0150] The housing 1230 of the control device 1200 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, the housing 1230 may be substantially similar, at least in form and / or function, to the housing 830 described in detail above. Accordingly, such similar portions of the housing 1230 will be identified below, but may not be described in further detail herein.

[0151] As shown in FIGS. 29-31, the housing 1230 forms and / or defines an isolation chamber 1234 in selective fluid communication with a first port 1245 and a second port 1246. The second port 1246 is configured to receive, include, and / or define a flow controller 1242 (see, e.g., FIG. 30) and a restrictive flow path 1232 (see, e.g., FIG. 31). Although shown to include a restrictive flow path 1232, in other embodiments, the housing need not include or receive a restrictive flow path (e.g., when excessive negative pressure is unlikely or otherwise not intended to be applied to the isolation chamber 1234, such as when the fluid collection device is a syringe or the like). The first port 1245 and the second port 1246 are at least fluidly coupled to a portion of the actuator 1250 and configured to allow selective fluid flow between the housing 1230 and the actuator 1250. As described in more detail herein, the isolation chamber 1234 is configured (1) to receive a selective flow and / or volume of bodily fluid from a portion of the actuator 1250 via a first port 1245, and (2) to isolate (e.g., separate, space, contain, hold, separate, etc.) a flow and / or volume of bodily fluid (e.g., an initial or first flow and / or volume of bodily fluid or any portion thereof) within the isolation chamber 1234.

[0152] The isolation chamber 1234 can have any suitable shape, size, and / or configuration. For example, in some embodiments, the isolation chamber 1234 can have any suitable size, volume, and / or fluid capacity, such as, for example, those described above with reference to the isolation chamber 134. In the embodiment shown in FIGS. 29-34, the isolation chamber 1234 can be, for example, a fluid flow path extending through and / or defined by at least a portion of the housing 1230. In some embodiments, the isolation chamber 1234 can be substantially similar, at least in form and / or function, to the isolation chamber 834 described above with reference to FIGS. 19-25. As shown in FIG. 30, the isolation chamber 1234 and / or the housing 1230 can differ from the isolation chamber 834 and / or the housing 830 by being arranged in a helical configuration, with, for example, a first port 1245 in fluid communication with an inner portion of the helical isolation chamber 1234 and a second port 1246 in fluid communication with, for example, an outer portion of the helical isolation chamber. In some embodiments, the isolation chamber 1234 can be, for example, a channel formed in a portion of the housing 1230 .

[0153] In some embodiments, the channel forming at least a portion of the isolation chamber 1234 can have a relatively small cross-sectional shape and / or size that can reduce and / or substantially prevent mixing of the initial volume of bodily fluid drawn into the isolation chamber 1234 (channel) with a volume of air in the isolation chamber 1234 (e.g., a volume of air that has not been exhausted or purged, as described in further detail herein). For example, in some examples, the relatively small cross-sectional shape and / or size of the isolation chamber 1234 (channel), the surface tension associated with the bodily fluid flowing into the isolation chamber 1234, and the contact angle between a surface of the housing 1230 forming the isolation chamber 1234 and the bodily fluid flowing into the isolation chamber 1234 can collectively limit and / or substantially prevent mixing of the bodily fluid in the isolation chamber 1234 with the volume of air.

[0154] As shown in FIG. 30 , the housing 1230 can include and / or be coupled to a cover 1238 configured to enclose the channel, thereby forming the isolation chamber 1234. The cover 1238 can be coupled to the housing 1230 in any suitable manner (e.g., via friction fit, snap fit, interference fit, adhesive, one or more mechanical fasteners, laser welding, ultrasonic welding, plasma techniques, annealing, heat boarding, and / or any other suitable coupling means or combinations thereof). In other embodiments, the cover 1238 is integrally formed with and / or coupled to the housing 1230. Additionally, in some embodiments, the cover 1238 can be at least partially transparent to allow a user to view the flow of bodily fluid through the isolation chamber 1234. In some embodiments, the arrangement of the housing 1230 and the cover 1238 can facilitate one or more manufacturing processes and / or make the control device 1200 easier to use, for example.

[0155] 30, the housing 1230 includes and / or defines a flow controller 1242 and a restricted flow path 1232. The flow controller 1242 may be, for example, a valve, membrane, diaphragm, restrictor, vent, selectively permeable member, port, etc., configured to selectively control (at least in part) the flow of fluid into and / or out of the isolation chamber 1234 and / or any other suitable portion of the housing 1230. For example, the flow controller 1242 may be a selectively permeable fluid barrier (e.g., a blood barrier) that includes and / or is formed of a porous material configured to selectively allow the flow of gas but prevent the flow of liquid therethrough. As such, the flow controller 1242 may be configured to evacuate and / or purge a volume of air in the isolation chamber 1234 through the flow controller 1242 in response to a negative pressure differential within a portion of the control device 1200. Such evacuating and / or purging of the volume of air within the isolation chamber 1234 may result in a suction force and / or negative pressure differential being applied and / or exerted within or on the isolation chamber 1234 that is operable to draw in an initial volume of bodily fluid. Additionally, by using a selectively permeable fluid barrier, air may be evacuated and / or purged without allowing a volume of bodily fluid to pass through the flow controller 1242. Thus, in some embodiments, the flow controller 1242 may be substantially similar to the flow controller 242 described in detail above with reference to Figures 2-5 and therefore will not be described in further detail herein.

[0156] The actuator 1250 of the control device 1200 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, the actuator 1250 may be substantially similar, at least in form and / or function, to the actuator 850 described in detail above. Accordingly, such similar portions of the actuator 1250 will be identified below, but may not be described in further detail herein.

[0157] As shown in FIGS. 32-34, the actuator 1250 includes a body 1251 and an actuator rod 1262. The body 1251 of the actuator 1250 includes an inlet 1252 and an outlet 1253. The inlet 1252 and the outlet 1253 may be substantially similar, at least in form and / or function, to the inlet 852 and the outlet 853, respectively, described above with reference to FIGS. 19-25. Thus, the inlet 1252 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen-containing device, such as a needle, IV catheter, PICC line, etc.). The outlet 1253 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 29-34), such as, for example, a sample reservoir, syringe, and / or other intermediate bodily fluid transfer device, adapter, or tank, such as, for example, a transfer device similar to those described in the '510 publication. In some embodiments, such a transfer device can provide negative pressure and / or act as an external energy source to enable desired function of the control device 1200 and power / characteristics of the fluid flow path.

[0158] The body 1251 of the actuator 1250 includes and / or defines a first port 1258 and a second port 1259. The first port 1258 is in fluid communication with the inlet 1252, and the second port 1259 is in fluid communication with the outlet 1252. Additionally, the first port 1258 and the second port 1259 are configured to be at least fluidly coupled to the first port 1245 and the second port 1246, respectively, of the housing 1230. In some embodiments, the arrangement of the ports 1258 and 1259 of the actuator 1250 and the ports 1245 and 1246 of the housing 1230 can enable and / or otherwise provide a means for physically coupling the housing 1230 to the actuator 1250 and fluidly coupling the housing 1230 to the actuator 1250. That is, in some embodiments, the arrangement of ports 1258 and 1259 of actuator 1250 and ports 1245 and 1246 of housing 1230 may enable a modular configuration or arrangement as described above with reference to control device 800. In other embodiments, housing 1230 and / or actuator 1250 need not be modular.

[0159] In some embodiments, the body 1251 and the actuator rod 1262 collectively include and / or collectively form a lock configured to at least temporarily lock the actuator 1250. For example, in some embodiments, the body 1251 and the actuator rod 1262 can each define an opening 1257 in or through which a locking member can be disposed. In such embodiments, when a locking member (not shown in FIG. 32 ) is provided in the opening 1257, the locking member can limit and / or substantially prevent the actuator rod 1262 from moving relative to the body 1251. Meanwhile, removal of the locking member from the opening 1257 can allow the actuator rod 1262 to move relative to the body 1251. Although described as forming a lock, in some embodiments, the body 1251 and the actuator rod 1262 collectively include and / or collectively form features and / or configurations that can limit and / or substantially prevent the actuator rod 1262 from being extracted from the body 1251. In such embodiments, the features may be snaps, latches, clasps, and / or any other suitable features and / or arrangements.

[0160] As shown in FIGS. 33 and 34 , a portion of the actuator rod 1262 includes and / or is coupled to a set of seals 1265. The seals 1265 can be, for example, O-rings, overmolded elastomeric materials, raised protrusions, and / or the like. As described above with reference to the actuator 850, the actuator 1262 and the body 1251 of the actuator 1250 can be arranged such that the seals 1265 form one or more fluid-tight seals between the actuator rod 1262 and the inner surface of the body 1251. In the embodiment shown in FIGS. 33 and 34 , the actuator rod 1262 includes and / or is coupled to three seals 1265 that form and / or define a first fluid flow passage 1233 in the body 1251 of the actuator 1250 and a second fluid flow passage 1254 in the body 1251 of the actuator 1250. In other embodiments, any number of seals can be used to achieve the desired performance.

[0161] As described above with reference to device 800, device 1200 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as, for example, microorganisms present on the skin, microorganisms external to the bodily fluid source, and / or the like. For example, actuator rod 1262 is configured to be moved or transitioned relative to body 1251 between a first position or configuration and a second position or configuration. In some embodiments, the transition of actuator rod 1262 can be accomplished and / or otherwise caused by user interaction and manipulation of actuator rod 1262, automatically in response to negative pressure and associated flow forces within device 1200, and / or by or in response to an external energy source that generates motive force to effect the transition of actuator rod 1262. As shown in FIG. 33, when in the first position and / or configuration, inlet 1252 of actuator 1250 is in fluid communication with first fluid flow channel 1233, which in turn is in fluid communication with first port 1258. The outlet 1253 of the actuator 1250 is in fluid communication with the second fluid flow path 1254, which in turn is in fluid communication with the second port 1259. Thus, when the actuator 1250 and / or actuator rod 1262 are in a first position and / or configuration (e.g., when the control device 1200 is in a first state or mode of operation), a negative pressure in the fluid collection device (not shown in FIGS. 29-34 ) creates a negative pressure (or negative pressure differential) in at least a portion of the isolation chamber 1234 that is operable to draw at least a portion of an initial flow, amount, or volume of bodily fluid from the inlet 1252, through the first fluid flow path 1233, and into the isolation chamber 1234. Further, in some examples, for example, an initial volume and / or flow of bodily fluid disposed within the isolation chamber 1234 can be transferred into the isolation chamber 1234 until the flow controller 1242 transitions from an open or non-sealing configuration or state (e.g., a state in which a flow of gas or air can be drawn therethrough) to a sealed configuration or state (e.g., a state in which a flow of gas and liquid cannot be drawn therethrough).

[0162] 34, a force may be applied to the end 1263 of the actuator rod 1262 to position the actuator rod 1262 and / or the actuator 1250 in its second position and / or configuration. As described above, in some examples, the actuator 1250 may be transitioned from a locked configuration or state to an unlocked configuration or state before a force is applied to the end 1263 of the actuator rod 1262. When the actuator rod 1262 and / or the actuator 1250 are positioned in their second position and / or configuration (e.g., when the control device 1200 is transitioned to a second state or mode of operation), each of the inlet 1252 and outlet 1253 of the actuator 1250 is in fluid communication with the second fluid flow path 1254, while the first fluid flow path 1233 is isolated, separated, and / or otherwise not in fluid communication with the inlet 1252 and outlet 1253. As discussed in detail above, in some instances, contaminants such as microorganisms present on the skin that are dislodged during venipuncture or throughout the bodily fluid collection process may be entrained and / or contained within the initial volume of bodily fluid and thus become isolated within the isolation chamber 1234 when the initial volume is isolated therein. As such, negative pressure otherwise exerted on or through the isolation chamber 1234 is now exerted on or through the second fluid flow path 1254. In response, bodily fluid may flow from the inlet 1252, through the second fluid flow path 1254, through the outlet 1253, and into a fluid collection device coupled to the outlet 1253. As such, the function of device 1200 will not be described in further detail herein, as device 1200 may function substantially similarly to the function of device 800.

[0163] 35-40 show a fluid control device 1300, according to one embodiment. The fluid control device 1300 may be similar, at least in form and / or function, to the fluid control devices described herein. More specifically, portions of the fluid control device 1300 may be similar and / or substantially the same as corresponding portions of the fluid control devices 200, 300, 800, 900, 1000, 1100, and / or 1200 described above. Accordingly, such portions of the fluid control device 1300 will not be described in further detail herein.

[0164] The fluid control device 1300 (also referred to herein as a "control device" or "device") includes a housing 1330 and an actuator 1350. As described above with reference to the control device 800, the control device 1300 can be arranged in a modular configuration such that the housing 1330 and the actuator 1350 can be physically and fluidly coupled to form the control device 1300. In other embodiments, the control device 1300 need not be modular. That is, in some embodiments, the control device 1300 can be assembled during manufacture and delivered to a supplier and / or end user as an assembled device. In other embodiments, the device 1300 can be integrally and / or collectively formed with, for example, a fluid collection device, as described above.

[0165] The housing 1330 of the control device 1300 may be of any suitable shape, size, and / or configuration. As shown in FIGS. 35-37, the housing 1330 forms and / or defines an isolation chamber 1334 that is in selective fluid communication with a first port 1345 and a second port 1346. The second port 1346 is configured to receive, contain, and / or define a flow controller 1342 (see, e.g., FIG. 36) and a restricted flow path 1332 (see, e.g., FIG. 37). The first port 1345 and the second port 1346 are at least fluidly coupled to a portion of the actuator 1350 and are configured to allow selective fluid flow between the housing 1330 and the actuator 1350. As described in further detail herein, the isolation chamber 1334 is configured to (1) receive a selective flow and / or volume of bodily fluid from a portion of the actuator 1350 via a first port 1345, and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) a flow and / or volume of bodily fluid (e.g., at least a portion of an initial or first flow and / or volume of bodily fluid) within the isolation chamber 1334. The isolation chamber 1334 can have any suitable shape, size, and / or configuration. For example, in some embodiments, the isolation chamber 1334 can be, for example, a channel formed in a portion of the housing 1330, which can include and / or be coupled to a cover 1338 configured to enclose the channel, thereby forming the isolation chamber 1334. In some embodiments, the housing 1330 can be substantially similar, at least in form and / or function, to the housing 1230 described in detail above with reference to FIGS. 29-34. Therefore, the housing 1330 will not be described in further detail herein.

[0166] The actuator 1350 of the control device 1300 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, the actuator 1350 may be substantially similar, at least in form and / or function, to the actuators 850 and / or 1250 described in detail above. Accordingly, such similar portions of the actuator 1350 will be identified below but may not be described in further detail herein.

[0167] As shown in FIGS. 38-40, the actuator 1350 includes a body 1351 and an actuator rod 1362. The body 1351 of the actuator 1350 includes an inlet 1352 and an outlet 1353. The inlet 1352 and the outlet 1353 may be substantially similar, at least in form and / or function, to the inlet 852 and the outlet 853, respectively, described above with reference to FIGS. 19-25. Thus, the inlet 1352 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen-containing device such as a needle, IV catheter, surgical tubing, other standard bodily fluid transfer device, PICC line, etc.). The outlet 1353 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 35-40), such as, for example, a sample reservoir, syringe, and / or other intermediate bodily fluid transfer device, adapter, or tank, such as, for example, a transfer device similar to those described in the '510 publication.

[0168] The body 1351 of the actuator 1350 includes and / or defines a first port 1358 and a second port 1359. The first port 1358 is in fluid communication with the inlet 1352, and the second port 1359 is in fluid communication with the outlet 1353. Additionally, the first port 1358 and the second port 1359 are configured to be at least fluidly coupled to the first port 1345 and the second port 1346, respectively, of the housing 1330. In some embodiments, the arrangement of the ports 1358 and 1359 of the actuator 1350 and the ports 1345 and 1346 of the housing 1330 can enable and / or otherwise provide a means for physically coupling the housing 1330 to the actuator 1350 and fluidly coupling the housing 1330 to the actuator 1350. That is, in some embodiments, the arrangement of ports 1358 and 1359 of actuator 1350 and ports 1345 and 1346 of housing 1330 may enable a modular configuration or arrangement as described above with reference to control device 800. In other embodiments, housing 1330 and / or actuator 1350 need not be modular.

[0169] 39 and 40, a portion of the actuator rod 1362 includes and / or is coupled to a set of seals 1365. The seals 1365 may be, for example, an O-ring, an elastomeric material, silicone, or any other suitable material or configuration, as described above with reference to the seal 1265. As described above with reference to the actuator 850, the actuator 1362 and the body 1351 of the actuator 1350 may be arranged such that the seals 1365 form one or more fluid-tight seals between the actuator rod 1362 and the inner surface of the body 1351. In the embodiment shown in FIGS. 33 and 34, the actuator rod 1362 includes and / or is coupled to three seals 1365 that form and / or define a first fluid flow passage 1333 in the body 1351 of the actuator 1350 and a second fluid flow passage 1354 in the body 1351 of the actuator 1350.

[0170] As described above with reference to device 800, device 1300 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as microorganisms present on the skin, microorganisms external to the bodily fluid source, and / or the like. For example, actuator rod 1362 is configured to be moved or transitioned relative to body 1351 between a first position or configuration and a second position or configuration. As shown in FIG. 39 , when in the first position and / or configuration, inlet 1352 of actuator 1350 is in fluid communication with first fluid flow path 1333, such that first fluid flow path 1333 is in fluid communication with first port 1358. Outlet 1353 of actuator 1350 is in fluid communication with second fluid flow path 1354, such that second fluid flow path 1354 is in fluid communication with second port 1359. Thus, when the actuator 1350 and / or actuator rod 1362 are in a first position and / or configuration (e.g., when the control device 1300 is in a first state or mode of operation), the negative pressure within the fluid collection device (not shown in FIGS. 35-40 ) creates a negative pressure (or negative pressure differential) within at least a portion of the isolation chamber 1334 that is operable to draw at least a portion of an initial flow, amount, or volume of bodily fluid from the inlet 1352, through the first fluid flow path 1333, and into the isolation chamber 1334. Further, in some examples, for example, an initial volume and / or initial flow of bodily fluid disposed within the isolation chamber 1334 can be transferred into the isolation chamber 1334 until the flow controller 1342 transitions from an open or non-sealing configuration or state (e.g., a state in which a flow of gas or air can be drawn therethrough) to a sealed configuration or state (e.g., a state in which a flow of gas and liquid cannot be drawn therethrough).

[0171] 35, a force may be applied to the first end 1363 of the actuator rod 1362 to position the actuator rod 1362 and / or the actuator 1350 in its second position, state, mode of operation, and / or configuration. As described above, in some examples, the actuator 1350 may be transitioned from a locked configuration or state to an unlocked configuration or state before a force is applied to the first end 1363 of the actuator rod 1362. In some embodiments, the transition of the actuator rod 1362 may be accomplished and / or otherwise caused by user interaction and manipulation of the actuator rod 1362, automatically in response to forces due to negative pressure and associated flows within the device 1300, and / or performed by or in response to an external energy source that generates a force that effects the transition of the actuator rod 1362.

[0172] When the actuator rod 1362 and / or the actuator 1350 are positioned in their second position and / or configuration (e.g., when the control device 1300 is transitioned to a second state or mode of operation), the inlet 1352 and outlet 1353 of the actuator 1350 are each in fluid communication with the second fluid flow path 1354, while the first fluid flow path 1333 is isolated, separated, and / or otherwise not in fluid communication with the inlet 1352 and outlet 1353. As described in detail above, in some instances, contaminants such as microorganisms present on the skin that are dislodged during venipuncture or throughout the bodily fluid collection process may be entrained and / or contained in the initial volume of bodily fluid and thus isolated within the isolation chamber 1334 when the initial volume is isolated therein. As such, negative pressure otherwise applied on or through isolation chamber 1334 is now applied on or through second fluid flow path 1354. In response, bodily fluid can flow from inlet 1352, through second fluid flow path 1354, through outlet 1353, and into fluid collection device 1353. As such, device 1300 may function substantially similarly to that of device 800, and therefore the function of device 1300 will not be described in further detail herein.

[0173] In some examples, it may be desirable to isolate the negative pressure source (e.g., the fluid collection device) from the inlet 1353, such as when it is desirable to collect multiple samples of bodily fluid using multiple fluid collection devices (e.g., syringes, etc.). For example, in some examples, after filling the fluid collection device, a user may use the actuator 1350 to apply a force to the second end 1364 of the actuator rod 1362 to move and / or transition the actuator rod 1362 from its second position and / or configuration toward its first position and / or configuration. As such, the second fluid flow path 1354 does not position the inlet 1352 in fluid communication with the outlet 1353. Additionally, the flow controller 134 2 may remain in a sealed state or configuration (e.g., fully saturated, wetted, and / or otherwise impeding flow therethrough) such that the outlet 1353 is substantially isolated or isolated or separated from the remainder of the control device 1300. In some examples, a user may then remove the filled fluid collection device and couple a new fluid collection device to the outlet 1353. As described above with reference to actuator 850, with the new fluid collection device coupled to the outlet 1353, a user may, for example, apply a force to the first end 1363 of the actuator rod 1362 to move and / or transition the actuator rod 1362 back to the second position, state, and / or configuration.

[0174] 41-44 show a fluid control device 1400, according to one embodiment. The fluid control device 1400 may be similar, at least in form and / or function, to the fluid control devices described herein. More specifically, portions of the fluid control device 1400 may be similar and / or substantially the same as corresponding portions of the fluid control devices 200, 300, 800, 900, 1000, 1100, 1200, and / or 1300 described above. Accordingly, such portions of the fluid control device 1400 will not be described in further detail herein.

[0175] The fluid control device 1400 (also referred to herein as a "control device" or "device") includes a housing 1430 and an actuator 1450. As described above with reference to the control device 800, the control device 1400 can be arranged in a modular configuration such that the housing 1430 and the actuator 1450 can be physically and fluidly coupled to form the control device 1400. In other embodiments, the control device 1400 need not be modular. That is, in some embodiments, the control device 1400 can be assembled during manufacture and delivered to a supplier and / or end user as an assembled device. In other embodiments, the device 1400 can be integrally and / or collectively formed with, for example, a fluid collection device, as described above.

[0176] The housing 1430 of the control device 1400 may be of any suitable shape, size, and / or configuration. The housing 1430 is configured to selectively fluidly communicate with a portion of the actuator 1450 via a first port 1458 and a second port 1459. As shown in FIGS. 43 and 44, the housing 1430 includes a bladder 1478 that can transition from a first configuration and / or state to a second configuration and / or state to form and / or define the isolation chamber 1434. As described in more detail herein, the bladder 1478 is configured to transition from a first configuration and / or state (FIG. 43) to a second configuration and / or state (FIG. 44) to form and / or define the isolation chamber 1434, whereby the isolation chamber 1434 is configured to receive a selective flow and / or volume of bodily fluid from a portion of the actuator 1450 via the first port 1458. After the bladder 1478 is positioned in the second configuration and / or state, the isolation chamber 1434 can isolate (e.g., separate, spaced, contain, hold, separate, etc.) a flow and / or volume of bodily fluid within the isolation chamber 1434 (e.g., at least a portion of an initial or first flow and / or volume of bodily fluid).

[0177] Although bladder 1478 is specifically shown in FIGS. 43 and 44, in other embodiments, bladder 1478 can be of any suitable shape, size, and / or configuration. Similarly, bladder 1478 can be formed of any suitable material (e.g., any suitable biocompatible material such as those described herein and / or any other suitable material). In some embodiments, bladder 1478 can be arranged and / or configured as, for example, a bellows, an expandable bag, a flexible pouch, and / or any other suitable reconfigurable container. Additionally, isolation chamber 1434 formed by bladder 1478 can have any suitable shape, size, and / or configuration. In some embodiments, housing 1430 can be substantially similar, at least in form and / or function, to housings 1230 and 1330, described in detail above with reference to FIGS. 29-34 and 35-40. Accordingly, housing 1430 will not be described in further detail herein.

[0178] The actuator 1450 of the control device 1400 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, the actuator 1450 may be substantially similar, at least in form and / or function, to the actuators 850, 1250, and / or 1350 described in detail above. Accordingly, such similar portions of the actuator 1450 will be identified below, but may not be described in further detail herein.

[0179] As shown in FIGS. 41-44, the actuator 1450 includes a body 1451 and an actuator rod 1462. The body 1451 of the actuator 1450 includes an inlet 1452 and an outlet 1453. The inlet 1452 and the outlet 1453 may be substantially similar, at least in form and / or function, to the inlet 1252 and the outlet 1253, respectively, described above with reference to FIGS. 29-34. Thus, the inlet 1452 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen-containing device such as a needle, IV catheter, surgical tubing, other standard bodily fluid transfer device, PICC line, etc.). The outlet 1453 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 41-44), such as, for example, a sample reservoir, syringe, and / or other intermediate bodily fluid transfer device, adapter, or tank, such as, for example, a transfer device similar to those described in the '510 publication.

[0180] The body 1451 of the actuator 1450 includes and / or defines a first port 1458 and a second port 1459. Although not shown, the first port 1458 is configured to be in fluid communication with the inlet 1452, and the second port 1459 is configured to be in fluid communication with the outlet 1453. Additionally, the first port 1458 is configured to be in fluid communication with the housing 1430, and more particularly, with an interior volume or inlet side of the bladder 1478 that forms the isolation chamber 1434. The second port 1459 is configured to be in fluid communication with a portion of the housing 1430 that is defined between an inner surface of the housing 1430 and an outer surface of the bladder 1478. In other words, the second port 1459 is in fluid communication with a portion of the housing 1430 that is separated and / or isolated from the interior volume of the bladder 1478 that forms the isolation chamber 1434. In some embodiments, the arrangement of the ports 1458 and 1459 of the actuator 1450 may enable and / or otherwise provide a means of physically coupling the housing 1430 to the actuator 1450, and a means of fluidically coupling the housing 1430 to the actuator 1450. That is, in some embodiments, the arrangement of the ports 1458 and 1459 of the actuator 1450 may enable a modular configuration or arrangement as described above with reference to the control device 800. In other embodiments, the housing 1430 and / or the actuator 1450 need not be modular.

[0181] 41-44, a portion of actuator rod 1462 includes and / or is coupled to a set of seals. Seals 1365 may be, for example, O-rings, elastomeric materials, silicone, or any other suitable material or configuration, as described above with reference to seals 1265 and / or 1365. As described above with reference to actuators 850, 1250, and / or 1350, actuator rod 1462 and body 1451 of actuator 1450 may be positioned such that the seals form one or more fluid-tight seals between actuator rod 1462 and an inner surface of body 1451. Further, as described above with reference to actuators 1250 and / or 1350, actuator rod 1462 may include and / or be coupled to set seals that selectively form and / or define a first fluid flow path configured to fluidly connect the inlet 1452 of actuator 1450 to a first port 1458 (e.g., when in a first position, state, operating mode, configuration), and a second fluid flow path configured to fluidly connect the inlet 1452 to the outlet 1453 (e.g., when in a second position, state, operating mode, configuration).

[0182] As described above with reference to devices 800, 1200, and / or 1300, device 1400 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as, for example, microorganisms present on the skin, microorganisms external to the bodily fluid source, and / or the like. For example, as described above with reference to devices 1200 and / or 1300, actuator rod 1462 can be configured to be moved or transitioned relative to body 1451 between a first position or configuration and a second position or configuration. When in the first position and / or configuration, inlet 1452 of actuator 1450 is in fluid communication with, for example, a first fluid flow path, such that first fluid flow path is in fluid communication with first port 1458 (not shown in FIGS. 41-44). Outlet 1453 of actuator 1450 is in fluid communication with second fluid flow path 1454, such that second fluid flow path 1454 is in fluid communication with second port 1459. Thus, when the actuator 1450 and / or actuator rod 1462 are in a first position and / or configuration (e.g., when the control device 1400 is in a first state or mode of operation), negative pressure within the fluid collection device (not shown in Figures 41-44) can create a negative pressure (or negative pressure differential) within a portion of the housing 1430 defined between the inner surface of the housing 1430 and the outer surface of the bladder 1478.

[0183] As shown in FIG. 43, the bladder 1478 may be in a first state and / or configuration before the fluid collection device is coupled to the outlet 1453. In some embodiments, for example, the bladder 1478 may have an inverted, everted, deflated, and / or empty configuration before coupling the fluid collection device to the outlet 1453. As shown in FIG. 44, the bladder 1478 may be configured to transition from a first state and / or configuration to a second state and / or configuration in response to a negative pressure differential caused by coupling the fluid collection device to the outlet 1453. In other words, the negative pressure differential may be operable to transition the bladder 1478 from a contracted or unexpanded configuration and / or state to an expanded configuration and / or state. For example, in some embodiments, the transition of the bladder 1478 may be similar to the transition and / or "inversion" of the diaphragm 576 described above with reference to FIGS. 11 and 12.

[0184] As described above, the bladder 1478 can be configured to transition from a first configuration and / or state to a second configuration and / or state to form and / or define the isolation chamber 1434. In some embodiments, transitioning the bladder 1478 increases the interior volume of the bladder 1478 (i.e., the isolation chamber 1434). The increase in the interior volume then creates a negative pressure differential between the isolation chamber 1434 defined by the bladder 1478 and the inlet 1452, which may be operable in drawing at least a portion of an initial flow, amount, or volume of bodily fluid from the inlet 1452, through the first port 1458, and into the isolation chamber 1434. Further, in some examples, the initial volume and / or initial flow of bodily fluid may be transitioned into the isolation chamber 1434, for example, until the bladder 1478 is fully expanded and / or until the negative pressure differential is reduced and / or equalized.

[0185] As described above in detail with reference to devices 1200 and / or 1300, after the initial volume of bodily fluid is transferred to the isolation chamber 1434, a force can be applied to the first end 1463 of the actuator rod 1462 to position the actuator rod 1462 and / or the actuator 1450 in its second position, state, mode of operation, and / or configuration. As described above, in some examples, the actuator 1450 can be transitioned from a locked configuration or state to an unlocked configuration or state before a force is applied to the first end 1463 of the actuator rod 1462. In some embodiments, the transition of the actuator rod 1462 can be accomplished and / or otherwise caused by user interaction and manipulation of the actuator rod 1462, automatically in response to forces due to negative pressure and associated flows within the device 1400, and / or performed by or in response to an external energy source that generates a force that causes the actuator rod 1462 to move.

[0186] When the actuator rod 1462 and / or the actuator 1450 are positioned in their second position and / or configuration (e.g., when the control device 1400 transitions to a second state or mode of operation), the inlet 1452 and outlet 1453 of the actuator 1450 are in fluid communication (e.g., via a second fluid flow path (not shown)), while the first fluid flow path (not shown) and / or the first port 1458 are isolated, separated, and / or otherwise not in fluid communication with the inlet 1452 and / or outlet 1453. As discussed in detail above, in some instances, contaminants such as microorganisms present on the skin that are dislodged during venipuncture or throughout the bodily fluid collection process may be entrained and / or contained in the initial volume of bodily fluid and thus isolated within the isolation chamber 1434 when the initial volume is isolated therein. As such, negative pressure otherwise applied to or through housing 1430 is now applied to or through outlet 1453 and inlet 1452, for example via a second fluid flow path (not shown). In response, bodily fluid can flow from inlet 1452, through body 1451 of actuator 1450, through outlet 1453, and into a fluid collection device coupled to outlet 1453. As such, device 1400 may function substantially similarly to the function of devices 800, 1200, and / or 1300, the function of device 1400 will not be described in further detail herein.

[0187] Although device 1400 is described above as including housing 1430 and actuator 1450, in other embodiments, the fluid control device can have, for example, an at least partially integrated design. For example, FIGS. 45-50 show fluid control device 1500, according to one embodiment. Fluid control device 1500 can be similar, at least in form and / or function, to the fluid control devices described herein. More specifically, portions of fluid control device 1500 can be similar and / or substantially the same as corresponding portions of at least fluid control device 1400 described above with reference to FIGS. 41-44. Accordingly, such portions of fluid control device 1500 will not be described in further detail herein.

[0188] Fluid control device 1500 (also referred to herein as a "control device" or "device") includes an actuator 1550 having an actuator body 1551 and an actuator rod 1562. The actuator 1550 may be of any suitable shape, size, and / or configuration. For example, in some embodiments, the actuator 1550 may be substantially similar, at least in form and / or function, to actuators 850, 1250, 1350, and / or 1450, described in detail above. Accordingly, such similar portions of actuator 1550 are identified below, but may not be described in further detail herein.

[0189] As shown in FIGS. 45-50, actuator 1550 includes an inlet 1552 and an outlet 1553, each in fluid communication with body 1551. Inlet 1552 and outlet 1553 may be substantially similar, at least in form and / or function, to inlet 1252 and outlet 1253, respectively, described above with reference to FIGS. 29-34. Thus, inlet 1552 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen-containing device such as a needle, IV catheter, surgical tubing, other standard bodily fluid transfer device, PICC line, etc.). Outlet 1553 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 45-50), such as, for example, a sample reservoir, syringe, and / or other intermediate bodily fluid transfer device, adapter, or tank, such as, for example, a transfer device similar to those described in the '510 publication.

[0190] As shown in FIGS. 48-50, the actuator 1550 includes a bladder 1578 that can transition from a first configuration and / or state (FIG. 48) to a second configuration and / or state (FIG. 49) to form and / or define the isolation chamber 1534. As described in more detail herein, the bladder 1578 is configured to transition from a first configuration and / or state (FIG. 48) to a second configuration and / or state (FIGS. 49 and 50) to form and / or define the isolation chamber 1534, such that the isolation chamber 1534 is configured to receive a selective flow and / or volume of bodily fluid from the inlet 1552. After the bladder 1578 is positioned in the second configuration and / or state, the isolation chamber 1534 can isolate (e.g., separate, spaced, contain, hold, separate, etc.) a flow and / or volume of bodily fluid within the isolation chamber 1534 (e.g., at least a portion of an initial or first flow and / or volume of bodily fluid). As such, bladder 1578 may be substantially similar, at least in form and / or function, to bladder 1478 described above with reference to Figures 41-44, and therefore will not be described in further detail herein.

[0191] 46 and 48-50, the body 1551 of the actuator 1550 includes and / or defines a port 1559 configured to be in fluid communication with the outlet 1553. Additionally, the port 1559 defines a fluid flow path configured to be in fluid communication with a portion of the actuator 1550 defined between an inner surface of the body 1551 and an outer surface of the bladder 1578. In other words, the port 1559 is in fluid communication with a portion of the actuator 1550 that is separated and / or isolated from an interior volume of the bladder 1578 that defines and / or is configured to define the isolation chamber 1534.

[0192] As described above with reference to devices 1200, 1300, and / or 1400, a portion of actuator rod 1562 includes and / or is coupled to a set of seals 1565. Seals 1565 may be, for example, O-rings, elastomeric materials, silicone, or any other suitable material or configuration, as described above with reference to seals 1265 and / or 1365. As described above with reference to actuators 850, 1250, and / or 1350, actuator rod 1562 and body 1551 of actuator 1550 may be arranged such that seals 1565 form one or more fluid-tight seals between actuator rod 1562 and an inner surface of body 1551. Further, as described above with reference to actuators 1250 and / or 1350, set seal 1565 can be positioned along actuator rod 1562 to selectively form and / or define a fluid flow path 1554 that is isolated and / or fluidly isolated from inlet 1552 when actuator rod 1562 is in a first position and / or configuration, and configured to fluidly position inlet 1552 in fluid communication with outlet 1553 when actuator rod 1562 is in a second position and / or configuration.

[0193] As described above with reference to devices 800, 1200, 1300, and / or 1400, device 1500 can be used to obtain a bodily fluid sample with reduced contamination from microorganisms, such as microorganisms present on the skin, microorganisms external to the bodily fluid source, and / or the like. For example, as described above with reference to devices 1200, 1300, and / or 1400, actuator rod 1562 can be configured to be moved or transitioned relative to body 1551 between a first position or configuration and a second position or configuration. When in the first position and / or configuration, inlet 1552 of actuator 1550 is in fluid communication with a fluid flow path, such that the fluid flow path is in fluid communication with body 1551 disposed on an inlet side of bladder 1578. In other words, the fluid flow path establishes fluid communication between inlet 1553 and bladder 1578 and / or isolation chamber 1534 defined at least in part by bladder 1578 when bladder 1578 transitions to the second configuration and / or state. The outlet 1553 of the actuator 1550 is in fluid communication with the port 1559. Thus, when the actuator 1550 and / or actuator rod 1562 are in a first position and / or configuration (e.g., when the control device 1500 is in a first state or mode of operation), a negative pressure within the fluid collection device (not shown in FIGS. 45-50 ) can create a negative pressure (or negative pressure differential) within a portion of the actuator body 1551 defined between an inner surface of the body 1551 and an outer surface of the bladder 1578, as described above with reference to device 1400.

[0194] 48, the bladder 1578 may be in a first state and / or configuration prior to coupling a fluid collection device to the outlet 1553. In some embodiments, for example, the bladder 1578 may have an inverted, inverted, contracted, and / or empty configuration prior to coupling a fluid collection device to the outlet 1553. Furthermore, when the actuator rod 1562 is in a first position and / or configuration, the fluid flow path 1554 is fluidly isolated from the inlet 1552. Thus, as shown in FIG. 49, the bladder 1578 may be configured to transition from a first state and / or configuration to a second state and / or configuration in response to a negative pressure differential caused by coupling a fluid collection device to the outlet 1553. In other words, the negative pressure differential may be operable to transition the bladder 1578 from a contracted or unexpanded configuration and / or state to an expanded configuration and / or state. For example, in some embodiments, the transition of the bladder 1578 may be similar to the transition and / or "flipping" of the diaphragm 576 described above with reference to Figures 11 and 12. In other embodiments, the bladder 1578 may be configured to be transitioned from a first state and / or configuration to a second state and / or configuration in any suitable manner, such as any of those described herein.

[0195] As discussed above, the bladder 1578 may be configured to transition from a first configuration and / or state to a second configuration and / or state to form and / or define the isolation chamber 1534. In some embodiments, transitioning the bladder 1578 increases the interior volume of the bladder 1578 (i.e., the isolation chamber 1534). The increase in the interior volume then creates a negative pressure differential between the isolation chamber 1534 defined by the bladder 1578 and the inlet 1552, which may be operable in drawing at least a portion of an initial flow, amount, or volume of bodily fluid from the inlet 1552 and a portion of the actuator body 1551 and into the isolation chamber 1534. Further, in some examples, the initial volume and / or flow of bodily fluid may be transitioned into the isolation chamber 1534, for example, until the bladder 1578 is fully expanded and / or until the negative pressure differential is reduced and / or equalized.

[0196] As described above in detail with reference to devices 1200 and / or 1300, after the initial volume of bodily fluid is transferred to the isolation chamber 1534, a force can be applied to the first end 1563 of the actuator rod 1562 to position the actuator rod 1562 and / or the actuator 1550 in its second position, state, mode of operation and / or configuration. As described above, in some examples, the actuator 1550 can be transitioned from a locked configuration or state to an unlocked configuration or state before a force is applied to the first end 1563 of the actuator rod 1562. In some embodiments, the transition of the actuator rod 1562 can be achieved and / or otherwise caused by user interaction and manipulation of the actuator rod 1562, automatically in response to negative pressure and associated flow forces within the device 1500, and / or performed by or in response to an external energy source that generates a force that effects the transition of the actuator rod 1562.

[0197] When the actuator rod 1562 and / or the actuator 1550 are positioned in their second position and / or configuration (e.g., when the control device 1500 is transitioned to a second state or mode of operation), the inlet 1552 and outlet 1553 of the actuator 1550 are in fluid communication with the fluid flow path 1554, while the isolation chamber 1534 is isolated, separated, and / or otherwise not in fluid communication with the inlet 1552 and outlet 1553. As discussed in detail above, in some instances, contaminants such as microorganisms present on the skin, for example, that are dislodged during venipuncture or throughout the bodily fluid collection process, may be entrained and / or contained in the initial volume of bodily fluid and thus isolated within the isolation chamber 1534 when the initial volume is isolated therein.

[0198] As described above with reference to devices 1200 and / or 1300, transitioning the actuator rod 1562 to a second position and / or configuration causes the fluid flow path 1554 to place the inlet 1552 in fluid communication with the outlet 1553. For example, transitioning the actuator rod 1562 to a second position and / or configuration can move the seal 1565 relative to the inlet 1552 such that the fluid flow path 1554 is placed in fluid communication with both the inlet 1552 and the outlet 1553. As such, negative pressure that would otherwise be applied to the outer surface of the bladder 1578 is now applied via the fluid flow path 1554 to or through the outlet 1553 and inlet 1552. In response, bodily fluid can flow from the inlet 1552, through the fluid flow path 1554, through the outlet 1553, and into a fluid collection device 1553 coupled to the outlet. Accordingly, the functionality of device 1500 may be substantially similar to the functionality of devices 800, 1200, 1300, and / or 1400, and therefore the functionality of device 1500 will not be described in further detail herein.

[0199] While actuators 850, 1250, 1350, 1450, and 1550 are described in detail above as transitioning in response to an external force, such as, for example, a user-applied force, in other embodiments, a fluid control device may include one or more actuators that may transition in response to any suitable force, input, state or configuration change, etc. For example, FIGS. 51 and 52 show a portion of a fluid control device 1600, according to one embodiment. Fluid control device 1600 may be similar, at least in form and / or function, to the fluid control devices described herein. More specifically, portions of fluid control device 1600 may be similar and / or substantially the same as corresponding portions of at least fluid control devices 500, 600, and / or 700 described above. Accordingly, such portions of fluid control device 1600 are not described in further detail herein.

[0200] As shown in FIGS. 51 and 52, the fluid control device 1600 (also referred to herein as a "control device" or "device") includes a housing 1630 having an inlet 1631 and an outlet 1636 and coupled to an actuator 1650. As described in further detail herein, the housing 1630 defines a set of fluid flow paths 1633 and 1654 configured to establish fluid communication between one or more portions of the housing 1630 to selectively receive a flow of fluid (e.g., liquid and / or gas) therethrough. The inlet 1631 is in fluid communication with a source of bodily fluid and configured to receive a flow of bodily fluid therefrom (e.g., via a lumen-containing device such as a needle, as described in further detail above). The outlet 1636 is configured to be fluidly coupled to a fluid collection device (not shown in FIGS. 51 and 52). The inlet 1631, the outlet 1636, and the fluid collection device may be substantially similar to those described above and therefore will not be described in further detail herein.

[0201] The housing 1630 may be of any suitable shape, size, and / or configuration. In some embodiments, the housing 1630 may have a size based at least in part on a volume of bodily fluid configured to be at least temporarily stored within one or more portions of the housing 1630, for example. As described above, the housing 1630 of the control device 1600 is configured to (1) receive a flow and / or volume of bodily fluid from the inlet 1631 and (2) isolate (e.g., separate, space, contain, hold, separate, etc.) the flow and / or volume of bodily fluid within an isolation chamber 1634 contained within and / or at least partially formed by the housing 1630. In some embodiments, aspects of the housing 1630 may be substantially similar to aspects of the housings 630, 730, and / or 830, for example. Accordingly, some portions and / or aspects of the housing 1630 are not described in further detail herein.

[0202] The housing 1630 includes and / or is coupled to an actuator 1650 configured to selectively control the flow of bodily fluid through the housing 1630. In this embodiment, the actuator 1650 includes a diaphragm 1676 and an actuator rod 1662 having a pair of seals (e.g., seals 1665 and 1666). As described in more detail herein, the diaphragm 1676 and the actuator rod 1662 are configured to transition, move, and / or otherwise reconfigure within the housing 1630 in response to a negative pressure differential within at least a portion of the device. More specifically, as described in more detail above with reference to the control device 500, the actuator 1650 is configured to move between a first state in which the inlet 1631 is disposed in fluid communication with the isolation chamber 1634 and a second state in which the inlet 1631 is disposed in fluid communication with the outlet 1636 via the fluid flow path 1654.

[0203] In some embodiments, the diaphragm 1676 can be similar to, for example, diaphragms 576, 676, and / or 776, as described in detail above. Thus, the diaphragm 1676 can be at least partially disposed in an isolated portion of the housing 1630 to define and / or form at least a portion of the isolation chamber 1634. As described in detail above, the diaphragm 1676 can be configured to transition, move, reverse, and / or otherwise reconfigure from a first state to a second state in response to a negative pressure differential that can be operable to draw an initial volume of bodily fluid into the isolation chamber 1634 and / or to isolate an initial volume of bodily fluid within the isolation chamber 1634 once disposed therein. Additionally, as shown in FIGS. 51 and 52, the diaphragm 1676 can include and / or be coupled to a flow controller 1642. The flow controller 1642 can be any suitable flow controller, such as any described herein. For example, in some embodiments, the flow controller 1642 can be a semi-permeable member or membrane, such as an air permeable / liquid impermeable barrier (eg, a blood barrier).

[0204] As described in detail above, the flow controller 1642 can be configured to transition from a first state in which the flow controller 1642 allows the flow of gas (e.g., air) through the flow controller 1642 but prevents the flow of liquid (e.g., bodily fluid) therethrough to a second state in which the flow controller 1642 restricts and / or substantially prevents the flow of gas and liquid through the flow controller 1642. In some embodiments, the flow controller 1642 can be configured to transition from the first state to the second state, for example, in response to contact with an initial volume of bodily fluid (e.g., at least a portion of the initial volume of bodily fluid can wet or saturate the flow controller 1642, placing the flow controller 1642 in the second state).

[0205] While diaphragms 576, 676, and 776 are shown and described above as including one or more seals (e.g., seals 565, 665, and 765, respectively) and / or including pins, rods, posts, etc. coupled thereto, in the embodiment shown in FIGS. 51 and 52, diaphragm 1676 includes pin 1677 (e.g., a rod, extension, protrusion, latch, detent, and / or any other suitable feature, member, and / or mechanism) that does not include a seal and / or is not coupled thereto. For example, in this embodiment, pin 1677 extends through a portion of housing 1630 and selectively engages a portion of actuator rod 1662, such that the portion of actuator rod 1662 includes one or more seals (e.g., seals 1665 and 1666), as described in further detail herein.

[0206] 51 and 52, the actuator rod 1662 is movably mounted, for example, in the actuator portion 1639 of the housing 1630. The actuator rod 1662 includes a first seal 1665 and a second seal 1666 and is in contact with an energy storage member 1667, such as a spring, mounted within the actuator portion 1639 of the housing 1630. In the embodiment shown in FIGS. 51 and 52, the actuator 1650 can be positioned such that a first end of the actuator rod 1662 selectively contacts a pin 1677 of a diaphragm 1676 and a second end of the actuator rod 1662 (opposite the first end) contacts and / or is otherwise engaged with the energy storage member 1667.

[0207] 51 , when the actuator 1650 is in the first state, the pin 1677 of the diaphragm 1676 can engage the actuator rod 1662 to maintain the actuator rod 1662 in a first or initial state and / or position in which the energy storage member 1667 has a relatively high potential energy (e.g., the energy storage member 1667 can be a spring that is maintained and / or held in a compressed state when in the first state). Additionally, a first seal 1665 coupled to and / or provided to the actuator 1662 is in a first or initial position in which the fluid flow passage 1633 allows fluid communication between the inlet 1631 and the isolation chamber 1634 when the actuator 1650 is in the first state. Similarly, as shown, a second seal 1666 coupled to and / or provided on the actuator rod 1662 is in a first or initial position in which the second seal 1666 is spaced from a seal surface 1640 formed by at least a portion of the actuator portion 1639 of the housing 1630.

[0208] In some embodiments, the second seal 1666 may be separate from the sealing surface 1640 such that the fluid flow path 1654 is in fluid communication with the outlet 1636 and with the isolation chamber 1634 via the restrictor flow path 1632 (see FIG. 52). In some embodiments, the restrictor flow path 1632 may be similar in form and / or function to any of the restrictor flow paths described herein (e.g., restrictor flow paths 232, 832, 1232, and / or 1332). Thus, the restrictor flow path 1632 may be configured to regulate the magnitude of a negative pressure differential applied on or within the isolation chamber 1634 and / or the rate at which the negative pressure differential increases within the isolation chamber 1634. In other embodiments, the outlet 1636 may be in fluid communication with the isolation chamber 1634 via any suitable flow path, port, opening, valve, etc. In other words, in some embodiments, the control device 1600 need not include the restrictor flow path 1632.

[0209] 51 , when the actuator 1650 is in a first state, the actuator rod 1662 may be maintained in a first state or position in which the fluid flow path 1633 fluidly places the inlet 1631 in communication with the isolation chamber 1634, and the fluid flow path 1654 fluidly places the outlet 1636 in communication with the isolation chamber 1634 via the restricted flow path 1632. Thus, when a fluid collection device (such as those described herein) is coupled to the outlet 1636, a negative pressure defined within and / or otherwise generated by the fluid collection device may be operable to draw an initial volume of bodily fluid into the isolation chamber 1634.

[0210] As described in detail above, the actuator 1650 may be transitioned to the second state and / or configuration in response to an initial volume being transferred to the isolation chamber 1634. For example, in some embodiments, an initial volume of bodily fluid may be drawn into the isolation chamber 1634 in response to a negative pressure applied through a flow controller 1642 (e.g., a selectively permeable membrane). In some examples, at least a portion of the bodily fluid drawn into the isolation chamber 1634 may come into contact with the flow controller 1642, thereby transitioning the flow controller 1642 from a first state to a second state (e.g., the flow controller 1642 restricts and / or substantially prevents the flow of gas and liquid therethrough). Thus, a negative pressure applied to a surface of the diaphragm 1676 may be generated, which may be sufficient to transition, move, and / or invert the diaphragm from a first state and / or configuration to a second state and / or configuration (see FIG. 52). In some embodiments, the transition of the diaphragm 1676 can correspond to and / or be responsive to the flow controller 1642 being transitioned from a first state to a second state (e.g., becoming fully wet, as described in detail above). In other embodiments, the diaphragm 1676 can transition before or after the flow controller 1642 transitions from the first state to the second state. In still other embodiments, the control device 1600 need not include a flow controller 1642, but rather the diaphragm 1676 can be configured to transition in response to exposure to a negative pressure differential generated by a fluid collection device. In some such embodiments, the diaphragm 1676 (and / or at least a portion thereof) can be configured to act in a manner similar to the flow controller 1642 by transitioning from a first state to a second state in a predictable and / or predetermined manner after exposure to a predetermined negative pressure differential or a predetermined rate of negative pressure change. Additionally, the transition of the diaphragm 1676 can be automatic (e.g., not due to user intervention).

[0211] As shown in FIG. 52, when the diaphragm 1676 is shifted, moved, flipped, etc., the pin 1677 can move within the housing 1630 and relative to the actuator rod 1662. More specifically, the transition of the diaphragm 1676 can move the pin 1677 an amount sufficient to disengage the pin 1677 from the actuator rod 1662. Thus, the energy storage member 1667 (e.g., a spring) can be configured to release and / or convert at least a portion of its potential energy. As a specific example, in this embodiment, the movement of the pin 1677 can expand the spring 1667 from a first state or compressed state to a second state or substantially uncompressed state. The transition of the energy storage member 1667 (e.g., a spring) from a first state to a second state moves the actuator rod 1662 within the actuator portion 1639 from a first state and / or position to a second state and / or position.

[0212] 52 , when the actuator rod 1662 is in the second state and / or position, the first seal 1665 can be positioned in a second or subsequent position where the first seal 1665 isolates the isolation chamber 1634 from the inlet 1631. Similarly, the second seal 1666 can be positioned in a second or subsequent position where it is pressed against the sealing surface 1640 (e.g., by the energy storage member 1667), thereby isolating the flow controller 1642 from the fluid flow path 1654. Further, when the actuator rod 1662 is in the second state and / or position, the first seal 1665 and the second seal 1666 are positioned such that the fluid flow path 1633 is disposed in fluid communication with the fluid flow path 1654. Thus, a negative pressure differential generated by a fluid collection device coupled to outlet 1636 may be operable to draw a subsequent volume of bodily fluid from inlet 1631, through fluid flow paths 1633 and 1654, through outlet 1636, and into the liquid collection device. Furthermore, by collecting and isolating an initial volume of bodily fluid, as described in detail above, a subsequent volume of bodily fluid that is substantially free of contaminants can be obtained.

[0213] 53, a flow chart is shown illustrating a method 10 of obtaining a bodily fluid sample with reduced contamination using a fluid control device, according to one embodiment. The fluid control device may be similar and / or substantially the same as any of the fluid control devices described in detail above. The method 10 includes, at step 11, enabling fluid communication between a source of bodily fluid and an inlet of a fluid collection device. For example, in some embodiments, a user may manipulate the fluid control device to physically and / or fluidly couple the inlet to an intraluminal containing device (e.g., a needle, IV, PICC line, etc.) that is in fluid communication with a patient.

[0214] At step 12, a fluid collection device is coupled to the outlet of the fluid control device. As described in detail above, coupling the fluid collection device to the outlet is configured to generate a negative pressure differential within at least a portion of the fluid control device. In some embodiments, for example, the fluid collection device may be a sample bottle or container that defines a negative pressure. In other embodiments, the fluid collection device may be a syringe or the like that can be operated to generate a negative pressure. Thus, a negative pressure differential may be generated within one or more portions of the fluid control device, as described above with reference to control devices 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, and / or 1600.

[0215] At step 13, an initial volume of bodily fluid is received from the inlet into the isolation portion of the fluid control device in response to a negative pressure differential. For example, in some embodiments, the isolation portion may be similar to and / or substantially the same as isolation chamber 1234 described above with reference to FIGS. 29-34. In other embodiments, the isolation portion may be similar to and / or substantially the same as isolation chamber 1634. In still other embodiments, the isolation portion may be similar to and / or substantially the same as any of the isolation chambers described herein. Additionally, in some instances, the initial volume of bodily fluid may have contaminants entrained therein that may otherwise cause erroneous results during testing of the bodily fluid sample.

[0216] In step 14, in response to contacting at least a portion of the initial volume of bodily fluid, the flow controller disposed in the isolation portion is transitioned from a first state in which the flow controller allows gas to flow through the flow controller and prevents the flow of bodily fluid through the flow controller to a second state in which the flow controller prevents the flow of gas and bodily fluid through the flow controller. For example, in some embodiments, the flow controller can be a selectively permeable member or membrane (e.g., a fluid or blood barrier and / or the like) as described above with reference to flow controller 242. In other embodiments, the flow controller can be similar and / or substantially the same as any of the flow controllers described herein. Thus, in some embodiments, contacting at least a portion of the initial volume of bodily fluid can, for example, wet or saturate the flow controller such that the flow controller limits and / or substantially prevents the flow of gas and liquid (e.g., bodily fluid) therethrough. In other embodiments, the flow controller can be a bladder and / or a diaphragm configured to transition in response to a negative pressure differential. For example, in such an embodiment, the flow controller may be a substantially impermeable bladder or diaphragm that can transition from a first state to a second state when a negative pressure differential applied across a surface of the bladder and / or diaphragm exceeds a negative pressure threshold.

[0217] In step 15, after the flow controller transitions to the second state, the initial volume of bodily fluid is sequestered within the isolation portion. For example, in some embodiments, the fluid control device may include an actuator and / or any other suitable feature or mechanism configured to transition after the flow controller is positioned in its second configuration and sequesters the initial volume of bodily fluid. In some embodiments, the actuator may transition from the first state to the second state to automatically sequester the initial volume of bodily fluid within the isolation portion, e.g., as described above with reference to actuator 1650. In other embodiments, the actuator may transition from the first state to the second state in response to a user-applied force, e.g., as described above with reference to actuator 850. In still other embodiments, the fluid control device may sequester the initial volume of bodily fluid within the isolation portion in any suitable manner, such as those described herein.

[0218] In step 16, after isolating the initial volume of bodily fluid, a subsequent volume of bodily fluid is transferred from the inlet through the outlet and into the fluid collection device. As described in detail above, in some instances, isolating the initial volume of bodily fluid within an isolation portion of the fluid control device can similarly isolate contaminants contained in the initial volume. Thus, contaminants in subsequent volumes of bodily fluid can be reduced or substantially eliminated.

[0219] While various embodiments have been described above, it should be understood that they are presented by way of example only and not by way of limitation. Where the schematic diagrams and / or embodiments described above show particular components disposed in particular orientations or positions, the placement of the components can be modified. Although the embodiments have been specifically shown and described, it should be understood that various changes in form and detail can be made. For example, although control devices 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, and / or 1500 have been described as transferring bodily fluids into the device as a result of negative pressure in the fluid collection device, in other embodiments, the devices described herein can be used with any suitable device configured to establish a pressure differential (e.g., a negative pressure differential). For example, in some embodiments, the outlet of the control device can be coupled to a syringe or a pump. In other embodiments, the control device may include a pre-charged isolation chamber, an exhaust isolation chamber, a manual activation device configured to generate a negative pressure, an energy source (e.g., a chemical energy source, a kinetic energy source, and / or the like), and / or any other suitable means for defining and / or creating a pressure differential within a portion of the control device. Additionally, as described above, the control device may be coupled to such a collection device by a user (e.g., a doctor, nurse, technician, physician, etc.) or may be coupled or assembled during manufacture. In some embodiments, pre-assembling the control device and collection device (e.g., a sample container or syringe) may enforce compliance with a sample acquisition protocol that calls for, for example, isolation of an initial volume of bodily fluid prior to collecting a sample volume of the bodily fluid.

[0220] While some of the embodiments described above include flow controllers and / or actuators having specific configurations and / or arrangements, in other embodiments, the fluid control device can include any suitable flow controller and / or actuator configured to selectively control the flow of bodily fluid through one or more portions of the fluid control device. For example, some embodiments include an actuator, such as a septum having one or more seals arranged as an O-ring or elastic overmold that is moved against the septum and a portion of the device (e.g., the inlet, the outlet, or any other suitable portion) when the septum transitions or flips from a first state to a second state, while in other embodiments, the fluid control device can include one or more seals having any suitable configuration. For example, in some embodiments, the fluid control device can include one or more seals arranged as an elastic sheet fixedly coupled to a portion of the control device. In such embodiments, a portion of the actuator, such as a pin or rod extending from the septum (see, e.g., FIGS. 11 and 12), extends through an opening defined in one or more elastic sheets, such that the elastic sheet forms a substantially fluid-tight seal with an outer surface of the pin or rod. Thus, when the actuator (e.g., a diaphragm) transitions from a first state to a second state, a portion of the actuator (e.g., a pin or rod) can move through one or more elastic sheets. In other words, a portion of the actuator moves relative to the one or more elastic sheets, whereby the elastic sheets remain in a substantially fixed position relative to a portion of the control device. In some embodiments, a detachable portion or portion of the actuator can allow fluid flow through an opening defined by the one or more elastic sheets that is blocked by a portion of the actuator. Thus, the one or more elastic sheets can function similarly to any of the seals described herein.Additionally, in some embodiments, such an arrangement can, for example, reduce the amount of friction associated with forming a desired fluid-tight seal, such that the fluid-tight seal can obviate the use of lubricants that might otherwise be used to facilitate movement of the seal within the control device.

[0221] Although the diaphragms (e.g., diaphragms 576, 676, and 776) are described herein as being configured to transition, move, reverse, and / or otherwise reconfigure in response to an amount of negative pressure applied on a surface of the diaphragm that exceeds a negative pressure threshold, in other embodiments, the fluid control device can include any suitable actuator or the like configured to transition, move, reverse, and / or otherwise reconfigure in response to exposure to a desired and / or predetermined amount of negative pressure. For example, in some embodiments, the fluid control device can include an actuator including and / or arranged to include a movable member, plug, plunger, occlusion member, seal, and / or the like configured to selectively control the flow of fluid through at least a portion of the fluid control device. More specifically, the movable member or the like can be transitioned from a first state and / or position in which the movable member or the like is provided and / or otherwise occluding an opening, to a second state and / or position in which the movable member or the like is removed from the opening. In such embodiments, negative pressure can be applied through a portion of the device to transition, for example, an initial volume of bodily fluid into an isolation portion and / or chamber.

[0222] As described in detail above, in some embodiments, the device may include a flow controller, such as a selectively permeable member or membrane, that may be configured to transition from a first state to a second state in response to being wetted (or otherwise transitioned) by an initial volume of bodily fluid. After transferring the initial volume of bodily fluid, and after the flow controller transitions to its second state, the amount of negative pressure exerted on a surface, such as the movable member, may increase until the magnitude of the negative pressure is sufficient to draw or displace the movable member from the opening, thereby allowing the flow of bodily fluid through an opening otherwise blocked by the movable member. In this manner, the movable member may function similarly to any of the diaphragms described herein (e.g., diaphragms 576, 676, and / or 776) that are configured to transition or reverse from a first state to a second state. In such embodiments, the movable member may be, for example, an elastic plug, a cork, a plunger, and / or any other suitable member that may be displaced or "unplugged" from such opening or portion of the flow path.

[0223] While some of the embodiments described above include a flow controller and / or actuator that selectively establishes fluid communication between the isolation chamber and a fluid collection device (e.g., a sample reservoir, a syringe, and / or any other suitable negative pressure source), in other embodiments, the control device can be arranged to transfer a flow of bodily fluid in response to a negative pressure differential arising from any suitable portion(s) of the device. For example, while the control device 200 is described above as including a flow controller 242 and a restricted flow path 232 that selectively places the isolation chamber 234 in fluid communication with the sample reservoir until the flow controller 242 is transitioned to a sealed or closed state (e.g., until the flow controller 242 is sufficiently wetted), in other embodiments, the control device can include an isolation chamber that is a pre-sealed vacuum chamber and / or a charging chamber such that establishing fluid communication between the inlet and the isolation chamber creates a negative pressure differential sufficient to draw an initial volume of bodily fluid into the isolation chamber. In such embodiments, the control device can be configured to transfer bodily fluid to the isolation chamber until the pressure differential is sufficiently reduced and / or the pressures are otherwise substantially equal. Further, in some such embodiments, the isolation chamber and / or the inlet can include a coupler, actuator, needle, septum, port, and / or any other suitable member capable of establishing fluid communication therebetween (e.g., capable of transitioning the isolation chamber from a sealed configuration to an unsealed configuration).

[0224] While some of the embodiments described above include a flow controller and / or actuator that physically and / or mechanically isolates one or more portions of the fluid control device, in other embodiments, the fluid control device need not physically and / or mechanically isolate one or more portions of the fluid control device. For example, in some embodiments, an actuator such as actuator 1250 may be transitioned from a first state in which an initial volume of bodily fluid may flow from an inlet to an isolated chamber or portion to a second state in which (1) the isolated chamber or portion is physically and / or mechanically isolated and (2) the inlet is in fluid communication with an outlet of the fluid control device. However, in other embodiments, the actuator and / or any other suitable portion of the fluid control device may be transitioned from a first state in which an initial volume of bodily fluid may flow from an inlet to an isolated chamber or portion to a second state in which the inlet is disposed in fluid communication with the outlet without physically and / or mechanically isolating (or isolating) the isolated chamber or portion. When such a control device is in a second state, one or more features and / or shapes of the control device can cause preferential flow of bodily fluid from the inlet to the outlet, and an initial volume of bodily fluid can remain in the isolation chamber or portion without being physically and / or mechanically isolated or separated.

[0225] Although the restricted flow path 232 is described above as regulating and / or controlling the amount of negative pressure applied to or through at least a portion of the device 200, in other embodiments, the control device may include any suitable features, mechanisms, and / or devices configured to regulate, create, and / or otherwise control one or more pressure differentials through at least a portion of the control device. For example, in some embodiments, a user may shift and / or move an actuator to change the size (e.g., shrink or enlarge) of one or more portions of a fluid flow path or fluid flow interface within a portion of the control device to manually adjust and / or otherwise control the amount or magnitude of negative pressure within one or more portions of the control device.

[0226] Although various embodiments are described as having certain combinations of features, concepts, and / or components, other embodiments can have any combination or subcombination of any features, concepts, and / or components from any of the embodiments described herein. For example, as described above, device 700 includes concepts, features, and / or elements of devices 200 and 600. As another example, any of the embodiments described herein can include a lock or other suitable feature configured to at least temporarily maintain one or more components in a desired position, state, arrangement, and / or configuration. As another example, any of the embodiments described herein can include and / or define an isolation chamber and / or isolation portion configured similarly to, for example, isolation chamber 1234 described above with reference to FIG. 30. In other words, any of the fluid control devices described herein can include an isolation chamber arranged and / or formed as a channel. In some embodiments, as described above with reference to isolation chamber 1234, the channel forming at least a portion of the isolation chamber can have a relatively small cross-sectional shape and / or size that can reduce and / or substantially prevent mixing of air and bodily fluid when an initial volume of bodily fluid is drawn into the channel. Moreover, such channels may have a helical shape and / or configuration similar to the isolation chamber 1234 described above and / or may have any other suitable shape and / or configuration.

[0227] As another example, as described above with reference to flow controller 242, for example, any of the control devices described herein can include a flow controller arranged as a selectively permeable member or membrane. More specifically, while control device 600 is not described as including a flow controller, in other embodiments, a portion of diaphragm 676 can include and / or form a flow controller formed at least in part of a selectively permeable material. In such embodiments, the flow controller can be configured to evacuate a volume of isolation chamber and / or portion 634 in response to exposure to a negative pressure differential (as described above). In other words, a volume of air can be drawn (e.g., evacuated or purged from) isolation chamber 634 via the flow controller in response to a negative pressure differential within a portion of fluid control device 600. In some examples, such an arrangement can enable a reduction in the size and / or volume of isolation chamber 634, as a volume of air that would otherwise occupy a portion of isolation chamber 634 is evacuated or purged through the flow controller in response to a negative pressure differential.

[0228] As another example, any of the embodiments described herein may include any suitable actuator and / or flow controller configured to selectively control the flow of fluid through at least a portion of the device. In particular, the flow controller or the like may be one or more of a selectively permeable material or membrane, a valve, a diaphragm, and / or any other suitable flow controller. While some of the embodiments are described as including an actuator rod configured to be transitioned from a first configuration or position to a second configuration or position (e.g., actuator rod 1262 of actuator 1250), in other embodiments, any actuator described herein may include an actuator rod configured to transition between a first position and a second position to at least temporarily isolate an outlet of the device from one or more other portions of the device (e.g., as described above with reference to actuators 850 and / or 1350). In some embodiments, such actuators may be configured for use with a given and / or predetermined collection device, such as, for example, a syringe. In other embodiments, such actuators may be used with any suitable collection device.

[0229] In some embodiments, the specific configuration of the various components may also be changed. For example, the size and specific shape of the various components may vary from the illustrated embodiments while still providing functionality as described herein. For example, while in FIGS. 45-50 the actuator body 1551, the isolation chamber 1534, and / or a portion of the bladder 1578 are shown as being substantially tubular with circular or substantially semicircular ends, in other embodiments the actuator body 1551, the isolation chamber 1534, and / or the bladder 1578 may have any suitable shape and / or size. In some embodiments, the size and / or shape of such components may be altered to reduce the overall size of the device 1500 and / or improve the ergonomics of the device 1500 without changing the functionality of the device 1500. As a specific example, the housing, the isolation chamber, and / or the bladder may have a substantially cylindrical shape with relatively flat ends, etc. Additionally, in some embodiments, the control device may include a bladder configured to "invert" in response to exposure to a negative pressure differential, similar to the diaphragm described above. In other embodiments, the bladder can be configured to gradually transition (e.g., stretch, open, unfold, and / or otherwise reconfigure) from the first state to the second state. In some examples, controlling the rate at which the bladder transitions can allow for regulation and / or control of the negative pressure differential created within the isolation chamber.

[0230] In other embodiments, the device can include a bladder (similar in form and / or function to bladder 1478 and / or 1578) disposed within a housing having a size, shape, and / or profile similar to housing 1230 and / or 1330. In some such embodiments, the bladder can define a volume that is similar in shape and / or size, overall size, and / or shape to the housing (e.g., cylindrical with a relatively low profile or height). In some examples, such an arrangement can leave at least a portion of the initial volume of bodily fluid in contact with a surface of the bladder (or diaphragm or other actuator), and the bladder can provide a visual indication to the user regarding the bodily fluid being transferred into the isolation chamber. In other embodiments, a housing similar to housing 1230 can define a spiral channel or any other suitable channel and can include a bladder disposed within at least a portion of the channel. In such embodiments, the bladder can function similar to bladder 1578, where the bladder expands, opens, and / or otherwise increases in volume in response to exposure to a negative pressure differential. In some embodiments, the bladder can define an enclosed volume configured to receive an initial volume of bodily fluid. In other embodiments, the bladder and a portion of the housing (e.g., surfaces defining the isolation chamber and / or channel) can collectively define a volume configured to receive an initial volume of bodily fluid. In this manner, the fluid control device can include a bladder configured to conform to any suitable shape, feature, channel, and / or configuration of the housing in which the bladder is provided. In some embodiments, the sizes and shapes of the various components can be specifically selected for a desired rate and / or volume of flow of bodily fluid into the fluid reservoir.

[0231] In some embodiments, the size and / or shape of the various components can be specifically selected for a desired or intended use. For example, in some embodiments, a device such as those described herein can be configured for use with or on an apparently healthy adult patient. In such embodiments, the device can include an isolation chamber having a first volume (e.g., about 0.5 ml to about 5.0 ml). In other embodiments, a device such as those described herein can be configured for use with or on, for example, a critically ill patient and / or a pediatric patient. In such embodiments, the device can include an isolation chamber having a second volume that is less than the first volume (e.g., less than about 0.5 ml). Thus, it should be understood that the size, shape, and / or arrangement of the embodiments and / or components thereof can be adapted for a given application unless the context explicitly dictates otherwise.

[0232] Although not shown, any of the devices described herein may include an opening, port, coupler, septum, Luer-Lok, gasket, valve, threaded connector, standard fluid interface, etc. (referred to as a "port" for simplicity) that allows fluid communication with the isolation chamber. In some such embodiments, the port may be configured to couple to any suitable device, reservoir, pressure source, etc. For example, in some embodiments, the port may be configured to couple to a reservoir, which allows the reservoir to divert and / or transfer a greater amount of bodily fluid into the isolation chamber. In other embodiments, the port may be coupled to a negative pressure source, such as a vacuum vessel, pump, syringe, and / or the like, to collect a portion or the entire volume of bodily fluid in the isolation chamber, channel, reservoir, etc., and use that volume of bodily fluid (e.g., a pre-test volume) for purposes of additional clinical and / or in vitro diagnostic testing. In other embodiments, the port can be configured to receive a probe, sampling instrument, testing device, and / or the like that can be used to perform one or more tests on the initial volume (e.g., tests that are not sensitive to potential contamination) while the initial volume is provided or isolated within the isolation chamber. In still other embodiments, the port can be coupled to any suitable pressure source or infusion device configured to reinfuse the initial volume of bodily fluid isolated within the isolation chamber into the patient and / or bodily fluid source (e.g., in the case of pediatric patients, critically ill patients, patients with low blood volume, and / or the like). In other embodiments, the isolation channel, chamber, and / or reservoir can be configured with the addition of other diagnostic testing components (e.g., paper tests) integrated within the chamber such that the initial bodily fluid is used for its testing.

[0233] In yet other embodiments, the isolation chambers, channels, and / or reservoirs can be designed, sized, and configured to be removable, compatible with testing equipment, and / or specifically accessible to other types of bodily fluid testing typically performed on patients with suspected conditions. By way of example, patients suspected of sepsis typically have blood samples taken for lactate testing, procalcitonin testing, and blood culture testing. All of the fluid control devices described herein can be configured such that the isolation chambers, channels, reservoirs, etc. can be removed (e.g., after receiving an initial volume of bodily fluid), and the bodily fluid contained therein can be used for these additional testing purposes before or after a subsequent sample is collected for microbiological testing.

[0234] Although not shown, in some embodiments, the fluid control device may include one or more lumens, channels, flow paths, etc. configured to selectively allow a "bypass" flow of bodily fluid, where an initial amount or volume of bodily fluid may flow from an inlet, through a lumen, channel, flow path, etc., bypassing the isolation chamber and into the collection device. In some embodiments, the fluid control device may include an actuator having, for example, at least three states, where in a first state, bodily fluid may flow from an inlet to an isolation chamber, in a second state, bodily fluid may flow from an inlet to an outlet after isolating an initial volume in the isolation chamber, and in a third state, bodily fluid may flow from an inlet through a bypass flow path to an outlet. In other embodiments, as described in detail above with reference to certain embodiments, the control device may include a first actuator configured to transition the device between a first state and a second state, and may include a second actuator configured to transition the device to a bypass configuration, etc. In still other embodiments, the control device may include any suitable device, feature, component, mechanism, actuator, controller, etc. configured to selectively position the fluid control device in a bypass configuration or state.

[0235] Any of the embodiments described herein may be used in conjunction with any suitable fluid transfer, collection, and / or storage device, such as, for example, the fluid reservoirs described in the '420 patent. In some examples, any of the embodiments described herein may be implemented using, for example, devices described in the '510 publication and / or other methods described in U.S. Patent Publication No. 2015 / 0246352, entitled "Apparatus and Methods for Disinfection of a Specimen Container," filed March 3, 2015; U.S. Patent No. 8,535,241, entitled "Fluid Diversion Mechanism for Bodily-Fluid Sampling," filed October 12, 2012; U.S. Patent No. 9,060,724, entitled "Fluid Diversion Mechanism for Bodily-Fluid Sampling," filed May 29, 2013; U.S. Patent No. 9,155,495, entitled "Syringe-Based Fluid Diversion Mechanism for Bodily-Fluid Sampling," filed December 2, 2013; U.S. Patent No. 9,155,495, entitled "Devices and Methods for Disinfection of a Specimen Container," filed June 13, 2016; No. 2016 / 0361006, entitled "Systems and Methods for Sample Collection with Reduced Hemolysis," filed November 20, 2017; and / or U.S. Patent Publication No. 2018 / 0140240, entitled "Apparatus and Methods for Maintaining Sterility of a Specimen Container," filed September 6, 2016, the disclosures of each of which are incorporated herein by reference in their entireties.

[0236] In some embodiments, a method of using a fluid control device such as those described herein can include sequenced steps that allow fluid communication between a source of bodily fluid (e.g., a blood vessel of a patient) and an inlet of the fluid control device. An outlet of the fluid control device is then fluidly disposed with and / or otherwise engaged with a negative pressure source. Such a negative pressure source can be a sample reservoir, a syringe, a vacuum vessel, an intermediate transfer device, and / or the like. The fluid control device can be in a first state or mode of operation when the outlet is coupled to the negative pressure source such that a negative pressure differential is applied through the fluid control device that draws an initial volume of bodily fluid into an isolation chamber of the fluid control device. For example, negative pressure in the sample reservoir can be operable in drawing an initial volume of bodily fluid from the patient and into the isolation chamber. Once the initial volume of bodily fluid is provided in the isolation chamber, the fluid control device is transitioned from the first state or mode of operation to a second state or mode of operation, either automatically or via user intervention, such that (1) the initial volume is isolated in the isolation chamber and (2) fluid communication is established between the inlet and the outlet. The initial volume can be isolated such that any contaminants entrained in the flow of the initial volume are similarly isolated within the isolation chamber. With the initial volume of bodily fluid isolated within the isolation chamber and with fluid communication established between the inlet and the outlet, a subsequent volume of substantially uncontaminated bodily fluid can be collected in one or more sample reservoirs.

[0237] Although the method of using the fluid control device is expressly described as including the recited ordered steps, in other embodiments, the order of certain events and / or procedures in any of the methods or processes described herein may be modified, and such modifications are in accordance with variations of the present invention. In addition, certain events and / or procedures may be performed simultaneously in a parallel process, and where possible, sequentially as described above. Certain steps may be partially completed or omitted before proceeding to a subsequent step. For example, while the device is described herein as transitioning from a first state to a second state, such as with a discrete operation, it should be understood that the device described herein may be configured to transition from the first state to the second state automatically and / or passively, and such transition may occur over a period of time. In other words, the transition from the first state to the second state may be relatively gradual, such that in some examples, the housing begins to transition from the first state to the second state when the last of the initial volume of bodily fluid is being transferred into the isolation chamber. In some examples, the rate of change when transitioning from the first state to the second state may be selectively controlled to achieve one or more desirable characteristics associated with the transition. Moreover, in some such instances, the entry of the final portion of the initial volume can limit and / or substantially prevent bodily fluid already disposed within the isolation chamber from escaping therefrom. Thus, the transition from the first state to the second state can occur over a period of time, but the isolation chamber can still isolate the volume of bodily fluid disposed therein.

Claims

1. A blood control device, comprising: a housing having an inlet and an outlet, the inlet being fluidly connectable to a patient and the outlet being fluidly connectable to a blood collection device, the housing forming at least a portion of a containment flow path and a collection flow path between the inlet and the outlet; an air permeable, blood impermeable, selectively permeable blood barrier disposed within the housing between the containment flow path and the outlet; a movable plug disposed within the housing and configured to block a flow path between the inlet and the outlet through the collection flow path when the movable plug is in a first position; the selectively permeable blood barrier allows air to flow through the selectively permeable blood barrier in response to a negative pressure differential between the inlet and the outlet, thereby allowing a volume of blood to enter the containment flow path; The selectively permeable blood barrier is configured, in response to contact with the volume of blood in the containment flow path, to create a negative pressure differential in at least a portion of the collection flow path between the movable stopper and the outlet sufficient to move the movable stopper from the first position to a second position in which the movable stopper allows blood to flow through the collection flow path to the outlet.

2. 2. The blood control device of claim 1, wherein the blood collection device is a syringe configured to be fluidly coupled to the outlet and then manipulated to create the negative pressure differential between the inlet and the outlet.

3. 2. The blood control device of claim 1, wherein the blood collection device is a sample vial that is at least partially evacuated and configured to create the negative pressure differential between the inlet and the outlet when fluidly coupled to the outlet.

4. The blood control device of claim 3 , wherein the housing forms a flow path between the containment flow path and the outlet, at least a portion of the flow path being configured to regulate the negative pressure differential between the inlet and the outlet when a volume of the blood is drawn into the containment flow path.

5. 2. The blood control device of claim 1, wherein the movable plug in the second position is configured to allow blood to flow from the patient through the collection channel to the outlet while at least a portion of the volume of the blood is contained in the containment channel.

6. The blood control device of claim 1 , wherein the movable bung is formed from an elastomeric material.

7. The blood control device of claim 1 , wherein the negative pressure differential in at least a portion of the collection flow path between the movable plug and the outlet exerts a force on a surface of the movable plug to move the movable plug to the second position.

8. The blood control device of claim 1 , wherein the movable bung is configured to be at least temporarily maintained in the second position.

9. The blood control device of claim 1 , wherein at least a portion of the movable plug is disposed within the collection flow channel when the movable plug is in at least one of the first position and the second position.

10. The blood control device of claim 1 , wherein the movable bung is configured to move from the first position to the second position by the negative pressure differential without manual intervention.

11. A blood control device comprising: a housing having an inlet and an outlet, the housing defining at least a portion of each of a containment flow path and a collection flow path between the inlet and the outlet; a selectively permeable, air-permeable, blood-impermeable blood barrier disposed within the housing between the containment flow path and the outlet, the blood barrier configured to allow air to flow from the containment flow path to the outlet in response to a negative pressure differential between the inlet and the outlet such that a volume of blood flows from the inlet to the containment flow path; a movable stopper disposed within the housing between at least a portion of the collection flow path and the inlet when in a first position, the movable stopper configured to prevent a volume of blood from flowing from the inlet to the outlet, the movable stopper configured to move from the first position to a second position in response to an increase in a negative pressure differential between the movable stopper and the outlet due to a volume of blood in the containment flow path such that a subsequent volume of blood is collected at the outlet from the inlet through the collection flow path.

12. The blood control device of claim 11 , wherein the inlet is fluidly connectable to a patient and the outlet is fluidly connectable to a syringe, and wherein operation of the syringe generates the negative pressure differential between the inlet and the outlet.

13. the inlet is fluidly connectable to a patient; The blood control device of claim 11 , wherein the outlet is fluidly coupleable to an at least partially evacuated sample vial to generate the negative pressure differential between the inlet and the outlet.

14. The blood control device of claim 13, further comprising a flow path between a proximal end portion of the containment channel and the outlet, at least a portion of the flow path configured to regulate the negative pressure differential between the inlet and the outlet when the volume of blood is drawn into the containment channel.

15. The blood control device of claim 11, wherein the movable plug in the second position is configured to draw the subsequent volume of blood through the collection channel from the inlet to the outlet while at least a portion of the volume of blood is contained in the containment channel.

16. The blood control device of claim 11 , wherein the movable bung is formed from an elastomeric material.

17. The blood control device of claim 11 , wherein the negative pressure differential in at least a portion of the collection flow path between the movable plug and the outlet exerts a force on a surface of the movable plug to move the movable plug to the second position.

18. The blood control device of claim 11 , wherein the movable bung is configured to be at least temporarily maintained in the second position.

19. The blood control device of claim 11 , wherein at least a portion of the movable plug is disposed within the collection flow channel when the movable plug is in at least one of the first position and the second position.

20. The blood control device of claim 11 , wherein the movable bung is configured to move from the first position to the second position by the negative pressure differential without manual intervention.

21. A blood control device comprising: a housing having an inlet and an outlet, the housing defining at least a portion of a containment flow path and a collection flow path between the inlet and the outlet; an air permeable, blood impermeable, selectively permeable blood barrier disposed within the housing between the containment flow path and the outlet; a movable plug disposed within the housing between at least a portion of the collection flow path and the inlet when in a first position; the selectively permeable blood barrier is configured to allow air to flow from the containment flow path to the outlet in response to a first negative pressure differential between the inlet and the outlet such that a volume of blood flows into the containment flow path; A blood control device, wherein the movable stopper is configured to move from a first position to a second position in response to a second pressure differential between the movable stopper and the outlet resulting from the flow of the volume of blood into the containment flow path, the second pressure differential being greater than the first negative pressure differential, the movable stopper in the first position configured to prevent the volume of blood from flowing from the inlet through the collection flow path to the outlet, and the movable stopper in the second position configured to allow a subsequent volume of blood to flow from the inlet through the collection flow path to the outlet.

22. 22. The blood control device of claim 21, wherein the inlet is fluidly connectable to a patient and the outlet is fluidly connectable to a syringe, operation of the syringe generating the negative pressure differential between the inlet and the outlet.

23. the inlet is fluidly connectable to a patient; 22. The blood control device of claim 21, wherein the outlet is fluidly coupleable to an at least partially evacuated sample vial to generate the negative pressure differential between the inlet and the outlet.

24. 24. The blood control device of claim 23, further comprising a flow path between a proximal end portion of the containment channel and the outlet, at least a portion of the flow path configured to regulate the negative pressure differential between the inlet and the outlet when the volume of blood is drawn into the containment channel.

25. 22. The blood control device of claim 21, wherein the movable plug in the second position is configured to draw the subsequent volume of blood through the collection channel from the inlet to the outlet while at least a portion of the volume of blood is contained in the containment channel.

26. The blood control device of claim 21 , wherein the movable bung is formed from an elastomeric material.

27. 22. The blood control device of claim 21, wherein the negative pressure differential in at least a portion of the collection flow path between the movable plug and the outlet exerts a force on a surface of the movable plug to move the movable plug to the second position.

28. The blood control device of claim 21 , wherein the movable bung is configured to be at least temporarily maintained in the second position.

29. 22. The blood control device of claim 21, wherein at least a portion of the movable plug is disposed within the collection flow channel when the movable plug is in at least one of the first position and the second position.

30. 22. The blood control device of claim 21, wherein the movable bung is configured to move from the first position to the second position by the negative pressure differential without manual intervention.

31. A blood control device comprising: a housing having an inlet and an outlet, the inlet being fluidly connectable to a patient and the outlet being fluidly connectable to a blood collection device, the housing forming at least a portion of a containment flow path and a collection flow path between the inlet and the outlet; a selectively permeable blood barrier at a proximal end portion of the containment flow path proximate the outlet, the blood barrier configured to allow air to flow from the containment flow path to the outlet in response to a negative pressure differential between the inlet and the outlet such that a volume of blood flows from the patient into the containment flow path; a movable stopper between a portion of the containment flow path and the collection flow path, the movable stopper configured to move from a first position to a second position in response to a negative pressure differential in at least a portion of the collection flow path between the movable stopper and the outlet exceeding a threshold pressure due to the volume of blood in the containment flow path, and configured to block a distal end portion of the collection flow path when the movable stopper is in the first position and not in the second position that allows blood to flow from the patient through the collection flow path to the outlet.

32. 32. The blood control device of claim 31 , wherein the blood collection device is a syringe configured to be fluidly coupled to the outlet and then manipulated to create the negative pressure differential between the inlet and the outlet.

33. 32. The blood control device of claim 31 , wherein the blood collection device is a sample vial that is at least partially evacuated and configured to create the negative pressure differential between the inlet and the outlet when fluidly coupled to the outlet.

34. 34. The blood control device of claim 33, wherein the housing forms a flow path between the proximal end portion of the containment flow path and the outlet, at least a portion of the flow path being configured to regulate the negative pressure differential between the inlet and the outlet when a volume of the blood is drawn into the containment flow path.

35. 32. The blood control device of claim 31, wherein the movable plug in the second position is configured to allow blood to flow from the patient through the collection channel to the outlet while at least a portion of the volume of the blood is contained in the containment channel.

36. The blood control device of claim 31 , wherein the movable bung is formed from an elastomeric material.

37. 32. The blood control device of claim 31, wherein the negative pressure differential in at least a portion of the collection flow path between the movable plug and the outlet exerts a force on a surface of the movable plug to move the movable plug to the second position.

38. The blood control device of claim 31 , wherein the movable bung is configured to be at least temporarily maintained in the second position.

39. 32. The blood control device of claim 31, wherein at least a portion of the movable plug is disposed within the collection flow channel when the movable plug is in at least one of the first position and the second position.

40. 32. The blood control device of claim 31, wherein the movable bung is configured to move from the first position to the second position by the negative pressure differential without manual intervention.

41. A blood control device comprising: a housing having an inlet and an outlet, the inlet being fluidly connectable to a patient and the outlet being fluidly connectable to a blood collection device, the housing forming at least a portion of a containment flow path and a collection flow path between the inlet and the outlet; a selectively permeable blood barrier at a proximal end portion of the containment flow path proximal to the outlet, the blood barrier being configured to allow air to flow from the containment flow path to the outlet in response to a negative pressure differential between the inlet and the outlet such that a volume of blood flows from the patient into the containment flow path; a movable stopper disposed within the housing, the movable stopper configured to move from a first position to a second position in response to a negative pressure differential in at least a portion of the collection flow path between the movable stopper and the outlet exceeding a threshold pressure due to the volume of the blood in the containment flow path, the movable stopper in the first position configured to prevent blood from flowing through the collection flow path from the inlet to the outlet, and the movable stopper in the second position configured to allow blood to flow from a patient through the collection flow path to the outlet.

42. The blood control device of claim 41 , wherein the movable plug is disposed between a portion of the containment channel and the collection channel.

43. 42. The blood control device of claim 41, wherein the movable plug in the first position is configured to block a distal end portion of the collection channel.

44. 42. The blood control device of claim 41, wherein the movable plug in the second position is configured to allow blood to flow from the patient through the collection channel to the outlet while at least a portion of the volume of the blood is contained in the containment channel.

45. The blood control device of claim 41 , wherein the movable bung is formed from an elastomeric material.

46. 42. The blood control device of claim 41, wherein the negative pressure differential in at least a portion of the collection flow path between the movable plug and the outlet exerts a force on a surface of the movable plug to move the movable plug to the second position.

47. The blood control device of claim 41 , wherein the movable bung is configured to be at least temporarily maintained in the second position.

48. 42. The blood control device of claim 41, wherein at least a portion of the movable plug is disposed within the collection channel when the movable plug is in at least one of the first position and the second position.

49. 42. The blood control device of claim 41, wherein the movable bung is configured to move from the first position to the second position by the negative pressure differential without manual intervention.

50. A blood control device comprising: a contained flow path formed between an inlet and an outlet of the blood control device; A collection channel formed between the inlet and the outlet; a selectively permeable blood barrier at a proximal end portion of the containment flow path proximate the outlet, the blood barrier being configured to allow air to flow from the containment flow path to the outlet in response to a negative pressure differential between the inlet and the outlet such that a volume of blood flows from a patient through the inlet into the containment flow path; a movable stopper between a portion of the containment flow path and the collection flow path, the movable stopper in a first position configured to prevent the blood from flowing from the inlet through the collection flow path to the outlet, the movable stopper moving to a second position in response to a negative pressure differential in at least a portion of the collection flow path between the movable stopper and the outlet exceeding a threshold pressure due to a volume of the blood in the containment flow path, the movable stopper in the second position configured to allow the blood to flow from a patient through the collection flow path to the outlet.

51. 51. The blood control device of claim 50, wherein the inlet is fluidly connectable to a patient and the outlet is fluidly connectable to a syringe, operation of the syringe generating the negative pressure differential between the inlet and the outlet.

52. the inlet is fluidly connectable to a patient; 51. The blood control device of claim 50, wherein the outlet is fluidly coupleable to an at least partially evacuated sample vial to generate the negative pressure differential between the inlet and the outlet.

53. 53. The blood control device of claim 52, further comprising a flow path between a proximal end portion of the containment channel and the outlet, at least a portion of the flow path configured to regulate the negative pressure differential between the inlet and the outlet when the volume of blood is drawn into the containment channel.

54. 51. The blood control device of claim 50, wherein the movable plug in the second position is configured to allow blood to flow from the patient through the collection channel to the outlet while at least a portion of the volume of the blood is contained in the containment channel.

55. The blood control device of claim 50 , wherein the movable bung is formed from an elastomeric material.

56. 51. The blood control device of claim 50, wherein the negative pressure differential in at least a portion of the collection flow path between the movable plug and the outlet exerts a force on a surface of the movable plug to move the movable plug to the second position.

57. The blood control device of claim 50 , wherein the movable bung is configured to be at least temporarily maintained in the second position.

58. 51. The blood control device of claim 50, wherein at least a portion of the movable plug is disposed within the collection flow channel when the movable plug is in at least one of the first position and the second position.

59. 51. The blood control device of claim 50, wherein the movable bung is configured to move from the first position to the second position by the negative pressure differential without manual intervention.

Citation Information

Patent Citations

  • Body fluids are diverted using a fluid diversion mechanism.

    JP2015519145A

  • Syringe type fluid diverting mechanism for body fluid sampling

    JP2016500278A

  • Blood sample optimization system and blood contaminant sequestration device and method

    US20170020427A1

  • Blood sampling assembly having porous vent means vein entry indicator

    US4207870A